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 ABSTRACT 
 B
ackground and A
im
s: P
oor adherence to inhaled corticosteroids is understood 
to be one of the largest contributors to problem
atic severe asthm
a in children  
(B
racken et al., 2009).  R
esearchers have sought to understand and target non-
adherence and assessm
ent of adherence is seen as crucial in this process.  
R
ecent research has cham
pioned electronic m
onitoring tools as the “gold 
standard” for accurately m
easuring adherence and these devices have been 
extensively evaluated (B
urgess, S
ly, D
evadason, 2011).  O
nly a sm
all am
ount 
of literature has considered how
 one experiences the process of adherence 
assessm
ent through electronic tools.  O
ne such device, the sm
art-inhaler has 
been introduced in the paediatric asthm
a team
 at the R
oyal B
rom
pton H
ospital.  
The proposed study aim
s to explore young people’s experiences of having their 
adherence to inhaled corticosteroids assessed through a sm
art-inhaler.  It w
ill 
also explore the experiences of their caregivers and healthcare professionals. 
 M
ethod: S
em
i-structured interview
s w
ere conducted w
ith eight young people 
w
ith asthm
a, aged 11-15, w
ho had been given a sm
art-inhaler as part of their 
care at the R
oyal B
rom
pton H
ospital, and eight of their caregivers.  A
 focus 
group w
ith seven healthcare professionals w
ho used the sm
art-inhalers in their 
practice w
as also carried out.  Interview
s w
ere analysed using a critical realist 
them
atic analysis. 
 R
esults: Three them
es w
ere identified: “they w
ere trying to help m
e get better”, 
“it’s clearly just to check up” and “w
ho is responsible?”.  They highlight the 
variety of perspectives and experiences participants had regarding the sm
art-
inhaler.  M
ore specifically the them
es highlighted the im
portance of participants’ 
priorities in influencing their experiences, the im
pact of the sm
art-inhaler on the 
healthcare relationship and on the transferring of responsibility for asthm
a to 
young people. 
 C
onclusions: 
The 
findings 
suggest 
that 
it 
is 
im
portant 
for 
healthcare 
professionals to engage in a shared decision-m
aking process w
ith their patients 
w
hen introducing healthcare interventions such as the sm
art-inhaler. 
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1. INTRODUCTION 
  This chapter aim
s to review
 the literature surrounding experiences of electronic 
adherence assessm
ent in chronic health conditions, w
ith a particular focus on 
the experiences of young people w
ith asthm
a.  I define a num
ber of key term
s, 
sum
m
arising som
e of the historical and theoretical context to these term
s and 
consider their relevance to healthcare.  I review
 the existing chronic health 
literature concerning electronic adherence assessm
ent and argue that further 
research is needed to consider the im
pact of electronic adherence assessm
ent 
on young people and their w
ider system
s.  In particular, I m
ake the argum
ent 
that further research is needed w
hich explores the beliefs young people hold 
about electronic adherence assessm
ent and the im
pact it has on their 
experiences of taking responsibility for their asthm
a self-care and of the 
healthcare relationship.  D
uring these discussions, I introduce a relatively new
 
adherence assessm
ent tool called the sm
art-inhaler [S
I], w
hich has been 
incorporated into clinical practice in the paediatric asthm
a team
 at the R
oyal 
B
rom
pton H
ospital [R
BH
], London.  Finally, I state the research questions for 
this study.  
 1.1. Literature Search 
 In order to collate the current research, a thorough literature search w
as 
conducted.  The term
s telehealth, telem
onitoring and electronic adherence 
assessm
ent w
ere paired w
ith other w
ords and phrases (e.g. asthm
a, chronic 
health conditions, young people, sm
art-inhaler, experiences, feasibility, 
acceptance, com
pliance etc.) and these search term
s w
ere entered into the 
follow
ing databases: PsychInfo, P
sychA
rticles, P
ubm
ed, S
cience D
irect, 
C
IN
A
H
L, W
iley O
nline Library and G
oogle S
cholar.  The search w
as lim
ited to 
w
ork w
ritten in the E
nglish language but included studies from
 across all 
countries.  A
ll dates w
ere covered in the search, although w
ith the focus of the 
study being on a relatively new
 area of healthcare (telehealth), the m
ajority of 
studies concentrating on this had been published since 2000.  A
cadem
ic 
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journals, review
s, dissertations and books/chapters w
ere included.  The search 
also included a review
 of key references of retrieved studies and books, internet 
searches and correspondence w
ith researchers.  A
ll studies deem
ed relevant to 
the research aim
s w
ere included (research w
hich had review
ed 
telem
onitoring/electronic adherence assessm
ent equipm
ent in chronic health 
conditions).  Papers adopting qualitative m
ethods and those carried out in the 
field of asthm
a w
ere prioritised for discussion in the literature review
 given the 
focus of this research being on peoples’ view
s and experiences of electronic 
adherence assessm
ent in asthm
a.  S
tudies that focused on adherence 
m
onitoring but that w
ere carried out in the field of m
ental health w
ere not 
included in the review
.  
 1.2. Definitions, Relevance to Healthcare and Theoretical Contributions  
 1.2.1. A
sthm
a  
A
sthm
a is a respiratory condition w
here there is inflam
m
ation of the air 
passages in the lungs.  This affects the sensitivity of the nerve endings in the 
airw
ays so they becom
e easily irritated.  In an attack, the lining of the passages 
sw
ells, causing the airw
ays to narrow
.  This reduces the flow
 of air in and out of 
the lungs (The W
orld H
ealth O
rganization, 2013).   A
sthm
a is often 
characterised by sym
ptom
s of coughing, w
heezing and breathlessness, 
how
ever these vary in severity and frequency from
 person to person (N
H
S
 
C
hoices, 2012a).   
 The W
orld H
ealth O
rganization (2013) estim
ates that 235 m
illion people suffer 
from
 asthm
a and state that it is the m
ost com
m
on chronic health condition in 
children.  H
ow
ever w
hilst com
m
on, asthm
a is also a very com
plex health 
condition and despite extensive investigation research has been unable to 
identify w
hat exactly causes asthm
a (N
ational A
sthm
a E
ducation & P
revention 
P
rogram
, 2007, N
H
S
 C
hoices, 2014).  Various factors have been identified as 
m
ediating the inflam
m
atory process; including both innate factors (such as our 
genetics and our gender) as w
ell as environm
ental factors, such as allergens 
(e.g. pets), viral respiratory infections (e.g. bronchiolitis/ influenza), exposure to 
irritants (e.g. tobacco sm
oke/ air pollution) and exercise (N
ational Asthm
a 
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E
ducation &
 P
revention P
rogram
, 2007).  P
sychological factors such as 
em
otions and stress levels are also view
ed as m
ediating factors in asthm
a 
(A
sthm
a U
K
, 2015a).  Taking into account the num
erous m
ediating factors, as 
w
ell as the heterogeneity in sym
ptom
 presentation from
 person to person, it is 
not surprising to learn that the diagnosis of asthm
a is not straightforw
ard and 
proves a com
plex challenge for healthcare professionals w
orking in the field 
(Jenkins et al., 1996, W
erk, Steinbach, A
dam
s &
 B
auchner, 2000).  
 A
sthm
a is argued to be the leading preventable cause of m
orbidity, m
ortality 
and healthcare cost w
orldw
ide (H
eaney &
 H
orne, 2012) and preventative 
m
edication is seen as the cornerstone of treatm
ent (B
urgess, S
ly &
 D
evadason, 
2011).  O
ne of the m
ost com
m
only prescribed m
edications for asthm
a is inhaled 
corticosteroids [IC
S
].  Taken regularly, IC
S
 are understood to decrease airw
ay 
inflam
m
ation, reducing the num
ber of asthm
a attacks, hospitalisations and 
asthm
a related m
ortality (B
irkhead, A
ttaw
ay, S
trunk, Tow
nsend & Teutsch, 
1989, Fong &
 Levin, 2007, O
rdonez, P
helan, O
linsky &
 R
obertson, 1998).   IC
S 
are often taken by patients through regular use of a preventer inhaler and also 
through as needed use of a reliever inhaler.  P
reventer inhalers are designed to 
help prevent asthm
a sym
ptom
s by reducing sw
elling and inflam
m
ation in the 
airw
ays.  They often contain a low
 dose of IC
S
 and are expected to be used 
regularly by patients, typically tw
ice a day (A
sthm
a U
K
, 2015b).   They differ to 
reliever inhalers, w
hich are used by patients in em
ergency situations to provide 
short acting, on the spot relief from
 the sym
ptom
s of asthm
a (A
sthm
a U
K
, 
2015c).  
 M
ost cases of paediatric asthm
a are m
anaged through IC
S
 (H
edlin, de 
B
enedictis &
 B
ush, 2012).  H
ow
ever, som
e children and young people 
experience ongoing and frequent sym
ptom
s and exacerbations of asthm
a 
despite being prescribed high doses of IC
S
 (B
racken et al., 2009).  This 
population are often described as having “problem
atic severe asthm
a” [P
S
A] 
and are estim
ated to m
ake up just under 5%
 of the childhood asthm
a 
population (Lang et al., 2008).  R
esearch by S
harples et al. (2012) 
dem
onstrated that children and young people described as having PS
A
 
com
prise of tw
o different groups; those described as having “difficult asthm
a” 
(w
hose asthm
a im
proves w
ithout further increases in treatm
ent w
hen the basics 
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of asthm
a m
anagem
ent such as adherence to IC
S
 are addressed), and those 
described as having severe therapy resistant asthm
a (those w
ho have ongoing 
severe asthm
a despite attention to the basics of asthm
a m
anagem
ent).  This is 
a key and com
plex issue in paediatric asthm
a team
s and the consequences of 
stepping up pharm
aceutical treatm
ents unnecessarily has enorm
ous 
im
plications for health, quality of life, financial cost and long-term
 w
ell-being 
(H
edlin et al., 2012, Sharples et al., 2012).  It is therefore of great im
portant for 
clinicians to identify w
hich young people fall into w
hich group in order to avoid 
escalations in treatm
ent w
hen they are not required.  
 In defining asthm
a, it is also im
portant to reflect on the use of the language 
used by professionals and researchers w
orking in this field.  Language and the 
w
ay people talk about things, is view
ed by m
any as central in the social 
construction of w
hat w
e regard as “know
ledge” (W
illig, 2013).  M
organ (2000) 
considers the pow
er that exists in language and posits that in society people 
can becom
e subjugated and oppressed by the language used.  W
hen 
considering the term
s “problem
atic” and “difficult” asthm
a, questions can be 
raised about the im
pact this choice of language has.   For instance, w
ho is the 
asthm
a “problem
atic” or “difficult”?  M
oreover, w
ith the term
s being used 
predom
inantly in the context of distinguishing patients w
ho are view
ed as 
m
anaging their asthm
a from
 those w
ho are not, do these choice of descriptions 
place the “difficulty” or “problem
” in the asthm
a or in the patient?  
 1.2.2. Adherence  
The term
 adherence form
s part of a w
ider debate w
ithin the healthcare literature 
related to a paradigm
 shift w
hich occurred in the late nineties m
oving from
 a 
com
pliance m
odel of healthcare to a concordance m
odel (Segal, 2007).  The 
aim
 of this shift w
as to m
ove from
 a paternalistic m
odel of care w
here a patient 1 
passively follow
ed their doctor’s orders, to a m
odel of consensual partnership 
and shared decision-m
aking, w
here both doctor and patient view
s are 
acknow
ledged equally (B
urgess, W
ilson, C
ooper, S
ly &
 D
evadason, 2006, 
W
illiam
s, M
anias & W
alker, 2008).  H
ow
ever the term
 concordance has not 
                                                        
1 The term
s “doctor”, “healthcare professional”, “patient” and “user” are used throughout this 
thesis, typically w
hen the literature being sum
m
arised uses them
, but also for the purpose of 
clarity.  They are also the term
s m
ost com
m
only used in the healthcare settings described and 
are also used by participants in the study.   
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been w
idely accepted and critics have argued that aside from
 a change in the 
term
 used, an ideology of com
pliance still exists in healthcare (S
egal, 2007).  
The term
 adherence has also em
erged during this tim
e.  V
iew
ed as neutral and 
non- judgem
ental, the notion of adherence w
as introduced to em
phasise a 
patient’s right to choose w
hether to follow
 the healthcare advice of a doctor and 
to rem
ove the concept of blam
e if they chose not to do so (H
eaney &
 H
orne, 
2012).  The N
ational Institute for H
ealth and C
linical E
xcellence [N
IC
E
] (2009) 
describes adherence as “an agreem
ent betw
een prescriber and patient about 
the prescriber's recom
m
endations.  A
dherence to m
edicines is defined as the 
extent to w
hich the patient's action m
atches the agreed recom
m
endations” 
(N
IC
E
, 2009, p.3).  This m
odel of patient m
edication use can be view
ed as a 
m
id-ground betw
een com
pliance and concordance, recognising the “expertise” 
of the healthcare professional in the relationship, w
hilst also acknow
ledging the 
role of the individual and any w
ider contributors w
hich m
ay influence their ability 
to act on these recom
m
endations.  H
ow
ever the term
inological and conceptual 
differences betw
een the three term
s are com
plex and som
e have argued that in 
practice, the notion of adherence still resem
bles som
e of the paternalistic 
features of a com
pliance m
odel of healthcare (H
orne, 2006).  D
espite this, the 
term
s adherence and non-adherence are used extensively w
ithin the chronic 
health literature (exam
ples of w
hich are included in m
any of the studies 
described below
) and w
ill be used for the rem
ainder of this study.  
 1.2.3. U
nderstanding and A
ssessing A
dherence  
W
hilst non-adherence m
ay consist of stopping m
edical treatm
ent altogether, it 
is also acknow
ledged that a significant num
ber of patients rem
ain in treatm
ent 
but do not follow
 their treatm
ent regim
en in the recom
m
ended w
ay to derive the 
optim
al benefit (O
ckene, H
aym
an, Pasternak, S
chron &
 D
unbar-Jacob, 2002).  
It is estim
ated that approxim
ately 50%
 of patients w
ith long-term
 health 
conditions w
ho rem
ain in treatm
ent are classified as non-adherent (Jackson et 
al., 2014).  M
edication non-adherence has been linked w
ith avoidable m
orbidity 
and m
ortality, m
edication w
astage and reduced quality of life (D
iM
atteo, 
G
iordane, Lepper, & C
roghan, 2002, W
illiam
s et al., 2004).  W
ithin the asthm
a 
literature poor adherence to IC
S
 is view
ed to be one of the m
ost im
portant 
contributors in problem
atic severe asthm
a and recent figures suggest that only 
43%
 of children w
ith problem
atic severe asthm
a filled m
ore than 80%
 of 
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prescriptions
 (B
racken et al., 2009).  G
uidelines therefore em
phasise the 
im
portance of healthcare professionals assessing adherence and prom
oting 
self-m
anagem
ent, independence and responsibility in controlling asthm
a 
(A
sthm
a U
K
, 2013, The B
ritish Thoracic S
ociety, 2011, N
IC
E
, 2013).  
 A
 variety of m
ethods to assess adherence have been developed and evaluated.  
This includes patient and caregiver self-report (M
ilgrom
 et al., 1996), clinician 
estim
ate, (M
ushlin &
 Appel, 1977), blood and lung function testing (G
illissen, 
2007), prescription uptake records (Lau, de Boer, Beuning, &
 P
orsius, 1997) 
and sym
ptom
 control and quality of life m
easures (B
ender &
 Zhang, 2008).  
H
ow
ever, it is recognised that each of these m
ethods is lim
ited in the extent to 
w
hich it can accurately predict levels of adherence.  For exam
ple in the 
research carried out by M
ilgrom
 et al. (1996) patients’ self-reported use of 
inhaled corticosteroids w
as 95.4%
, w
hereas the actual use w
as 58.4%
.  In the 
research carried out by M
ushlin and Appel (1997) clinicians only predicted non-
adherence accurately in 35%
 of their patients.  S
ubsequently, m
ore recent 
research has cham
pioned electronic m
onitoring devices as the “gold standard” 
for accurately m
easuring adherence (B
urgess et al., 2011).  There is a general 
consensus w
ithin the literature that developing better tools for identifying those 
w
ho are poorly adherent is im
portant, so that intervention strategies for 
adherence can be targeted at the appropriate individuals (B
racken et al., 2009, 
G
am
ble, S
tevenson, M
cC
lean &
 H
eaney, 2009).  
 A
dherence to m
edical treatm
ent is clearly a key concern w
ithin the chronic 
health literature.  There is an abundance of research seeking to understand the 
factors that contribute to adherence and on supporting individuals living w
ith 
asthm
a and their fam
ilies to adhere to preventative m
edication (B
racken et al., 
2009, G
am
ble, S
tevenson &
 H
eaney, 2011, P
enza-C
lyve, M
ansell &
 M
cQ
uaid, 
2004).  R
esearch has suggested that individuals’ beliefs about illness and 
treatm
ent shapes their asthm
a self-m
anagem
ent and adherence to m
edication 
(C
lifford, B
arber &
 H
orne, 2008, H
orne et al., 2007), as w
ell as doctor-patient 
com
m
unication (C
lark et al., 1998), coping style (B
arton, C
lark, Sulaim
ain &
 
A
bram
son, 2003), psychological factors (C
lark &
 V
alerio, 2003), fam
ily 
functioning (Bender, M
ilgrom
, R
and &
 A
ckerson, 1998) and the social 
environm
ent (B
ourbeau &
 Bartlett, 2008).  In a review
 carried out alm
ost 20 
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years ago, it w
as understood that as m
any as 200 factors could influence 
adherence behaviour (M
eichenbaum
 & Turk, 1987).   
 S
ubsequently a num
ber of m
odels and fram
ew
orks have been developed w
hich 
seek to understand adherence and non-adherence (see K
ardas, Lew
ek, &
 
M
atyjaszczyk, 2013, M
unro, Lew
in, S
w
art &
 Volm
ink, 2007 for a m
ore thorough 
review
 of these).  W
ithin the field of asthm
a Leventhal, D
iefenbach and 
Leventhal’s (1992) S
elf R
egulatory M
odel [S
R
M
] has been applied extensively 
in developing understanding of adherence and non-adherence.  W
ithin the 
S
R
M
, adherence to treatm
ent is understood as one of a num
ber of “coping” 
responses that a patient (w
ho is view
ed as an “active problem
 solver”) m
ay 
adopt.  This coping behaviour w
ill represent a “com
m
on sense” response based 
on the cognitive and em
otional interpretations the patient m
akes of their 
experiences (for exam
ple the sym
ptom
s they experience or the inform
ation they 
are given).  These interpretations are a central feature of the S
R
M
 and w
ill 
shape how
 the patient conceptualises their illness and the beliefs they hold 
about it (H
orne &
 W
einm
an, 2002).  Leventhal et al.’s (1992) research 
suggested that there are five m
ain groups of beliefs w
hich include beliefs about 
the nature (identity) of the illness, beliefs about the likely tim
e-course (tim
eline) 
of the illness, beliefs about the personal im
pact (consequences) of the illness, 
beliefs about the causal factors (cause) of the illness and beliefs about control 
or cure (control/cure) of the illness.  These sets of beliefs are often described as 
“illness representations” and have been found to be a strong predictor of health 
behaviours such as m
edication adherence in asthm
a and other chronic health 
conditions (B
ucks et al., 2009, C
lifford et al., 2008, H
orne &
 W
einm
an, 2002, 
M
enckeberg et al., 2008, O
’C
arroll et al., 2011).  
 M
ore recently the S
R
M
 has been extended in order to further understand 
treatm
ent adherence and non-adherence in asthm
a (H
orne &
 W
einm
an, 2002).  
In addition to the beliefs a patient holds about their illness, H
orne and W
einm
an 
(2002) posit that the beliefs a patient holds about the prescribed treatm
ent itself 
w
ill also influence their adherence behaviours.  They suggest “adherence 
decisions are influenced by an interaction of personal beliefs about the 
necessity of the treatm
ent for m
aintaining or im
proving health and concerns 
about the potential adverse effects of adhering to it” (H
orne &
 W
einm
an, 2002, 
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p19).   S
ubsequent research has supported this (C
lifford et al., 2008, 
M
enckeberg et al., 2008); correlating patients’ beliefs about IC
S
 treatm
ent w
ith 
self-reported adherence levels and prescription-uptake records.  This lends 
support to the recom
m
endations of H
orne and W
einm
an (2002) w
ho advocate 
for clinicians to use a “necessity-concern fram
ew
ork” in their interactions w
ith 
patients as a useful m
eans of eliciting and understanding their perception of 
asthm
a and its treatm
ent, and to prom
ote adherence through interventions 
w
hich address necessity beliefs and concerns.  
 In addition to understanding how
 ones beliefs influence adherence behaviour, 
researchers seeking to explore the factors that contribute to non-adherence 
have also argued that “unintentional factors” w
ill play a role (H
orne, 2006 
W
einm
an, 2012, W
roe, 2002).  In 2006, H
orne put forw
ard an explanation of 
adherence behaviour referred to as the Perceptions and P
racticalities A
pproach 
[P
A
P
A
].  This approach recognised that perceptual barriers such as patients’ 
beliefs and m
otivations can influence adherence and can lead to intentional 
non-adherence.  H
ow
ever the approach also acknow
ledged that patients m
ay 
not adhere because of practical barriers related to their skills, ability and 
resources in taking their m
edication (e.g. forgetfulness, poor technique).  This 
w
as described as unintentional non-adherence (H
orne, 2006).  This 
categorisation of non-adherence w
as not claim
ed to be w
atertight and it w
as 
recognised that there w
as a degree of overlap betw
een the tw
o (H
orne, 2006).  
H
ow
ever the division is seen to be conceptually useful as it identifies different 
targets for intervention, w
ith perceptual and practical barriers needing to be 
addressed differently (H
orne &
 C
latw
orthy, 2010).  The P
A
PA
 has also been 
incorporated into N
IC
E guidelines (2009) on adherence to support healthcare 
professionals in responding to the different factors that influence adherence 
behaviour.  
 N
on-adherence rem
ains both a concern and challenge to healthcare 
professionals (H
orne, 2006) and w
hilst the theoretical contributions described 
above generate a w
ider understanding of adherence and non-adherence, it is 
im
portant to note that they do not offer causal explanations of adherence.  
Indeed the S
R
M
 has received criticism
 for not providing a fully com
prehensive 
understanding of adherence behaviours, neglecting contributors such as 
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autom
atic processes and social factors (Jackson, E
liasson, B
arber &
 W
einm
an, 
2014).  H
ow
ever, these theoretical contributions are becom
ing increasingly 
used in understandings of adherence in asthm
a and have aided the 
developm
ent of a variety of healthcare interventions aim
ed at im
proving 
adherence across the chronic health field.  This includes a range of com
plex 
interventions targeted at the individual and w
ider system
 level including 
com
binations of inform
ation, rem
inders, self-m
onitoring, reinforcem
ent, 
counselling, fam
ily therapy, psychological therapy, crisis intervention, m
anual 
telephone follow
-up, im
proved com
m
unication in the healthcare relationship, 
and m
ore convenient, collaborative and supportive healthcare (G
illissen, 2007, 
H
aynes, A
ckloo, S
ahota &
 M
cD
onald, 2008, H
aynes, M
cK
ibbon &
 K
anani, 
1996, H
orne &
 C
latw
orthy, 2010).   
 1.2.4. E
lectronic Adherence A
ssessm
ent Tools 
M
ore recently electronic assessm
ent tools have been introduced to the 
healthcare field, view
ed as a m
ore objective and accurate m
ethod of assessing 
adherence com
pared to the earlier m
entioned m
ethods (B
ender et al., 2000).   
The S
I (w
hich is the focus of the current study) is one such electronic 
assessm
ent tool.  The S
I is attached by a healthcare professional to a patient’s 
usual inhaler.  O
nce attached, sensors on the device w
ill detect w
hen the 
m
edication is taken and w
ill record this inform
ation onto its m
em
ory.  A
 
healthcare professional can later access this inform
ation by uploading the 
recordings from
 the S
I onto their com
puter.  This inform
ation w
ill show
 the 
healthcare professional the patient’s frequency of inhaler use, the tim
es and 
dates of inhaler use and the dose of IC
S
 taken.  They can then discuss the 
inform
ation recorded on the inhaler w
ith the individual w
ho is using it (B
urgess 
et al., 2006).  In the context of the current study, the SI w
as used on 
participants’ preventer inhalers.  
 A
s w
ell as offering a m
ore objective m
eans of assessing adherence, electronic 
m
ethods of assessm
ent such as the S
I are also receiving increased attention as 
a form
 of healthcare technology know
n as “telem
onitoring”; w
hich form
s part of 
the third generation of “telehealth” equipm
ent (S
tow
e &
 H
arding, 2010).  
Telehealth equipm
ent involves the delivery of healthcare through technology.  It 
has been im
plem
ented across the N
ational H
ealth S
ervice [N
H
S
], often 
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accom
panied by rhetoric of prom
oting patients’ ability to self-care and take 
responsibility for m
onitoring their ow
n health (N
H
S
 C
hoices, 2012b).  A
 variety 
of telehealth equipm
ent exists, not all of w
hich is used for the purpose of 
m
onitoring adherence.  This includes w
eb-based applications, m
obile phone 
and alert system
s and telephone and video conferencing w
ith patients to nam
e 
a few
 (Finkelstein, S
peedie & P
otthoff, 2006, Lee, C
hen, H
siao &
 Tseng, 2007, 
P
innock, S
lack, P
agliari, P
rice &
 Sheikh, 2007).  Telem
onitoring involves the 
m
easurem
ent, collection and analysis of a particular form
 of data in a user's 
hom
e (for exam
ple a user’s adherence to IC
S
).  This data can then be sent 
electronically to an internet portal that can be accessed by another, typically a 
healthcare professional, but possibly also by the user, their relatives and carers.  
D
ata can be collected continuously, but is not alw
ays im
m
ediately available to 
view
 (S
tow
e &
 H
arding, 2010).  
 1.3. Literature Review 
 E
lectronic m
easures of adherence such as the S
I and other variations of 
telem
onitoring equipm
ent have been extensively evaluated in asthm
a as w
ell as 
a range of other chronic health conditions (S
ee B
rettle, B
row
n, H
ardiker, 
R
adcliffe & Sm
ith, 2013, C
han et al., 2007, Spaulding, D
evine, D
uncan, W
ilson 
&
 H
ogan, 2012, Stow
e &
 H
arding 2010).  W
ithin the field of asthm
a, research 
has com
pared the accuracy of electronic devices in assessing adherence to 
other m
ethods such as self-report (Bender et al., 2000) and has investigated 
the efficacy of electronic adherence assessm
ent devices as part of an 
intervention designed to reduce non-adherence (C
han et al., 2007).  They have 
also been used in a recent study to assess participants’ adherence w
ith trial 
m
edication (P
atel et al., 2013) and in research carried out by B
urgess et al. 
(2006), the reliability of the S
I specifically w
as evaluated.   
 H
ow
ever, only a sm
all am
ount of the chronic health literature has considered 
how
 individuals experience the process of adherence assessm
ent through 
telem
onitoring and the ethical and professional im
plications of using electronic 
m
onitoring tools in healthcare settings.  To date, the S
I has not been 
researched in this w
ay and little attention has been afforded to understanding 
the beliefs patients form
 about the use of this equipm
ent and the perceptual and 
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practical barriers that m
ay shape their experience of using this equipm
ent, 
despite the em
phasis on this elsew
here in the asthm
a-adherence field (C
lifford 
et al., 2008, H
orne, 2006, H
orne & C
latw
orthy, 2010, H
orne &
 W
einm
an, 2002, 
M
enckeberg et al., 2008).  I w
ill now
 go on to review
 the existing literature, w
ith 
focus on the role of electronic adherence assessm
ent and telem
onitoring 
equipm
ent in prom
oting an individual’s ability to self-care/ m
anage their health 
condition.  A
 focus w
ill also be placed on how
 the m
onitoring process im
pacts 
on the healthcare relationship, as w
ell as the interactions that take place in the 
healthcare relationship itself w
hich influence how
 the process of electronic 
adherence assessm
ent is experienced.  
 1.3.1. E
lectronic Adherence A
ssessm
ent and S
elf-C
are 
W
ith the introduction of telem
onitoring equipm
ent to healthcare settings, one 
issue w
hich has been raised relates to its role in prom
oting an individual’s ability 
to be responsible for their ow
n self-care of their health.  Fairbrother et al. (2013) 
describe the process of self-care as “relating to the acquisition and/or use of 
know
ledge and skills by patients to support their ow
n care” (p.403) and describe 
how
 the term
 form
s part of the patient em
pow
erm
ent agenda.  Indeed the idea 
of em
pow
ering or prom
oting one/the ability to self-care and take responsibility 
for m
onitoring their ow
n health in chronic health conditions is increasingly 
recognised in the N
H
S
, w
ith the developm
ent of a variety of initiatives aim
ed at 
supporting self-care, including electronic assessm
ent tools (H
orne et al., 2007, 
N
H
S
 C
hoices, 2012b).  W
ithin the field of asthm
a it has been recognised that 
good outcom
es rely not only on the availability of m
edications but also on their 
appropriate use by patients and their “optim
al self-m
anagem
ent” (H
orne, 2006, 
p. 65).  In a review
 of the existing literature of technology’s role in respiratory 
care, Sm
ith, E
lkin and P
artridge (2009) called for future research to consider 
w
hether telem
onitoring in respiratory care “em
pow
ers the patient to self m
anage 
their condition” or leads to a “dependence upon advice received back in 
response to technology-based m
onitoring” (p.162).  H
ow
ever, despite this the 
research literature exploring the role of electronic adherence assessm
ent and 
telem
onitoring equipm
ent in prom
oting an individual’s ability to take 
responsibility for their self-care is lim
ited and contains m
ixed findings.  
 In a study conducted by S
eto et al. (2012), healthcare professionals and adult 
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patients experiencing heart failure shared their experiences of using m
obile 
phone based telem
onitoring as part of the healthcare process.  Patients w
ere 
required to use the telem
onitoring system
 to take daily w
eight and blood 
pressure readings and to answ
er daily sym
ptom
 questions on a m
obile phone 
for 6 m
onths.  This inform
ation w
as then sent autom
atically and w
irelessly via a 
m
obile phone to the data repository at the hospital, w
here a healthcare 
professional could access it.  The system
 could also send rem
inders to ensure 
that the patients took their readings, and inform
ation based on their readings 
w
ould be accessible securely online for both the individual and healthcare 
professional to see.  The patients and healthcare professionals w
ere then 
interview
ed about their experience of using this system
 w
ith a focus placed on 
understanding w
hether the system
 im
pacted on self-care.  O
ne of the findings 
from
 the interview
s w
as that the telem
onitoring system
 did indeed prom
ote self-
care, through increasing individuals’ aw
areness, know
ledge and confidence in 
m
anaging their condition.  H
ow
ever som
e participants described feeling like 
they w
ere being w
atched long-term
 and concerns w
ere raised about becom
ing 
dependent on the system
 and w
hat w
ould happen if it w
ere taken aw
ay.   
 R
esearch carried out by Fairbrother et al. (2013) has also explored the view
s of 
professionals and adult patients w
ith chronic obstructive pulm
onary disease 
[C
O
P
D
] on self-m
anagem
ent in the context of telem
onitoring.  They carried out 
sem
i-structured interview
s w
ith patients and healthcare professionals and 
explored experiences of using telem
onitoring and its effect on the “doctor-
patient relationship”.  The findings from
 the interview
s w
ith the patients 
suggested that telem
onitoring em
pow
ered self-m
anagem
ent by enhancing their 
understanding and know
ledge of C
O
P
D
 and provided a sense of reassurance 
and support.  C
onversely, the findings from
 the professionals’ interview
s 
indicated that they view
ed the telem
onitoring process as prom
oting com
pliance 
w
ith m
edical advice, w
ith professionals suggesting that w
hilst telem
onitoring 
encouraged their patients to exercise personal responsibility it also ran the risk 
of prom
oting the sick role and creating dependence on the system
.  In their 
conclusions, the researchers stated that w
hilst the process of telem
onitoring 
em
pow
ered those living w
ith C
O
P
D
 to take responsibility for their healthcare 
through increased access to inform
ation about their health, it did so 
paradoxically in that it prom
oted the view
 of a com
pliant self-m
anager w
ho 
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w
ould ultim
ately rem
ain dependent on the expertise of the healthcare 
professional. 
 These studies highlight one of the em
erging com
plexities associated w
ith 
im
plem
enting telem
onitoring and electronic adherence assessm
ent tools in 
healthcare settings.  W
hilst these tools can increase the sense of responsibility 
an individual has for m
onitoring their ow
n health and self-caring, they do so in a 
w
ay that m
aintains a reliance on the healthcare system
 and on the advice of a 
healthcare professional.  The claim
 that telem
onitoring and electronic 
adherence assessm
ent tools prom
ote self-care and responsibility for m
onitoring 
one's ow
n health can therefore be questioned.  O
n the one hand it could be 
argued that these findings reflect the underlying ethos of an adherence m
odel 
of health care, recognising that a healthcare professional w
ill possess expertise 
that they can draw
 upon to advise their patients w
ho can in turn (if they so w
ish) 
use electronic m
onitoring tools in conjunction w
ith this advice to care for 
them
selves.  O
n the other hand, it could be argued that this alleged handing 
over of responsibility for m
anaging ones ow
n health is a m
erely tokenistic 
gesture and that, ultim
ately, patients w
ill rem
ain dependent on and com
pliant 
w
ith the ideas and practices of their healthcare professional w
ith little true 
responsibility for m
anaging their ow
n health.   
 This raises the additional com
plexity of using telem
onitoring in healthcare 
practice and begs the question as to w
hether the process of electronic 
assessm
ent is m
ore closely aligned to a com
pliance m
odel of healthcare than to 
an adherence m
odel of healthcare.  N
IC
E
 guidelines on m
edicines adherence 
(2009) stress that “the purpose of assessing adherence is not to m
onitor 
patients but rather to find out w
hether patients need m
ore inform
ation and 
support” (p.13).  H
ow
ever B
ourdin et al. (2012) argued that electronic 
assessm
ent devices quantify com
pliance rather than adherence to a 
prescription.  A
dditionally, S
cherm
er (2009) argued that current form
s of 
telem
onitoring prom
ote com
pliant self-m
anagem
ent w
here a patient is m
erely 
an extension of their healthcare professional, undertaking practical tasks that 
w
ould traditionally be perform
ed by their healthcare professional rather than an 
individual w
ho takes responsibility for caring for their ow
n health.   
H
ow
ever, this does not necessarily m
ean that a com
pliance m
odel of healthcare 
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cannot be experienced as em
pow
ering by patients.  The findings of both 
Fairbrother et al. (2013) and S
eto et al. (2012) do seem
 to suggest that the 
patients involved in the m
onitoring process of self care did experience it as 
em
pow
ering; aiding their understanding, know
ledge and confidence in 
m
anaging their health.  A
dditional research is therefore needed to explore the 
process of electronic adherence assessm
ent tools on self-care further and to 
understand the m
echanism
s through w
hich an approach that m
ay sim
ply 
perpetuate a traditional doctor-patient healthcare relationship of com
pliance, 
can nevertheless be experienced as em
pow
ering by users and prom
ote self-
care.   
 1.3.2. E
lectronic Adherence A
ssessm
ent and the H
ealthcare R
elationship 
The role of the “doctor-patient relationship” in health outcom
es has been 
extensively researched (B
eckm
an, M
arkakis, S
uchm
an &
 Frankel, 1994, 
Ferguson &
 C
andib, 2002, S
tew
art, M
cW
hinney &
 B
uck, 1979).  This is 
particularly the case w
ithin the chronic health literature, w
here research has 
dem
onstrated that aspects of the healthcare relationship, such as the patient's 
perceptions of how
 understood they feel by their healthcare professional, can 
interact w
ith how
 w
illing they are to accept a healthcare professionals’ advice 
(S
elfe, M
atthew
s &
 S
tones, 1998).  R
esearch has also highlighted that an 
alliance betw
een healthcare professional and patient w
here shared goals are 
developed and there is a lack of focus on negative behaviours, can im
prove 
adherence to m
edication in young people w
ith asthm
a (G
avin, W
am
boldt, 
S
orokin, Levy &
 W
am
boldt, 1999).  Indeed even existing guidance in asthm
a 
m
anagem
ent stresses the im
portance of the relationship betw
een patient and 
healthcare professional as a prim
ary com
ponent of optim
al treatm
ent (N
ational 
H
eart Lung &
 B
lood Institute, 1997).  W
ith this is m
ind, it seem
s im
portant to 
consider the w
ays electronic adherence assessm
ent equipm
ent interacts w
ith 
the healthcare relationship.  
 O
ne particular concern in the literature related to telem
onitoring and the 
healthcare relationship is the extent to w
hich patients using this equipm
ent in 
their lives experience this process as intrusive.  The findings in the S
eto et al. 
(2012) study highlighted that som
e participants did not like feeling like they 
w
ere being w
atched long term
 by healthcare professionals.  A
dditionally in their 
  
15 
review
 of the use of telem
onitoring equipm
ent in an older adult population, 
S
tow
e and H
arding (2010) likened m
onitoring system
s to a form
 of surveillance 
that could im
pact on one’s privacy.  They also considered the pow
er differential 
betw
een healthcare professionals and their patients and acknow
ledged that 
patients m
ay accept the im
plem
entation of these tools in their lives regardless 
of the intrusion.  C
ertainly, one could argue that having a healthcare 
professional rem
otely assess the am
ount of tim
es you take your m
edication, the 
dose you take and the specific tim
e you take it, is not far rem
oved from
 a form
 
of health surveillance m
onitoring (Bauer &
 O
lsén, 2009).  It is possible that this 
process could therefore be experienced as intrusive, possibly prom
oting 
feelings of distrust in the healthcare relationship.  
 The above is of particular concern w
hen considering the use of telem
onitoring 
equipm
ent w
ith young people w
ho are transitioning from
 childhood to 
adulthood.  Young people are often at a stage in their lives w
here the desire for 
independence em
erges and this, along w
ith rejection of adult authority can form
 
a key stage of identity developm
ent  (E
rikson, 1968).  A
s a group w
hich already 
has significant experiences of living in a w
orld w
here the practices of 
surveillance are rife (Vaz &
 B
runo, 2003), young people in particular m
ay be 
m
ore rejecting and suspicious of the introduction of this equipm
ent into another 
area of their lives.  O
n the other hand, it could be argued that young people 
m
ight be m
ore used to and accepting of electronic m
onitoring as m
ore of their 
lives are lived publically via technology and various social m
edia applications 
(Lenhart, Purcell, Sm
ith &
 Zickuhr, 2010).  In this case, young people m
ay 
experience telem
onitoring equipm
ent such as the S
I as an innovative addition 
to the healthcare relationship, w
hich possibly m
irrors other areas of their lives 
and encourages them
 to engage w
ith the advice of their healthcare 
professional.  
 It therefore seem
s im
portant for research to consider how
 telem
onitoring and 
electronic adherence assessm
ent m
onitoring tools such as the S
I are view
ed by 
those using them
 and in particular w
hether patients perceive them
 as intrusive 
or innovative?  The extended S
R
M
 m
odel w
hich incorporates patients’ beliefs 
about the necessity of and concerns about a treatm
ent (H
orne & W
einm
an, 
2002) m
ay provide a useful fram
ew
ork for understanding how
 patients 
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experience the SI.  For instance, if young people believe that the technology 
involved in the S
I provides a m
ore m
odern and innovative w
ay of receiving 
healthcare, are they m
ore likely to accept the equipm
ent then if they are 
concerned that it is being used as a m
eans of surveillance?  R
esearch carried 
out by Tierney, Fraser and K
ennedy (2013) and R
ohan et al. (2013) has started 
to explore this.  Tierney et al. (2013) used focus groups to explore users' 
experiences of hom
e m
onitoring of health w
ith specific regard to physical 
activity m
onitors.  They interview
ed 14 participants w
ith rheum
atoid arthritis w
ho 
had taken part in a physical activity m
onitoring study and had w
orn physical 
activity m
onitors for seven days in their hom
es.  They found that users’ 
concerns about having their health m
onitored in the hom
e w
ere lim
ited and 
instead their experiences of the technology w
ere largely positive, w
ith 
participants finding the equipm
ent helpful for facilitating physical activity choices 
and overall unobtrusive.  H
ow
ever, this research w
as carried out in an older 
population and the findings m
ay differ in other age groups.  For instance, 
research carried out by R
ohan et al. (2013) interview
ed six children and young 
people aged 5-14 and their caregivers w
ho had participated in an adherence 
prom
otion intervention.  O
f these six, four fam
ilies
2 responded positively to 
feedback on their adherence levels and w
ere view
ed to readily problem
 solve 
jointly w
ith the healthcare professional about w
ays to im
prove their adherence.  
O
f note how
ever is that the tw
o fam
ilies in this study w
ith poorer rates of 
adherence w
ere described as reacting defensively to the feedback and 
suggested that the electronic m
onitoring data w
as not valid.  The findings also 
highlighted that w
hen the adherence m
onitoring and feedback ceased, 
adherence rates declined to pre-intervention levels.  This raises questions 
about the effectiveness of m
onitoring tools in the long term
 if individuals just 
stop adhering once they are no longer being m
onitored.  The authors therefore 
called for further research to explore healthcare professionals and patients' 
experiences w
ith adherence m
onitoring and feedback in m
ore detail. 
 These studies again highlight som
e of the additional com
plexities healthcare 
services face w
hen deciding w
hether to im
plem
ent telem
onitoring and electronic 
adherence assessm
ent equipm
ent; in this case the different w
ays in w
hich the 
                                                        
2 Interestingly the authors did not specify w
hose response w
as positive; the young person or 
caregiver and instead generalised to “the fam
ily”.  I w
ill discuss this further later in the chapter.   
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healthcare relationship can be affected.  It rem
ains unclear at this stage 
w
hether the im
plem
entation of telem
onitoring equipm
ent w
ill be experienced as 
having a positive or negative affect on the healthcare relationship, although it 
seem
s plausible that one’s experience w
ill be shaped by a num
ber of factors 
such as how
 patients view
 the equipm
ent (and any concerns they have about it 
and w
hether these outw
eigh their view
s on the necessity/need for it).  These 
studies have also started to highlight that the w
ay inform
ation is collected 
through this technology, and the w
ays the inform
ation is used and fed back 
w
ithin the healthcare relationship is im
portant.  This is consistent w
ith the earlier 
review
 of the literature surrounding interventions aim
ed at im
proving adherence, 
w
hich highlighted that elem
ents of the healthcare relationship such as the 
am
ount of support, collaboration and reinforcem
ent given, as w
ell as im
proved 
com
m
unication can prom
ote adherence (G
illissen, 2007, H
aynes et al., 2008, 
H
aynes et al.,1996, H
orne &
 C
latw
orthy, 2010).  I w
ill discuss this further below
.  
 O
ne line of thinking w
hich has em
erged w
ithin the literature on electronic 
adherence assessm
ent tools is that giving feedback on adherence levels 
increases adherence.  In research conducted by B
urgess, S
ly and D
evadason 
(2010), children and young people w
ith asthm
a w
ho w
ere given feedback on 
their adherence levels (m
easured through an electronic m
onitoring device) w
ere 
show
n to increase their use of preventive m
edication.  Furtherm
ore, in the 
research described above, som
e of the findings suggest that giving positive 
feedback on adherence levels m
ay be beneficial for the healthcare relationship.   
 It is possible that if a doctor and patient can think together about w
hat the 
findings collected on an electronic adherence assessm
ent tool show
, this m
ay 
prom
ote a sense of partnership and collaboration in the healthcare relationship 
and potentially prom
ote adherence behaviours (H
aynes et al., 2008, H
aynes et 
al.,1996, H
orne &
 C
latw
orthy, 2010).  This seem
ed particularly im
portant in the 
findings of R
ohan et al., (2013) w
here four of the fam
ilies (w
ho had acceptable 
levels of adherence) reported positive experiences of the feedback process.  
S
paulding et al. (2012) have also acknow
ledged this.  Their research evaluated 
the effect of electronic m
onitoring on adherence rates in paediatric asthm
a.  
W
ithin their discussions they acknow
ledged that positive feedback from
 staff, or 
the absence of negative feedback from
 staff m
ay have a favourable effect on 
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adherence for som
e children. This idea w
as supported by the findings of Penza-
C
lyve et al. (2004), w
here children w
ith asthm
a reported that they w
ere m
ore 
likely to take their m
edication w
hen rew
arded for doing so.  Finally, in the w
ork 
of R
ogers, K
irk, G
ately, M
ay and Finch (2011) it w
as noted that individuals can 
experience a sense of achievem
ent from
 the m
onitoring process.   
 H
ow
ever, not all electronic m
onitoring has been found to have positive 
outcom
es.  For instance R
ohan et al. (2013) suggested that the fam
ilies in their 
study w
ho w
ere view
ed as having poorer adherence levels reacted less 
positively to feedback on adherence.  C
onsideration therefore needs to be 
given to how
 healthcare professionals approach conversations w
ith individuals 
w
here adherence is view
ed as poor.  This is of particular im
portance w
hen 
considering the PA
P
A
 m
odel of intentional and unintentional adherence put 
forw
ards by H
orne (2006), w
hich recognised that both perceptual and practical 
barriers can influence one’s adherence.  For those w
ho had poorer levels of 
adherence in R
ohan et al.’s (2013) study, it is not clear w
hether the contributors 
to this w
ere explored.  It is possible that w
ithout an acknow
ledgem
ent of any 
barriers contributing to the poorer adherence levels being recorded, any 
feedback could be experienced as punitive and lacking in aw
areness for the 
reasons w
hy this occurred.  Interestingly how
ever, som
e researchers have 
acknow
ledged that feedback on poor adherence levels can im
prove adherence 
(V
asbinder et al., 2013).  Indeed S
paulding et al. (2012) acknow
ledged in their 
research that electronic m
onitoring and feedback on adherence m
ay involve 
negative reinforcem
ent, w
here patients are m
otivated to use their inhalers 
correctly in order to avoid a clinic visit w
here data clearly show
s non-adherence.  
This again fits w
ith the earlier review
 of the literature surrounding interventions 
aim
ed at im
proving adherence, w
hich highlighted that elem
ents of the 
healthcare relationship such as the type of reinforcem
ent given can im
prove 
adherence (H
aynes et al., 2008, H
aynes et al.,1996, H
orne & C
latw
orthy, 
2010).  H
ow
ever, the im
pact of this on the healthcare relationship could be 
detrim
ental.  M
cN
icholl and H
eaney (2013) highlighted that for som
e patients, 
overt m
onitoring even w
hen done sensitively, w
ill feel too confronting and som
e 
m
ay then resort to trying to conceal their data or find w
ays around the system
 
(for exam
ple through inhaler dum
ping- w
here som
eone em
pties the contents of 
the inhaler- S
im
m
ons, N
ides, R
and, W
ise & Tashkin, 2000).  Furtherm
ore, 
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W
einstein (2005) has questioned how
 healthcare professionals then use 
inform
ation about poor adherence levels.  In his review
 of the literature 
concerning the reasons to carry out objective form
s of adherence assessm
ent, 
he considers how
 inform
ation on adherence is com
m
unicated to those paying 
for m
edical care such as healthcare insurance com
panies and w
hether this 
could lead to reim
bursem
ent for m
edical treatm
ent costs being denied.  W
hilst 
this is not currently a m
ajor issue in the N
H
S w
here healthcare at this tim
e 
rem
ains free, it does raise questions about w
hat effect having inform
ation that 
indicates poor adherence has on healthcare professionals offering care to 
individuals.  D
o they then feel less supportive of or m
otivated w
ith individuals 
w
ho are not follow
ing healthcare advice?  
 This all raises concerns about the long-term
 im
pact of telem
onitoring on 
healthcare relationships, particularly for children and young people w
here som
e 
of these encounters could be their first experiences of form
ing healthcare 
relationships and could shape their later relationships to help (R
eder &
 
Fredm
an, 1996).  It also begs the question of w
ho the telem
onitoring equipm
ent 
is actually m
onitoring; the young person or the caregiver?  For exam
ple, R
ohan 
et al. (2013) focused on adherence prom
otion interventions for fam
ilies and it 
rem
ains unclear w
ho the m
ajority of the healthcare interactions w
ere w
ith and 
w
ho specifically received the feedback on adherence levels.  Finally, it also 
highlights the need for future research to m
ore closely consider the specific 
processes that m
ay play a role in adherence behaviour change.  For instance is 
it positive feedback, or the absence of negative feedback from
 healthcare 
professionals that has a favourable effect on adherence?  O
r does a negative 
reinforcem
ent contingency increase adherence in som
e patients and if so for 
w
ho?  M
oreover, w
hat is the im
pact of these processes on the healthcare 
relationship itself?   
 The findings of the literature review
ed so far also highlight the need for a clear 
dialogue about telem
onitoring equipm
ent in the healthcare relationship.  
R
esearch by P
ruette, Fadrow
ski, B
edra and Finkelstein (2013) evaluated the 
feasibility of a m
obile blood pressure telem
anagem
ent system
 in children w
ith 
hypertension.  They explored children and caregivers’ acceptance of the 
system
, w
hich involved self-m
onitoring and reciprocal exchange of m
edication 
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adherence and blood pressure m
easurem
ent inform
ation betw
een patients and 
healthcare professionals.  The findings indicated the need for healthcare 
professionals to clearly com
m
unicate to fam
ilies that professionals could 
im
m
ediately review
 the self-testing results.  Even m
ore im
portant to consider for 
the healthcare relationship is w
hen individuals are m
onitored w
ithout this being 
com
m
unicated to them
.  In research carried out by M
ilgrom
 et al. (1996) 24 
children w
ith m
oderate to severe asthm
a w
ere prescribed IC
S
 and m
onitored 
electronically w
ithout their know
ledge.  This raises a serious ethical concern 
about the purpose of adherence m
onitoring.  O
ne can question w
hether this 
process is actually about prom
oting responsibility for self-care and having a 
positive healthcare relationship, or is instead m
erely a w
ay for healthcare 
professionals to check up on individuals and see if they are doing as told.  W
ith 
m
ore and m
ore research concluding that successful m
anagem
ent of chronic 
health conditions requires a paradigm
 shift in healthcare relationships tow
ards a 
m
ore active partnership involving greater collaboration (Bodenheim
er, Lorig, 
H
olm
an &
 G
rum
bach, 2002, Fairbrother et al., 2013, Finch, M
ort, M
air &
 M
ay, 
2008), the process of electronic adherence assessm
ent needs further 
exploration as to w
hether it is supporting this shift or is in fact m
oving further 
from
 it.  
 From
 the review
 of the literature so far it is clear that there are m
ixed view
s on 
the role of telem
onitoring and electronic adherence assessm
ent in chronic 
health conditions including asthm
a.  W
hilst certain form
s of telem
onitoring can 
prom
ote patients taking responsibility for self-care, through increasing 
aw
areness, know
ledge and confidence in m
anaging chronic health conditions, 
they can also be view
ed as prom
oting a dependency on the healthcare system
 
and a com
pliance m
odel of care.  H
ow
ever, the im
pact of this on the healthcare 
relationship and w
hether patients experience this technology as em
pow
ering 
self-care or not m
ay be influenced by their beliefs about the equipm
ent and the 
extent to w
hich the perceived need for the equipm
ent outw
eighs the perceived 
concerns about using the equipm
ent.  A
dditionally, particular features of the 
healthcare relationship m
ay influence how
 the process of electronic adherence 
assessm
ent is experienced.  For exam
ple the w
ay the inform
ation collected 
through this technology is used and fed back w
ithin the healthcare setting m
ay 
shape w
hether or not the overall process is experienced as a collaborative 
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endeavour w
hich aligns the healthcare professional and patient in an active 
partnership.  Finally, the additional com
plexities involved in carrying out 
telem
onitoring and electronic adherence assessm
ent w
ith different populations 
such as w
ith children, young people and their fam
ilies has started to em
erge.  I 
w
ill now
 go on to discuss w
hy further research is needed in this area specifically 
w
ith young people and also their fam
ilies and healthcare professionals. 
1.3.3. C
urrent R
esearch w
ith Young People and their W
ider S
ystem
s 3 
A
s noted earlier, asthm
a is considered to be the m
ost com
m
on chronic health 
condition in children and young people (The W
orld H
ealth O
rganization, 2013).   
A
 large body of research has acknow
ledged the im
pact asthm
a can have on the 
quality of life of young people, during w
hat is view
ed as a tim
e of transition from
 
childhood to adulthood (G
ibson, H
enry, V
im
pani &
 H
alliday, 1995, N
ew
acheck, 
M
cM
anus &
 Fox, 1991, R
utishauser, S
aw
yer, &
 B
ow
es, 1998).  Anderson and 
C
oyne (1993) describe how
 this transition period is likely to be associated w
ith 
appropriate increases in a young person’s m
anagem
ent of his or her ow
n 
illness, w
hich develop in tandem
 w
ith other increases including needs for 
privacy, control, and peer acceptance.  C
erreto and Travis (1984) suggest 
sim
ilarly that young people need to becom
e personally responsible for self-care 
activities, w
hile fam
ilies w
ithdraw
 their involvem
ent to little m
ore than occasional 
m
onitoring.  In line w
ith this thinking, recent research and guidance in asthm
a 
has focused on the need for young people to be supported in taking increasing 
responsibility for controlling their asthm
a as they approach adulthood 
(B
laakm
an, C
ohen, Fagnano, &
 H
alterm
an, 2014, The B
ritish Thoracic S
ociety, 
2011, P
rice, 1996).  It is therefore of no surprise that telem
onitoring and 
electronic adherence assessm
ent equipm
ent has begun to be introduced to and 
evaluated in the child and young person population.  M
any of the exam
ples of 
research that w
ere review
ed above w
ere exam
ples of this (M
ilgrom
 et al., 1996, 
P
ruette et al., 2013, R
ohan et al., 2013, S
paulding et al., 2012).  
                                                        
3 The current study predom
inantly uses the term
 “young people”.  This term
 is a flexible term
 
that can encom
pass a broad age range that includes those w
ho w
ould som
etim
es be referred to 
as “older children” or “adolescents”.  It does not typically include younger children w
ho w
ould 
instead be described as “children” (G
eneral M
edical C
ouncil, 2014).  It is used in this study 
w
hen referring to participants aged 11 to 16, how
ever it is im
portant to recognise that it could 
apply to a w
ider age group in other contexts, including som
e of the other studies described.  
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 H
ow
ever, evidence suggests that is com
m
on for adherence to m
edical regim
es 
to decrease during adolescence (A
nderson, H
o, B
rackett, Finkelstein and Laffel 
1997), w
ith the cognitive changes that take place during this period m
aking it 
m
ore likely that young people w
ill think differently about adherence behaviour 
then they did during childhood (H
olm
beck, 2002).  Furtherm
ore, E
isner (1993) 
has described how
 potential conflicts in the shifting of responsibility to young 
people can occur during this period of tim
e, w
ith parents expressing concerns 
about their child’s level of conscientiousness about these responsibilities.  
A
nderson and C
oyne, (1993) suggest that these parental concerns can lead to 
a m
iscarried helping process w
hich H
olm
beck et al. (2002) argue is 
problem
atic; as increases in parental control during this period of developm
ent 
are often linked w
ith low
er levels of autonom
y in young people.  
 R
iekert and R
and (2002) suggest that the process of telem
onitoring could assist 
fam
ilies in appropriately transferring responsibility of asthm
a care from
 parents 
to adolescents.  H
ow
ever, w
ithin the existing literature there w
as only a lim
ited 
exploration
4 into the experiences of young people using telem
onitoring 
equipm
ent in their lives, the beliefs they form
 about the equipm
ent and the 
im
pact it has on their relationships w
ith healthcare professionals.  Furtherm
ore, 
there w
as an absence w
ithin the literature of any research exploring the im
pact 
of telem
onitoring equipm
ent on shifting the responsibility for self-care from
 a 
parent/caregiver 5 to the young person.  Further research is therefore required to 
explore young people’s experiences and how
 the process of telem
onitoring 
through devices such as the S
I m
ay contribute to the shifting of responsibility 
from
 caregivers to young people. 
 From
 the review
 of the literature, it is also im
portant to acknow
ledge that there 
are m
ultiple view
s regarding electronic adherence assessm
ent tools such as the 
S
I.  This is not surprising.  R
esearch has previously dem
onstrated that young 
people and their parents have differing view
s on living w
ith and m
anaging 
                                                        
4 See H
afetz & M
iller (2010), how
ever this research w
as not specific to m
onitoring using 
electronic equipm
ent.   
5 The term
s “caregiver” and “parents” are used interchangeably.  I have used both to try and 
reflect m
y aw
areness that caregivers can encom
pass a w
ider group than the term
 parent.  
H
ow
ever, at tim
es, usually w
hen previous research or the participants in the current study have 
used it, I have w
ritten the w
ord parent.  
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asthm
a (Jonsson, Egm
ar, H
allner &
 K
ull, 2013).  In this study the young people 
spoke about w
anting to develop their ow
n strategies for self-m
anagem
ent of 
asthm
a, w
hich included not alw
ays taking m
edication as prescribed.  The 
parents described w
anting to be m
et w
ith com
petence and understanding in 
asthm
a care from
 healthcare professionals.  The research concluded that 
developing a partnership betw
een young people, their parents/caregivers and 
healthcare professionals could be a successful w
ay to im
prove the care of 
patients w
ith asthm
a.  W
ith research such as this in m
ind, it can be argued that 
exploring the view
s of both young people and their parents/caregivers is integral 
to generating a m
ore rounded understanding of electronic adherence 
m
onitoring in asthm
a.  This is also in line w
ith the thinking of H
orne and 
W
einm
an (2002) described earlier in this chapter, w
ho recom
m
ended that 
clinicians elicit and understand their patients’ perception of asthm
a and its 
treatm
ent, in order to prom
ote adherence.  
 A
dditionally, the literature base described throughout this chapter has indicated 
the added benefit of eliciting the often differing view
s of healthcare 
professionals regarding telem
onitoring and electronic adherence assessm
ent.  
W
hilst slightly m
ore research has been carried out in this area exploring the 
im
pact of telem
onitoring on self-care and healthcare relationships in adult 
populations (Fairbrother et al., 2013, H
opp, H
ogan, W
oodbridge &
 Low
ery, 
2007, Seto et al., 2012), any further insights that subsequent research can offer 
to this area (specifically to healthcare w
ith young people) w
ill rem
ain useful.  
 1.4. Research Aim
s 
 The proposed study therefore aim
s to explore the experiences of young people 
w
ith asthm
a and their caregivers, of having their adherence to IC
S
 assessed 
through electronic adherence assessm
ent equipm
ent, in this case the S
I.  The 
S
I has been selected, as it is a relatively new
 device that has been introduced 
into the clinical practice of the paediatric asthm
a team
 at the R
oyal B
rom
pton 
H
ospital London.  This team
 offers m
ultidisciplinary care for children and young 
people w
ith P
S
A
 and has one of the largest populations of children w
ith P
S
A
 for 
w
hom
 poor adherence is a leading cause of sub-optim
al control (B
racken et al., 
2009).  The S
I is currently offered to all young people referred to the service as 
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part of the difficult asthm
a assessm
ent protocol.  A
s this protocol involves a 
healthcare professional view
ing data collected on the S
I and feeding this back 
to fam
ilies, the proposed study also aim
s to explore healthcare professionals’ 
experiences of assessing adherence through the SI (although the focus on this 
w
ill be less given the attention already paid to this in the existing literature).  
A
ttention w
ill be given to experiences of electronic adherence assessm
ent and 
self-care and w
hether young people experience the S
I as prom
oting their 
responsibility to self-care or not.  To help achieve this, I w
ill look out for the 
different view
s participants hold about the S
I and the im
pact it has on the 
process of transferring responsibility for asthm
a to the young people.  A
 focus 
w
ill also be placed on how
 the m
onitoring process im
pacts on the healthcare 
relationship, in particular how
 the beliefs the young people hold about the SI 
influence their experiences of the healthcare relationship.  
 1.4.1. R
esearch Q
uestions 
The proposed study is therefore concerned w
ith the experiences of electronic 
adherence assessm
ent in young people, their caregivers and healthcare 
professionals and seeks to explore how
 assessm
ent of adherence to asthm
a 
m
edication through the S
I is experienced by those involved in this process. 
  The research questions the study seeks to answ
er are: 
 
x 
H
ow
 do young people and caregivers experience being assessed 
through the S
I? 
 
x 
H
ow
 do healthcare professionals involved in assessing adherence using 
the SI experience this process? 
 
x 
H
ow
 does the process of having IC
S
 adherence assessed through the S
I 
influence experiences of self-care and do participants experience the S
I 
as prom
oting young people’s responsibility for self-care or not? 
 
x 
H
ow
 does the process of being given the S
I interact w
ith the relationship 
betw
een the healthcare professional and the young person/caregiver? 
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2. EPISTEM
OLOGY AND M
ETHODOLOGY  
  The purpose of this chapter is to describe the study’s m
ethodology and m
ethod.  
I start by outlining m
y epistem
ological position and the project’s m
ethodology 
and m
ethod.  I then reflect on m
y role as a researcher and how
 I thought this 
m
ay be influential.  I go on to describe the procedure of the study, giving 
inform
ation about the participants, recruitm
ent, ethical considerations and the 
data collection.  Finally I explain how
 I conducted the analysis and how
 I 
planned to evaluate this. 
 2.1. Epistem
ological Position 
 E
pistem
ology has been defined as “a branch of philosophy concerned w
ith the 
theory of know
ledge” (W
illig, 2009, p.2) and is concerned w
ith how
 individuals 
com
e to know
 inform
ation and attain know
ledge.  M
ethodology can be 
understood as “a general approach to studying research topics” (S
ilverm
an, 
1993, p. 1)” w
hilst m
ethod can be understood as “a specific research technique” 
(S
ilverm
an, 1993, p. 1).  D
ifferent m
ethodologies w
ill therefore be influenced by 
one's epistem
ological position and w
ill reflect different assum
ptions about 
know
ledge and the w
ays individuals com
e to know
 and m
ake sense of things 
(W
illig, 2009).  O
ne’s epistem
ological position w
ill also influence the am
ount of 
em
phasis placed on the role and influence of the researcher in the research 
process and w
ill shape decisions m
ade about research design and m
ethods 
(C
arter &
 Little, 2007).  A
 researcher's epistem
ological stance should therefore 
be acknow
ledged. 
 The proposed study is situated w
ithin a critical realist position, based on the 
view
 that inform
ation collected through research can indeed tell us som
ething 
about the “real w
orld”, how
ever the know
ledge created is not a direct reflection 
of reality but reflects the subjective experiences of the participants and the 
interpretations of the researcher (G
reen &
 Thorogood, 2010).  A
 critical realist 
approach differs from
 the positivist or “naive realist” view
 that assum
es that 
research can provide objective and unbiased findings, w
hich the researcher 
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rem
ains outside of.  It acknow
ledges that although research data can tell us 
som
ething about w
hat is going on in the w
orld, it does not do so in a self-
evident, unm
ediated fashion (W
illig, 2009).  This epistem
ological position fits 
w
ith m
y ow
n view
 of the w
orld, in that I understand phenom
ena such as asthm
a 
to be “real” m
edical conditions that exist.  H
ow
ever I also believe that how
 each 
person experiences and talks about such phenom
ena can differ and can be 
shaped by historical, cultural and social factors, w
hich lead to different 
subjective versions of reality (B
urr, 2003).  
 2.2. M
ethodology 
 The current research aim
s to explore experiences of electronic adherence 
assessm
ent equipm
ent.  A
 qualitative approach to research tends to be 
concerned w
ith how
 participants m
ake sense of the w
orld and how
 they 
experience events (W
illig, 2013).  Q
ualitative approaches provide a m
eans for 
rich, in-depth descriptions of experience to be heard (W
illig, 2009).  Q
ualitative 
research is therefore interested in answ
ering questions like “w
hat it is like to 
experience particular conditions” and “how
 people m
anage certain situations” 
(W
illig, 2013, p. 8).  The qualitative researcher focuses on the exploration of 
participants’ personal and social experiences (G
reen &
 Thorogood, 2010).  A
 
qualitative approach is also concerned w
ith identifying recurring patterns and is 
view
ed as aiding the understanding of natural phenom
ena (e.g. asthm
a), 
focusing on the m
eaning, experiences and view
s of participants (A
l-B
usaidi, 
2008).  It also aim
s to give a voice to those w
hose accounts are often not heard 
(W
illig, 2009).  This is particularly im
portant for the current study, w
here w
ithin 
the existing literature there is only a lim
ited exploration into the experiences of 
young people using telem
onitoring equipm
ent in their lives.  Taking this into 
consideration, a qualitative m
ethodology therefore seem
ed fitting. 
 2.3. M
ethod 
 2.3.1. M
ethods of D
ata C
ollection 
In order to collect data from
 m
ultiple sources (young people, caregivers, 
healthcare professionals) I decided to em
ploy tw
o different m
ethods of data 
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collection; sem
i-structured interview
s w
ith the young people and caregivers, and 
a focus group w
ith the healthcare professionals.  U
sing m
ore than one m
ethod 
of data collection to gather the view
s of m
ultiple sources is often described as 
“triangulation” and is view
ed as a w
ay of increasing understanding over and 
above w
hat any m
ethod could achieve in isolation (H
ow
itt, 2010).  
 Interview
s offer a pragm
atic m
eans of listening to the view
s of participants, 
typically related to a particular aspect of their lives or experiences that the 
researcher is concerned w
ith (W
illig, 2013).  Sem
i-structured interview
s can 
com
bine relatively form
al interview
 features such as clear roles for interview
er 
and interview
ee and a set interview
 schedule, w
hilst also incorporating features 
of an inform
al conversation such as open-ended questions and a focus on 
narratives and experience (Firth &
 G
leeson, 2012).  The im
portance of 
establishing and m
aintaining rapport in interview
s is key and the sem
i-
structured form
at selected arguably lends itself w
ell to this, particularly for 
engaging the young people in the study.  
 Focus groups provide an alternative to sem
i-structured interview
s and provide a 
m
ore “naturalistic” setting.  H
ere, the additional elem
ent of the group interaction 
can be utilised as a m
eans of generating arguably richer inform
ation; as 
participants can be m
obilised to respond to and add to each other’s com
m
ents.  
Focus groups also offer a tim
e-lim
ited w
ay of collecting m
ultiple view
s (in the 
current study for very busy and tim
e-lim
ited healthcare professionals), (W
illig, 
2013).  
 2.3.2. M
ethod of D
ata A
nalysis 
I considered several approaches w
hen selecting a m
ethod of data analysis (see 
appendix 1).  O
ne such approach w
as interpretative phenom
enological analysis 
[IP
A
].  IPA
 aim
s to “explore in detail how
 participants are m
aking sense of their 
personal and social w
orld” (S
m
ith &
 O
sborn, 2008, p.53), w
hilst also 
acknow
ledging the role of the researcher and their relationship w
ith participants 
(W
illig, 2013).  H
ow
ever, IP
A as an approach to analysis is situated w
ithin an 
epistem
ology of phenom
enology.  W
hile phenom
enology is concerned w
ith 
subjective, lived experience it does not address issues of m
ateriality.  Taking 
this into account, an approach to analysis grounded in phenom
enology w
ould 
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not perm
it for sufficient attention to be paid to the context in w
hich the 
participants’ experiences occurred.  W
ith the current study focusing on the 
broader investigation of participants’ experiences w
ith sm
art-inhalers, and the 
factors that influenced this (e.g. the w
ays healthcare professionals introduced 
the SI to participants and how
 this im
pacted on how
 they view
ed the device), I 
decided that IP
A
 w
ould not fit w
ith m
y ow
n epistem
ology and the study’s 
research questions.  I therefore decided to conduct a them
atic analysis [TA].     
 TA
 involves a system
atic search through a data set to identify and analyse 
salient patterns of m
eaning and aim
s to organise and describe these (B
oyatzis, 
1998, B
raun &
 C
larke, 2006).  TA
 is com
parable to aspects of content analysis, 
how
ever it also aim
s to m
ove beyond the observed aspects of a data set and 
allow
s the researcher to approach and exam
ine data flexibly, rather than 
w
orking solely from
 a theoretically driven fram
ew
ork (Joffe, 2012).  TA
 can be 
approached from
 different epistem
ological positions and is view
ed as being 
com
patible w
ith a critical realist epistem
ological position (B
raun &
 C
larke, 
2006).  A
 TA
 from
 this perspective can therefore acknow
ledge the w
ays 
individuals construct m
eaning from
 their experience, as w
ell as the w
ays the 
broader social context im
pinges on those m
eanings, w
hilst also retaining focus 
on the m
aterial and other lim
its of “reality” (B
raun &
 C
larke, 2006, p. 81).  TA 
w
as therefore chosen as it is seen to fit w
ell w
ith research questions that aim
 to 
explore “the specific nature of a given group’s conceptualisation of the 
phenom
enon under study” (Joffe, 2012, p. 212).  TA w
as  
 Them
es identified in TA
 can be developed either in an inductive m
anner or 
deductive m
anner (B
raun &
 C
larke, 2006).  An inductive TA w
orks from
 the 
bottom
 up, w
ith the researcher approaching the data w
ithout a theoretically 
inform
ed coding fram
e.  H
ere them
es are seen to be firm
ly grounded in the data 
rather than reflecting the researcher’s theoretical com
m
itm
ents (W
illig, 2013).  A
 
deductive TA on the other hand involves m
apping the data onto a form
 of 
coding tem
plate, usually derived from
 the relevant literature in order to code 
data and develop them
es (C
rabtree &
 M
iller, 1999).  It is also possible to use a 
com
bination of inductive and deductive TA
, w
hereby a priori tem
plate is used to 
organise the data to begin w
ith, but w
here novel them
es are also identified from
 
analysis (Fereday &
 M
uir-C
ochrane, 2006).  The tw
o are then integrated in 
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order to generate a com
prehensive them
atic description of the data.  A
 
com
bination of inductive and deductive approaches w
as therefore adopted for 
the current study in order to fit w
ith the study’s exploratory aim
s and critical 
realist epistem
ological stance, but to also hold in m
ind the current literature and 
the study’s research questions.  This com
bined approach enabled m
e to attend 
to references to issues that previous research has identified as im
portant, w
hile 
also enabling the data to drive the analysis w
ith the intention of being sensitive 
to the possibility of identifying new
 and unanticipated issues 
 Them
es identified in TA
 can also em
erge from
 a m
anifest or at a latent level. 
Them
es at a m
anifest level (also know
n as sem
antic level) refer to that w
hich 
can be directly observed in the data.  B
raun and C
larke (2006) argue that 
them
es identified at a m
anifest level are m
ostly associated w
ith a realist 
perspective.  A
lternatively them
es at a latent level are associated w
ith the ideas 
and assum
ptions that m
ay shape the m
anifest/sem
antic level and are 
associated aligned w
ith a m
ore constructionist perspective (B
oyatzis, 1998). 
Taking into consideration that TA
s often draw
 on both types of them
es (Joffe, 
2013) and the critical realistic perspective of this study, both m
anifest and latent 
them
es w
ere identified.  Joffe (2012) states that a “dual deductive-inductive and 
latent-m
anifest set of them
es are used together in high-quality qualitative 
research” (p. 210).  The current study therefore adopted this approach to the 
TA
. 
 2.4. Reflexivity 
 W
illig (2013) in her discussions surrounding reflexivity acknow
ledges the 
“im
possibility of rem
aining outside of one’s subject m
atter w
hilst conducting 
research” (p. 10).  G
reen and Thorogood (2010) also recognised this, arguing 
that objectivity in research is not possible, as both the research and the 
researcher exist as part of a w
orld w
here subjectivity is inevitable.  The process 
of reflexivity therefore requires researchers to explore and reflect on the w
ays 
their values, beliefs and experiences, am
ongst other factors, m
ay influence their 
reactions to the research context and data, and im
pact on the eventual 
outcom
es of the study (N
ightingale &
 C
rom
by, 1999).  This can be understood 
as “personal reflexivity” (W
illig, 2013, p. 10).  I felt that m
y position as a young, 
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w
hite B
ritish, professional fem
ale (in relatively good health) m
ight have 
influenced both m
y interactions w
ith and m
y understanding of the participants’ 
experiences.  
 A
dditionally W
illig (2013) posits that one m
ust also be concerned w
ith 
“epistem
ological reflexivity” (p. 10), w
here w
e reflect upon the assum
ptions 
(about the w
orld, about know
ledge) that w
e have m
ade in the course of the 
research.  In developing this research project I w
as aw
are that in positioning 
m
yself as a critical realist (described above), I w
as aligning m
yself to a 
particular view
 of the w
orld that the participants in the study m
ay not share.  I 
w
as therefore m
indful that in constructing aspects of the research project such 
as the research questions and interview
 schedule, that I w
as constructing these 
in a particular w
ay based on m
y view
 of the w
orld, and this view
 m
ay then have 
been im
posed on the participants.  W
illig (2009) highlights that a pow
er 
differential betw
een researcher and participant can exist w
hen carrying out 
research and that it is particularly im
portant to acknow
ledge and address this.  
W
hilst it can be difficult to rem
ove this pow
er dynam
ic, I hoped that m
y 
approach to certain aspects of the research (e.g. introducing m
yself as being 
outside of the clinical team
 at R
B
H
, prom
oting ethical aspects of the study such 
as the right to confidentiality and the right to w
ithdraw
 and using a sem
i-
structured interview
 schedule w
hich w
as guided by participants as m
uch as 
possible in the interview
s) helped m
inim
ise the pow
er differential.  I also kept a 
reflexive journal (appendix 2) during the com
pletition of this study to help m
e 
reflect on certain aspects of the research process.  I w
ill discuss ideas around 
reflexivity in further detail during the D
iscussion C
hapter.  
 2.5 Selection and Recruitm
ent of Participants 
 2.5.1. Sam
ple 
K
endall et al. (2009) posit that m
ulti-perspective or “linked qualitative interview
s 
conducted w
ith patients and their inform
al and professional carers can generate 
a richer understanding of needs and experiences than the single perspective 
m
ost com
m
only used in qualitative studies” and that “interview
 dyads or tri‐ads, 
w
here tw
o or three participants are interview
ed as a set or case study, can 
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explore com
plex com
plem
entary as w
ell as contradictory perspectives, and 
there is considerable scope for using this m
ethod in a range of long-term
 
conditions.” (p.196).  The process of adherence assessm
ent described in the 
introduction involves several people; the young person asked to use the S
I, the 
caregiver (and arguably other fam
ily m
em
bers) of this young person, and the 
healthcare professionals using the S
I w
ith this young person as part of their 
clinical practice.  E
ach of these people w
ill have their ow
n experience and view
s 
of the SI and these m
ay com
plem
ent or contradict that of each other.  The 
sam
ple selected, therefore, com
prised not only of young people w
ith difficult 
asthm
a receiving care at R
B
H
, but also the caregivers of these young people 
and their healthcare professionals at this hospital.  
 The R
B
H
 has one of the largest populations of children w
ith problem
atic severe 
asthm
a for w
hom
 poor adherence is a leading cause of sub-optim
al control 
(B
racken et al., 2009).  This is a tertiary service, w
hich receives referrals largely 
from
 South East England but occasionally from
 further afield.  The SI is 
currently offered to all young people referred to the service as part of the difficult 
asthm
a assessm
ent protocol.  These young people w
ill have long-term
 asthm
a 
and w
ill have been using IC
S
 for at least a year. 
 2.5.2. Inclusion and E
xclusion C
riteria 
The inclusion criteria for the young people recruited to participate in this study 
w
ere as follow
s: 
 
x 
A
ged 11-16 years. 
x 
R
eferred w
ith difficult asthm
a to the paediatric asthm
a team
 at R
B
H
. 
x 
Issued w
ith the SI as part of their clinical care (during the study's set tim
e 
period of July 2014 to Jan 2015). 
 
C
aregivers of the young people w
ho m
et these inclusion criteria w
ere also 
invited to participate, as w
ere m
em
bers of staff w
ho used the S
I in their clinical 
practice at R
B
H
. 
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D
ue to the financial and tim
e lim
itations im
posed on the study there w
as no 
funding available for translation services.  Therefore only those able to 
understand and speak E
nglish w
ere invited to participate in the study.  
H
ow
ever, it w
as not anticipated that this w
ould neglect a particular participant 
group as the m
ajority of young people attending the R
B
H
 clinic can speak 
E
nglish.  Furtherm
ore during the recruitm
ent period of the study all potential 
participants did indeed understand and speak E
nglish.  
 2.5.3. Sam
ple S
ize 
It w
as intended that approxim
ately 24 interview
s w
ould be carried out, 12 w
ith 
the young people and 12 w
ith a caregiver.  This w
as in line w
ith the 
recom
m
endations of G
uest, B
unce and Johnson (2005) w
ho advise that a 
m
inim
um
 of six interview
s should be carried out and that data saturation  “the 
point at w
hich no new
 inform
ation or them
es are observed in the data” (p. 59) 
can be reached from
 approxim
ately 12 interview
s.  I therefore aim
ed to 
interview
 a m
inim
um
 of six and as close to 12 young people and 12 caregivers 
as w
as possible during the study tim
e fram
e.  
 It w
as hoped that approxim
ately six to eight healthcare professionals w
ould be 
able to participate in the study.  This num
ber w
as calculated based on 
inform
ation received from
 the paediatric asthm
a team
 regarding the num
ber of 
staff w
orking in their team
 w
ho used the S
I as part of their clinical practice.   
 2.5.4. R
ecruitm
ent  
2.5.4.1. Young people and caregivers 
A
s the S
I is given out to young people in the paediatric asthm
a team
 at R
B
H
 as 
part of the difficult asthm
a assessm
ent protocol, it w
as agreed w
ith the team
 
that the healthcare professional issuing the S
I w
ould introduce the young 
person and their caregiver to the study during a routine clinic appointm
ent 
w
here the SI w
as discussed.  The healthcare professional asked the young 
person and their caregiver if they w
ould be happy to be interview
ed by a 
researcher independent of the clinical team
 about their view
s and experiences 
of using the SI.  They also inform
ed them
 that choosing w
hether or not to 
participate w
ould not affect the care they received at R
B
H
.  Any young people 
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and caregivers w
ho expressed an interest at this stage w
ere then given an 
inform
ation sheet (appendices 3-5) w
ith m
ore details, and verbal consent w
as 
sought for their details to be shared w
ith m
e.  I then m
et these potential 
participants (for the young people this w
as done in the presence of their 
parent/caregiver) to tell them
 m
ore about the study and to confirm
 that they 
w
ould like to take part.  A
head of the interview
 I w
ould go through the 
inform
ation sheet w
ith them
 again and asked them
 to sign a consent/age 
appropriate assent form
 (appendices 6-8).  Interview
s w
ere carried out follow
ing 
the appointm
ent w
here the S
I w
as due to be returned (approxim
ately 6-8 w
eeks 
after it w
as issued). 
 2.5.4.2. Healthcare professionals 
I approached the healthcare professionals of the young people w
ho m
et the 
inclusion criteria for the study during one of their w
eekly team
 m
eetings at R
B
H
.  
This w
as arranged in advance w
ith the support of one of the C
onsultants in the 
paediatric asthm
a team
 w
ho introduced the study to the team
 via em
ail ahead 
of this m
eeting.  D
uring this m
eeting I gave the team
 m
ore inform
ation about the 
study, giving them
 an inform
ation sheet (appendix 9) and asked those w
ho 
w
ere interested in sharing their view
s to sign a consent form
 (appendix 10).  
The focus group w
as then carried out w
ith those w
ho agreed to participate.  It 
com
m
enced by agreeing a set of ground rules, w
hich included an agreem
ent of 
confidentiality w
ithin the group, as w
ell as som
e discussion around the 
im
portance of all participants’ view
s being heard equally.  
 2.6. Participants 
 2.6.1. Young People and C
aregivers 
A
ll 12 young people and 12 caregivers w
ho attended R
B
H
 during the study’s 
recruitm
ent period and m
et the inclusion criteria w
ere approached by the clinical 
team
 and introduced to the study.  O
f these potential participants, eight young 
people and eight caregivers consented to take part in the study and w
ere 
subsequently interview
ed.  O
f the others w
ho w
ere approached one caregiver 
declined to participate and did not give perm
ission for their child to participate, 
another caregiver and young person initially agreed to participate but left the 
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clinic prior to the interview
 and another caregiver and young person also agreed 
in principle but requested the interview
 to take place at a later date w
hich I w
as 
unable to m
ake.  A
nother caregiver and their child did express an interest in 
participating but did not m
eet the inclusion criteria and w
ere therefore not 
interview
ed. 
 Tables 1 and 2 (overleaf) sum
m
arise the basic dem
ographic details of the 
participants w
ho took part.  
 2.6.2. H
ealthcare P
rofessionals 
S
even healthcare professionals from
 the paediatric asthm
a team
 took part in 
the focus group.  This included four C
onsultants, tw
o S
pecialist N
urses and one 
R
esearch N
urse.  
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 Table 1: Young People Demographics  
Pp No. Pseudonym Gender Ethnicity Age at 
Interview 
Location 
of 
interview 
Duration of 
Interview 
Returned 
SI? 
Feedback 
on SI 
Results 
Joint or 
Separate 
Feedback 
on Study 
1 Theo Male White 
British 
11 Hospital 
Bed 
24m 15s Yes No Separate Yes 
2 Sam Male  White 
British 
12 Hospital 
Bed 
22m 31s Yes No Separate Not 
requested at 
this time 
3 Aysha Female Asian 
British 
11 Hospital 
Bed 
20m 45s 
(Total duration 
35m 57s) 
No No Joint Not 
requested at 
this time 
4 Chanelle Female White 
British 
14 Outpatient 
Clinic 
27m 52s No No Separate Not 
requested at 
this time 
5 Gary Male White 
British 
14 Outpatient 
Clinic 
26m 45s 
(Total duration 
45m 09s) 
Yes No Joint Not 
requested at 
this time 
6 Isla Female White 
British 
15 Hospital 
Bed 
35m 14s No No Separate Yes 
7 Rabhya Female Asian 
British 
13 Outpatient 
Clinic 
32m 54s Yes No Separate Not 
requested at 
this time 
8 Claire Female White 
British 
13 Outpatient 
Clinic 
30m 34s Yes No Separate Not 
requested at 
this time 
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Table 2: Caregiver Demographic
Pp No. Pseudonym Gender Ethnicity Relationship 
to Young 
Person 
Location 
of 
interview 
Duration 
of 
Interview 
Returned 
SI? 
Feedback 
on SI 
Results 
Joint or 
Separate 
Feedback 
on Study 
1 Jessica Female White 
British 
Mother Hospital 
bed 
17m 20s Yes No Separate Yes 
2 Lizzie Female White 
British 
Mother Hospital 
bed 
16m 13s Yes No Separate Not 
requested 
at this time 
3 Samia Female Asian 
British 
Mother Hospital 
bed 
15m 12s 
(Total 
duration 
35m 57s) 
No No Joint Not 
requested 
at this time 
4 Danielle Female White 
British 
Mother Outpatient 
Clinic 
19m 37s No No Separate Not 
requested 
at this time 
5 Estelle Female White 
British 
Mother Outpatient 
Clinic 
18m 24s 
(Total 
duration 
45m 09s) 
No No Joint Not 
requested 
at this time 
6 Janet Female White 
British 
Mother Hospital 
bed 
25m 12s No No Separate Yes 
7 Nimisha Female Asian 
British 
Mother Outpatient 
Clinic 
11m 10s Yes No Separate Not 
requested 
at this time 
8 Sarah Female White 
British 
Mother Outpatient 
Clinic  
24m 13s Yes No Separate Not 
requested 
at this time 
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2.7. Data Collection- Interview and Focus Group Procedures 
 The interview
s w
ere carried out face to face in a private setting at R
BH
 and took 
place follow
ing the appointm
ent w
here the S
I w
as due to be returned 
(approxim
ately 6-8 w
eeks after it w
as issued).  For four of the young people and 
their caregivers the S
I w
as due to be returned during a prearranged inpatient 
adm
ission to R
B
H
 and therefore interview
s w
ere conducted in their hospital 
room
s.  For the other young people and their caregivers, interview
s w
ere 
carried out follow
ing outpatient appointm
ents w
here the S
I w
as due to be 
returned.  A clinical room
 in the outpatient departm
ent w
as used for these 
interview
s.  A
s discussed earlier, prior to com
m
encing the interview
 I w
ould go 
through the relevant inform
ation sheets w
ith both the young person and their 
caregiver before asking the caregiver to sign a consent form
 for them
selves and 
another to give consent for their child to participate.  The young people w
ere 
then invited to sign an age appropriate assent form
.  I then carried out the 
interview
s; starting w
ith the young person and then m
oving onto the 
caregivers
6.  The interview
s w
ere guided by an interview
 schedule
7, w
hich 
consisted of several open-ended questions that w
ere influenced by m
y research 
aim
s (appendices 11-12).  Interview
s lasted on average 27 m
inutes for the 
young people and 18 m
inutes for the caregivers.  Tw
o sets of young people and 
their caregivers requested for their interview
s to be carried out jointly (in the 
presence of each other), both requested this due to their tim
e lim
itations.  I 
discussed this w
ith m
y university supervisor at the tim
e and w
e agreed that for 
the purpose of encouraging participation in the study that this request could be 
m
et.  D
uring these interview
s I attended to the relationship dynam
ic betw
een 
young person and caregiver and later m
ade notes in m
y reflexive journal related 
to this, to help m
e consider w
hether the process of answ
ering questions in front 
of each other had influenced their responses.  I w
ill com
e back to this in m
y 
discussion section.  Follow
ing each interview
, I explained to participants that 
they could contact m
e if they w
ould like a sum
m
ary of the results.  At the tim
e of 
                                                        
6 O
f note w
as that all eight caregivers interview
ed w
ere m
others.  O
f the other four approached, 
tw
o w
ere fathers.  I w
ill consider this absence of fathers further in m
y discussion. 
7 The interview
 schedule w
as piloted w
ith a young person from
 R
BH
 w
ho had used the SI 
previously and their caregiver, prior to the interview
s being carried out.  This allow
ed a 
“practice-run” of the interview
 process and also generated positive feedback on the relevance 
and acceptability of the questions being asked. 
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w
riting four participants have requested this (tw
o young people and their 
caregivers).  
 The focus group took place at R
B
H
 in the form
at described above.  It lasted half 
an hour.  The focus group w
as also guided by an interview
 schedule, w
hich 
consisted of several open-ended questions that w
ere influenced by m
y research 
aim
s (appendix 13).  In consultation w
ith m
y university supervisor regarding the 
lim
its to m
y tim
e and resources in com
pleting this study, it w
as agreed that the 
focus group w
ould not be recorded and transcribed, but that instead I w
ould 
take basic notes during the group on the m
ain ideas and view
s shared.  A
t the 
end of the focus group I fed back w
hat I had noted dow
n to the participants and 
agreed these notes and the m
ain ideas generated from
 their discussion w
ith 
them
. 
 2.8. Apparatus 
 Interview
s w
ere recorded w
ith a digital voice recorder, w
hich w
as placed in view
 
of the participants.  P
articipants w
ere m
ade aw
are of this in the inform
ation 
sheet and gave consent for their interview
 to be recorded.  O
nce com
pleted, 
interview
s w
ere transcribed on a com
puter. 
 2.9. Ethical Issues 
 2.9.1. Ethical Approval 
 
The study w
as granted ethical approval from
 the S
chool of P
sychology 
R
esearch Ethics C
om
m
ittee (appendix 14), the U
niversity of East London 
R
esearch Ethics C
om
m
ittee (appendix 15), an N
H
S
 R
esearch E
thics 
C
om
m
ittee (appendix 16) and the local R
esearch and D
evelopm
ent O
ffice 
(appendix 17).   
 2.9.2. C
onsent 
P
rior to any interview
s or the focus group inform
ed consent w
as obtained from
 
all participants.  A
s the young people participating w
ere under the age of 18, 
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consent w
as sought from
 their caregiver.  H
ow
ever an assent form
 tailored to 
11-16 year olds w
as also given to each young person.  
B
efore giving consent 
participants had the opportunity to read through the relevant inform
ation sheet 
and w
ere invited to ask any questions and discuss their rights (e.g. to 
confidentiality, to w
ithdraw
 from
 the study and to term
inate the interview
). 
 2.9.3. C
onfidentiality and Anonym
ity 
I preserved the confidentiality and anonym
ity of participants taking part in the 
study in line w
ith the D
ata P
rotection A
ct (B
ritish P
arliam
ent, 1998).  I explained 
to all participants their right to confidentiality and anonym
ity verbally and also 
outlined this in the inform
ation sheets and consent form
s.  I w
as the only person 
to collect data and transcribe interview
s.  A
ny identifiable data that w
as 
collected w
as anonym
ised, w
ith participants assigned a pseudonym
 and a 
participant num
ber.  These w
ere used w
hen transcribing and any identifying 
references that w
ere discussed during interview
s w
ere changed at the tim
e of 
transcription (e.g. nam
es, locations etc.).  C
onsent form
s (w
hich included the 
participants’ nam
es and signatures) w
ere stored in a locked filing cabinet aw
ay 
from
 all other data.  A
ll other data w
as kept on m
y personal com
puter, w
hich 
requires a passw
ord to access.  I explained the nature of the study to all 
participants and that this m
eant that m
y university supervisor and exam
iners 
w
ould be able to read extracts from
 the anonym
ised transcriptions of interview
s.  
I also advised that there w
as a possibility that I w
ould develop the research at a 
later stage (for publication, for exam
ple).  W
ith this is m
ind I explained that all 
audio recordings w
ould be destroyed after exam
ination of the study, but that 
electronic copies of anonym
ised transcripts w
ould be kept securely for three 
years in order for m
e to develop the research further.  
 2.9.4. Further Support 
 
A
lthough no adverse effects w
ere anticipated as a consequence of taking part 
in the study, the inform
ation sheets highlighted that participants could contact 
U
E
L if they had any concerns about their participation in the study.  In addition, 
as young people w
ere involved in the study I arranged w
ith one of the local 
collaborators (a qualified C
linical P
sychologist) that they w
ould be available to 
support m
e if any concerns did arise.  
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2.10. Data Analysis 
 A
ttride-S
tirling, (2001) stresses the im
portance of describing how
 data is 
analysed in order to clarify how
 final conclusions com
e about and to understand 
the steps that w
ere taken in reaching them
.  A
s detailed above, TA
 w
as used to 
analyse the data.  M
y university supervisor provided supervision of the analysis.  
Them
es w
ere developed follow
ing analysis of each interview
 and the data set 
as a w
hole.  W
hile som
e participants spoke m
ore than others, all view
s w
ere of 
equal im
portance and therefore them
es chosen w
ere those w
hich captured 
im
portant elem
ents from
 across the data (B
raun &
 C
larke, 2006).  
 It is im
portant to recognise that any form
 of qualitative data analysis w
ill involve 
a level of interpretation.  Interpretation involves engaging w
ith the research data 
in a w
ay to m
ake sense of and finding m
eaning in it in a w
ay that m
ay not 
im
m
ediately obvious (W
illig, 2013).  D
ifferent interpretations w
ill be m
ade 
depending on one’s epistem
ological position and the different questions being 
asked.  In positioning m
yself as a critical realist I w
as therefore aw
are that I m
ay 
have attended to and interpreted the content of the interview
s differently to how
 
another w
ho view
ed the w
orld differently and held a different epistem
ological 
position w
ould.  
 2.10.1. Transcription 
 
Transcription can be view
ed as one of the first and key stages of data analysis 
and there are different w
ays for interview
s to be transcribed, w
hich w
ill be 
inform
ed by one’s epistem
ology and m
ethodology (B
ird, 2005, W
ilkson, 2008).  
TA
 does not require the sam
e level of detail in transcription as conversation, 
discourse or narrative analysis (B
raun &
 C
larke, 2006).  H
ow
ever the transcript 
should include all inform
ation from
 the verbal account.  Interview
s w
ere 
transcribed at a sem
antic level, w
ith attention placed on w
hat w
as said rather 
than the w
ay in w
hich it w
as said (e.g., tone, em
phasis etc.).  The transcription 
conventions used for this study w
ere adapted from
 P
arker (2005) and are 
show
n in appendix 18.  To be thorough, I listened to the interview
s again after 
transcription (Parker, 2005).     
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2.10.2. The P
rocess of TA
 
The process of analysis w
as inform
ed by the guidelines set out by Braun and 
C
larke (2006).  A
lthough these guidelines form
 a fram
ew
ork w
ith w
hich to 
approach the data, B
raun and C
larke (2006) note the flexibility of these and 
stress that they are not strict rules to be follow
ed, but should be adapted to best 
suit the research.  They stress that analysis is not a linear process, but requires 
m
ovem
ent back and forth throughout the phases.  
 2.10.2.1. Fam
iliarity with data 
B
raun and C
larke (2006) note that regardless of w
hether or not you are aim
ing 
for an overall or detailed analysis, are searching for latent or sem
antic them
es, 
or are data or theoretically driven it is im
portant to be fam
iliar w
ith all aspects of 
your data.  The initial stages of carrying out and transcribing the interview
s 
described above aided this process.  Interview
s w
ere analysed individually w
ith 
recordings listened back to at least tw
ice.  Initial annotations w
ere m
ade by 
hand, w
ith notes m
ade about anything thought relevant, for exam
ple initial 
thoughts about codes, content and language.  This helped w
ith generating an 
initial list of ideas about w
hat w
as in the data.  
 2.10.2.2. Generating initial codes 
This phase involved the identification of initial codes from
 the data.  C
odes can 
be defined as “the m
ost basic segm
ent, or elem
ent, of raw
 data or inform
ation 
that can be assessed in a m
eaningful w
ay” (B
oyatzis, 1998, p. 63).  C
oding w
as 
carried out by hand on the transcripts, w
ith som
e segm
ents given m
ultiple 
codes (see appendix 18 for an exam
ple from
 one transcript).  C
oded transcripts 
w
ere re-read to ensure all data segm
ents had been included.  A
ll codes w
ere 
transferred into a spreadsheet to form
 a “coding m
anual” (Joffe, 2012) w
ith 
associated data segm
ents from
 across the data set (see appendices 20-22). 
 2.10.2.3. Search for them
es 
This phase re-focused the analysis at the broader level of them
es and involved 
organising the different codes into provisional them
es.  This w
as done visually 
using m
aps (see appendix 23) and involved collating all relevant coded data 
extracts w
ithin the identified them
es.  I considered “the relationship betw
een 
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codes, betw
een them
es, and betw
een different levels of them
es (e.g. m
ain 
overarching them
es and sub-them
es w
ithin them
)” (B
raun &
 C
larke, 2006, pp. 
89-90).  S
om
e codes later becam
e them
es w
hilst others w
ere collapsed into 
other them
es.  A
s suggested by B
raun and C
larke (2006) a list of m
iscellaneous 
codes that appeared not to fit w
ithin initial them
es w
as kept.  A
t the end of this 
phase, provisional them
es had been identified w
hile som
e codes and them
es 
w
ere discarded.  In their guidance B
raun and C
larke (2006) highlight that 
them
es can be determ
ined by salience w
ithin each data item
 and prevalence 
across the w
hole data set.  H
ow
ever, they also recognise that the “keyness” 
(B
raun & C
larke, 2006, p.82) of a them
e should not solely be based on its 
frequency in the data, but also through its relevance to the research question 
and on researcher judgem
ent.  Therefore, although repetitions of them
es w
ere 
assum
ed to be reflective of salience, these other factors also contributed to 
them
e developm
ent.  A
 list of three provisional them
es w
as identified at the end 
of this stage (appendix 23).  
 2.10.2.4. Review of them
es 
This phase involved review
ing and refining them
es (B
raun &
 C
larke, 2006), 
considering w
hether them
es are heterogeneous and that codes w
ithin them
es 
are hom
ogeneous (P
atton, 1990).  I re-read the extracts w
ithin each them
e to 
ensure that they all related to the identified them
es.  I then review
ed the 
different them
es and their extracts to ensure they w
ere distinctive.  I then re-
read the entire data set in order to consider the validity of the them
es in relation 
to the transcripts and to ascertain w
hether the them
atic m
ap accurately 
reflected the m
eanings evident in the data set as a w
hole (B
raun &
 C
larke, 
2006).  D
uring this stage, them
es w
ere m
erged and discarded and sub-them
es 
developed.  Them
es w
ere then review
ed across the w
hole data set.  This w
as 
carried out w
ith the aim
 of developing a set of them
es that provided an accurate 
representation of the data.  A
t the end of this phase, three revised them
es w
ere 
identified, each w
ith sub-them
es w
ithin them
 (appendix 24).  
 2.10.2.5. Defining and nam
ing them
es 
O
nce satisfied w
ith the them
atic m
ap of the data, the next phase in the TA
 
process involves defining and nam
ing the them
es.  This process involves 
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identifying aspects of the data that each them
e and sub-ordinate them
e 
capture, w
hat is interesting about them
 and w
hy.  I considered the story that 
each them
e told to help m
e define them
.  I also considered the extent to w
hich 
each them
e related to the research aim
s (appendix 25).  A
t this point changes 
w
ere m
ade to them
es and final nam
es decided upon.  
 2.10.2.6. Producing the report 
The final stage of the analysis w
as the production of the report, w
hich is found 
in the follow
ing chapter and aim
s to provide a precise and coherent sum
m
ary of 
the data.  N
um
erous data extracts are given to illustrate them
es and invite the 
reader to evaluate w
hether the them
es and quotes are reflective of the story 
being told about the data.  The research questions are also kept in m
ind. 
 P
articipants are referred to using their pseudonym
.  I included broad categories 
to describe how
 m
any participants reported certain them
es; i.e. “som
e”, 
“several”.  The rationale behind this w
as to highlight to the reader the differing 
responses rather than to provide a quantification of the data. 
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3. RESULTS 
 From
 m
y them
atic analysis, three super-ordinate them
es and six sub-ordinate 
them
es w
ere identified, as show
n in table 3 and appendix 24.  
 Table 3: Super-Ordinate and Sub-Ordinate Them
es  
3.1. 
“They W
ere Trying To Help 
M
e G
et B
etter” 
3.1.1. 
“It Feels Like I’m
 K
ind O
f 
D
ying” 
 
 
 
3.1.2 
“It H
elps U
s To G
et The 
B
asics R
ight” 
3.2. 
“It’s Clearly Just To Check 
U
p” 
3.2.1. 
“It W
as A
 Little B
it S
pyee” 
 
 
3.2.2. 
“They S
hould P
ut The Tracker 
In Y
our Throat”  
3.3. 
W
ho Is Responsible? 
3.3.1. 
“A
s I’m
 O
lder N
ow
 S
he Tells 
M
e It’s M
y R
esponsibility” 
 
 
 
3.3.2. 
“It R
eversed B
ack To B
eing 
U
s” 
  3.1. “They W
ere Trying To H
elp M
e G
et B
etter” 
 This them
e highlights som
e of the w
ays in w
hich participants’ beliefs about 
asthm
a and their understandings of the risks and vulnerabilities it posed 
influenced their expectations of the healthcare relationship and their experience 
of being given the S
I.  It encom
passes tw
o sub-ordinate them
es: “It feels like I’m
 
kind of dying” outlines som
e of the beliefs participants held about asthm
a and 
the need for m
edical treatm
ent.  “It helps us to get the basics right “ describes 
participants’ view
s of the S
I as helping healthcare professionals to im
prove 
patients’ health.    
 3.1.1. “It Feels Like I’m
 K
ind O
f D
ying”  
Throughout the interview
s, the descriptions of asthm
a that w
ere shared 
portrayed the health condition as a scary and life threatening illness for w
hich 
frequent hospital adm
issions and m
edical treatm
ent w
ere required.  A
t the 
beginning of m
y interview
 w
ith A
ysha and her m
other Sam
ia, Sam
ia told m
e 
about the im
pact of asthm
a on A
ysha’s life and som
e of the m
edical treatm
ent 
she had received: 
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S
am
ia: It just happens her asthm
a is quite an unusual case w
here she 
could be fine one m
inute and the next m
inute she could be like w
heezing 
and can’t breathe and stuff, she ended up in intensive care tw
ice in the 
last year last N
ovem
ber and last April  
A
m
y: G
osh so that m
eans you have to go into hospital quite a lot then? 
S
am
ia: S
ince June now
 cause she’s had one of them
 these err asthm
a 
related injections she’s been fine but before that the last tw
o years it’s 
been really really hard cause since she w
as 10 w
e’ve been in hospital 
once a w
eek som
etim
es tw
ice, and then she had a m
assive cardiac arrest 
on the w
ard as w
ell back in N
ovem
ber  
(S
am
ia, A
ysha &
 S
am
ia, 22-31) 
 O
ther participants also described sim
ilarly the severe nature of their asthm
a and 
their experiences of requiring urgent m
edical attention.  R
abhya described just 
how
 scary asthm
a could be for her: 
 
 
A
m
y: C
an you tell m
e a bit about your asthm
a? 
R
abhya: It m
akes m
e unw
ell, 
it’s 
really 
painful, 
hard 
to 
breath 
and 
som
etim
es I have to go to A
 and E
 to get nebulizers and IV
s to help  
A
m
y: S
o it had a yeh a really big, it’s a big deal then? 
R
abhya: Yeh [coughs] 
A
m
y: A
nd have you had asthm
a your w
hole life? 
R
abhya: E
rm
 no m
um
 said that I, it w
as discovered w
hen I w
as 2 years old  
A
m
y: O
k and w
he-, so bit of a strange question but can you rem
em
ber 
w
hen you knew
 you had asthm
a, w
hen you w
ere like oh that’s w
hat that is, 
or did som
ebody tell you? 
R
abhya: I think erm
 w
hen I w
as in year 1, cause I w
as in hospital for a-, I 
w
ent to em
ergency cause I had collapsed so the-, I w
ent to hospital and 
got IV
s nebulizer and I had to have saline put through m
y body [Am
y: O
h 
gosh] yeh that’s w
hen I realised [A
m
y: Yeh], it w
as really scary as I w
as 
like really young at that tim
e  
A
m
y: I bet, w
hen you’re really young to have to go through that it sounds 
really scary [R
abhya: Y
eh], and so you w
ere saying that like up to now
 it’s- 
still there’s tim
es w
hen you have to go to hospital? 
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R
abhya: E
ven now
 it’s still scary because it feels like to m
e it feels like I’m
 
kind of dying [Am
y: Yeh yeh] 
(R
abhya, 1-24) 
 These accounts, as w
ell as others contributed to the em
erging picture of a 
healthcare relationship w
here patients go to their healthcare professional w
ith 
asthm
a related health concerns to receive m
edical treatm
ent to im
prove their 
health.  Additionally m
any of the participants talked about w
hat have been 
described by H
orne and W
einm
an (2002) as treatm
ent necessity beliefs, in this 
case the need for IC
S
.  For exam
ple in Theo’s interview
, he talked about w
hy 
he felt he needed to take IC
S
 and the things this perm
itted him
 to do that he 
w
ould otherw
ise be unable to do: 
 
A
m
y: W
hy do you think it helps [taking your inhaler]? 
Theo: B
ecause I can do m
ore as in w
hen I didn’t have it I tried to do like a 
m
ile race or round that and I couldn’t but now
 like the past year w
hen I 
took it before the race I could do it all 
(Theo, 113-116) 
 C
laire’s m
other S
arah also spoke about the necessity of IC
S
 and how
 she 
encouraged her daughter to use them
 to avoid unnecessary hospitalisations: 
 
S
arah: Y
eh I m
ean cause the m
ore if she doesn’t forget to take it [the 
inhaler] then I keep saying to her the you w
on’t have to com
e up the 
hospital as often I said and that w
ay you know
 so touch w
ood you never 
hap- nothing ever happens I said but if you do keep forgetting to take it 
there could be an instance w
here you know
 I m
ight have to call the 
num
bers [em
ergency num
bers] yeh so 
(S
arah, 117-121) 
 
Theo and S
arah’s responses also highlight som
e of the different priorities 
participants had surrounding their m
otivations for taking IC
S
.  W
hilst in Theo’s 
case, IC
S enabled him
 to do things that he valued such as playing sports, for 
S
arah, as a m
other, her priorities centred around helping her daughter avoid 
negative consequences such as hospitalisation.  
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 3.1.2. “It H
elps U
s To G
et The B
asics R
ight”  
S
everal of the young people described how
 the S
I w
as som
ething introduced to 
“help” them
: 
  
A
m
y: A
nd w
hen they [the healthcare professionals] gave it you did they 
say w
hy they w
anted you to have it? 
G
ary: They said so w
e can m
onitor your like usage and to see w
hen 
you’re taking it and w
hen you’re not taking it so w
e can help you w
ith a 
plan of attack  
(G
ary, G
ary &
 E
stelle, 126-129) 
 C
laire: They said that they w
ere gonna erm
 record m
e to see if I w
as 
taking it cause I w
eren’t really taking it before [A
m
y: O
k] and they said that 
err they w
ere trying like to help m
e get better and because I w
asn’t taking 
it properly that that I needed to m
ake sure I w
as taking it to get better and 
cause I w
eren’t taking it yeh  
(C
laire, 115-119) 
 
C
laire’s w
ords also bear resem
blance to som
e of the descriptions above, w
ith 
IC
S
 again being view
ed as som
ething that is needed to im
prove health.  C
laire 
also described having “got better” since using the S
I, explaining that she no 
longer needed to use her reliever inhaler: 
 
A
m
y: W
hat did you think about that [being given the sm
art-inhaler]?  
C
laire: I thought it w
as a good idea cause ever since I’ve been taking it like 
I’ve got better I don’t even use the blue one cause I used to use the blue 
one all the tim
e [A
m
y: W
ow
 ok] but since I’ve been using the red one I 
don’t take the r- blue one that m
uch 
(C
laire, 125-129).  
 The discussion points from
 the healthcare professionals’ focus group also 
reflected the idea of the S
I being associated w
ith health benefits and illustrates 
their priorities as helping patients avoid negative consequences: 
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Focus 
group 
discussion: 
O
ne 
patient 
said 
this 
[sm
art-inhaler] 
has 
substantially im
proved her lung function too so health benefits are also a 
benefit of using the sm
art-inhaler.  It also helps the patients avoid having 
to have m
ore invasive treatm
ents such as a test of steroid responsiveness 
w
hich is quite invasive 
(H
C
P
 focus group, 34-38) 
 
There w
as also som
e acknow
ledgem
ent in participant accounts of the portability 
benefits the S
I offered; extending the healthcare assessm
ent to patients’ hom
es 
and reducing the need for hospital observation: 
 
A
m
y: Yeh and in your ow
n personal opinion w
hat do you think it’s for? 
S
am
ia:  Sam
e kind of thing it’s probably like a research that they’ve com
e 
up w
ith and then they just w
ant to like, obviously cause w
hen they are in 
London and w
e are in [location far aw
ay] they cant really check w
hat 
you’re doing so it just records dow
n everything that’s been happening and 
then they get, they can even keep that in your records to show
 that this 
person has been taking their inhalers and that they’ve been on a test for 6 
w
eeks 
(S
am
ia, 198-204) 
 A
m
y: S
o kind of yeh on the w
hole seeing them
 as a good thing that can 
help fam
ilies and doctors? 
E
stelle: Yeh yeh exactly if they can w
ork it out instead of having (unclear 
‘to’) it takes out the need of being in hospital under observation for a w
hile 
A
m
y: Y
eh that’s a really good point actually I guess because I’ve m
et a lot 
of young people w
ho have to be in hospital  
E
stelle: =Y
eh to be observed, it’s just som
ething that it just take it hom
e 
and do regularly in regular life and then just plug it into a m
achine then 
that saves, takes tw
o three w
eeks out of your life you know
 
(E
stelle, G
ary &
 E
stelle, 345-353) 
 
P
articipants also highlighted that the S
I results could aid m
edical understanding 
and place an onus on healthcare professionals to change their practice in 
  
50 
response to the results.  For exam
ple, w
ithin the focus group som
e of the 
im
plications of using the S
I in clinical practice w
ere discussed: 
 
Focus group discussion: The data the sm
art-inhaler gives us helps to see 
if asthm
a control is bad or good and see if this is linked to their difficult 
asthm
a or not 
(H
C
P
 focus group, 7-10) 
 Focus group discussion: It also avoids us having to do m
ore invasive 
treatm
ents as described above.  It also helps us to get the basics right  
(H
C
P
 focus group, 49-51) 
 
R
abhya and Sarah also described how
 they believed the S
I results could aid 
healthcare professionals’ understanding of the contributors to a young person’s 
asthm
a and w
hat the relevant treatm
ent m
ay be: 
 
A
m
y: Yeh yeh and w
hat do you think w
ould be good about them
 being 
able to see that you’ve been using it?  
R
abhya: They’ll be able to get som
e kind of idea like because erm
 the-, if 
you’re not using it then they’ll be like oh because then it’s a a bit like it your 
not controlling the asthm
a but if they are using it the asthm
a is controlled 
and there m
ust be som
ething else going on 
(R
abhya, 163-168) 
 S
arah: E
rm
 I suppose you know
 like if she w
as taking it like she took it 
every day and m
aybe they m
ight m
aybe increase the dose if they thought 
no it’s not this and their could be another reason w
hy yeh 
A
m
y: Yeh cause actually it could, you could 
S
arah: = M
m
m
 cause they’re thinking you know
 w
e know
 she she’s taking 
it so then there m
ight be room
 for their im
provem
ent so yeh 
(S
arah, 126-128) 
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3.2. “It’s C
learly Just To C
heck U
p”  
 This them
e illustrates how
 participants experienced the introduction of the SI to 
the healthcare relationship as being to m
onitor their inhaler use.  It consists of 
tw
o subordinate them
es.  “It w
as a little bit spyee” outlines how
 the introduction 
of the SI raised issues of m
istrust and fear in the healthcare relationship, 
prom
oting a sense of surveillance of young people, both from
 healthcare 
professionals and from
 caregivers.  It also acknow
ledges that despite these 
feelings, the process im
proved young people’s adherence w
hilst using the SI.  
“They should put the tracker in your throat” illustrates the w
ays som
e 
participants view
ed the S
I as inadequate at recording real life inhaler use.  
 3.2.1. “It W
as A
 Little Bit S
pyee”  
A
cross several of the interview
s the idea of the S
I as som
ething healthcare 
professionals use to check up on young people and their fam
ilies w
as 
introduced.  This w
as very clear during the interview
s w
ith caregivers Jessica 
and Lizzie: 
 A
m
y: A
nd I guess in term
s of w
hen they set up the sm
art-inhaler and 
feeling like you’re being checked up on do you think there are any other 
things the sm
art-inhaler is for? 
Lizzie: N
o [laughs] it’s clearly just to check up 
(Lizzie, 25-28) 
 A
m
y: W
hat do you think the sm
art-inhaler is for? 
Jessica: To track his use to check up on us 
A
m
y: W
hen you got the sm
art-inhaler w
hat do you think your son thought 
it w
as for?  
Jessica: To check up on him
 
(Jessica, 18-22) 
 
Jessica’s description of the S
I checking up on both of them
 also suggested that 
there m
ay be a blurring of responsibility for her son’s IC
S
 use, w
ith the S
I being 
used to check he w
as taking it and that she w
as m
aking sure of this.  For both 
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caregivers there w
as a sense of shock that healthcare professionals w
ould 
need to check this and for Lizzie, the process insulted her: 
 
Jessica: Yeh because one of m
y big things is that they alw
ays question 
has he had his m
edication and of course he does I can’t im
agine him
 not I 
know
 she said last tim
e som
e kids don’t but I cant im
agine him
 not or any 
child w
ho needs m
edication not taking it  
(Jessica, 66-69) 
 A
m
y: O
k and like you said so it kinda felt like they w
ere checking up on 
you? 
Lizzie: I felt insulted 
A
m
y: Yeh, w
ell I w
as going to ask you w
hy you think they gave it you and 
how
 you felt about it? 
Lizzie: W
ell yes it is insulting and I think if it is your child’s health and their 
life you are going to give them
 their inhaler and I just think it’s m
adness it’s 
like if you w
ere a diabetic and you don’t take your insulin you’d die I think 
it’s ridiculous 
A
m
y: S
o it feels insulting? 
Lizzie: You feel like you are being treated like a child 
(Lizzie, 15-24) 
 C
aregiver D
anielle described suspecting that the SI had been introduced as 
healthcare professionals didn’t believe her daughter w
as taking her IC
S
: 
 
A
m
y: S
o w
hat w
ere your view
s? 
D
anielle: W
ell to be honest m
e and m
y husband’s view
 is w
e’re not 
particularly over happy w
ith it, it’s like their trying to sort of catch you out at 
cause if it’s like she’s not taking it and I adm
inister, I’m
 on her all the tim
e 
and you know
 w
e do feel a bit, I dunno how
 to explain it really you know
, 
as if they feel w
ell she’s not taking it and I know
 w
ith all doctors they like to 
know
 that the m
edicines w
orking for, so I know
 they’ve got a job b-but you 
know
 it feels, I dunno how
 to explain it really you know
 m
-m
y, w
ell I 
explained it to m
y husband and to be honest he w
asn’t very happy about it 
and er you know
, it’s just I feel that they feel that she’s not taking it  
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(D
anielle 82-92) 
 M
any participants likened the introduction of the S
I to a process of covert 
surveillance, w
hich raised feelings of m
istrust in the healthcare relationship:  
 
Janet: but from
 m
y daughters perspective if she w
asn't taking it then that 
could be a quite a frightening thing to have to com
e and see a doctor and 
get told off, like big brother's w
atching you 
(Janet, 16-18) 
 
A
m
y: W
hat did you think about that? 
S
am
: H
m
m
 err it w
as a little bit spyee 
A
m
y: A
 little bit w
hat? 
S
am
:  Spyee 
A
m
y: A
 bit spyee! Ah! W
hy do you think it felt a little bit spyee? 
S
am
: W
ell because they are checking up to see if I’m
 taking m
y inhaler 
A
m
y: A
nd w
hat did you think about that? 
S
am
: E
rr w
ell I didn’t really like it that m
uch but I’m
 ok w
ith it 
A
m
y: A
nd the w
ay [nurse] explained it can you rem
em
ber how
 
S
am
: = S
he said that she said that it w
ould record how
 m
any tim
es I take it 
and that they can see you and w
hether w
hether I’ve been taking it or not 
A
m
y: A
n so you said like it felt a little bit spyee do you think anything else 
about it and w
hy you w
ere given it? 
S
am
: M
aybe she thought I w
asn’t taking it 
A
m
y: A
nd w
hat do you think about that? 
S
am
: That she w
as w
rong 
(S
am
, 87-102) 
 The process also contributed to a sense of fear in the healthcare relationship, 
w
ith participants predicting that the inform
ation recorded could land young 
people in trouble, w
ith lim
ited opportunities to explain their side of the story: 
 A
m
y: A
nd how
 does it feel for you G
ary, kind of know
ing that they are 
going to look at them
 in that w
ay? 
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G
ary: It feels scary cause w
henever I don’t, w
henever I think of taking it 
but I haven’t it’s like oh, w
henever your found or som
eone says you 
haven’t done this and you plead innocence they are alw
ays gonna say that 
they w
ont believe you cause it’s the results but you thi-, you say ok I’d 
thought I’d tooken it but I didn’t know
 if I had and yeh 
A
m
y: Yeh so it’s kind of like feels like i- there’s this thing w
here they are 
like here’s som
e evidence and [G
ary: Y
eh] and that doesn’t feel very nice 
cause like you say you’re trying to plead your innocence 
G
ary: Yeh exactly and then say if you get m
ore they are gonna be like w
hy 
are you doing this for and then you think oh I don’t know
 if I have tooken it 
so I took it again but I don’t know
 if I took it 
A
m
y: A
nd is that different to before did it not fe-, did you not feel so 
pressured before cause they didn- they w
eren’t able to look at it like is it 
any different or w
as there still that argum
ent about [G
ary: =N
o] w
ho 
G
ary: = W
ell if I didn’t have the sm
art-inhaler it w
as like oh oh they w
ont 
know
 so yeh I could take it then take it then take it then and then fine but 
then now
 it’s like oh if I don’t take it I’ll be in trouble 
(G
ary, G
ary &
 E
stelle, 154-172) 
 Isla and R
abhya also raised sim
ilar issues, fearing the presence of the SI in the 
healthcare relationship w
ould m
ean their ow
n explanations for their inhaler use 
w
ould not be listened to or believed:  
 
A
m
y: Y
eh yeh and like you say I guess if you’d given it in and you knew
 
they w
ere gonna look at it and obviously like you say you’ve not been able 
to use it all the tim
e [Isla: Yeh] do you think that w
ould have been like quite 
hard to explain or how
 do you think you w
ould have m
anaged that?  
Isla: I w
ould have explained it but I don’t think like they w
ould believe m
e 
sort of thing [Am
y: Yeh ok] but I have been [laughs] I have [Am
y: Yeh]  
(Isla, 108-113) 
 
R
abhya: I think they like m
ight think like the doctor m
ight like saying have 
you taken your m
edication and so yeh, not like shout at them
 but be a bit 
like told off like a w
arning like you have to take it it’s not good and then I 
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think like kids are gonna get scared and say oh I don’t like the doctor they 
are m
aking m
e take m
y m
edication w
hen I’m
 saying I don’t w
ant to take it  
(R
abhya, 114-118) 
 Interestingly how
ever, several of the young people explained how
 the process 
of having healthcare professionals check their adherence through the S
I had 
im
proved their inhaler use: 
 
A
m
y: If you w
ere thinking about using a sm
art-inhaler do you think 
know
ing that a doctor, do you think that w
ould m
ake you m
ore likely to use 
it like m
ore often?  
Isla: P
robably it w
ould m
ake m
e think oh w
ait doctors are gonna look at 
this so I better use it, but yeh I think it w
ould have m
ade m
e a bit m
ore 
aw
are that I have to do it (Isla, 229-233) 
 A
m
y: A
nd w
hen you thought that she m
ight be able to see [how
 S
am
 used 
his inhaler] did that affect how
 you used the inhaler? D
id it m
ake you w
ant 
to take it m
ore or less or the sam
e? 
S
am
: I just took it-w
ell it pressured m
e to take it to m
ake sure I take it all 
the tim
e so it w
as alw
ays on m
y m
ind 
(S
am
 103-106) 
 
S
everal of the caregiver participants also acknow
ledged that the S
I could aid 
their ow
n ability to m
onitor their child’s inhaler use: 
 
A
m
y: A
nd do you think that the sm
art-inhaler helps w
ith asthm
a control 
and m
anagem
ent? D
o you think it’s som
ething that could help to have it as 
part of your routine care to look at the graphs w
ith the doctors? 
Jessica: Yeh m
aybe it w
ould be good to see you know
, w
e know
 he takes 
it in the evening but it w
ould be good to see you know
 w
hen he takes it at 
the other tim
es. 
(Jessica, 36-41) 
 For caregiver Janet, this m
onitoring could then extend to tim
es w
hen her 
daughter w
as in her estranged husbands care:  
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A
m
y: A
nd thinking generally about the sm
art-inhalers? 
Janet: They're good as a parent to see a bit m
ore about w
hat she's doing 
and if she's taking it as she should, I'm
 trying to be a bit m
ore hands off as 
she gets older but you know
 I still w
ant to know
 that she's taking it and 
cause she's w
ith m
y husband half the tim
e so she has to be responsible 
for it as neither of us are there all the tim
e especially now
 she's older too 
(Janet, 161-121) 
 
The healthcare professionals also described how
 parents had fed back to them
 
that the S
I enabled them
 to supervise their child’s adherence better: 
 Focus group discussion point: Parents have said they now
 feel that they 
can supervise their child’s adherence better 
(H
C
P
 focus group, 32-33) 
 
3.2.2. “They S
hould P
ut The Tracker In Y
our Throat”  
A
cross the interview
s it w
as also acknow
ledged that even w
ith the presence of 
the S
I, som
e just didn’t believe the results:  
 
Focus group discussion: S
om
e parents still do not believe the graph w
ith 
the results on  
(H
cp focus group 66-67) 
 C
aregiver Janet also raised this idea w
hen thinking about how
 the S
I results 
could be com
m
unicated to her daughter: 
 
A
m
y: C
ause do you think w
ith these sort of things w
hen they're then 
presented w
ith evidence that they've not taken it, do you think that helps 
w
ith responsibility? 
Janet: I don't know
 if you're gonna show
 em
 a graph they are just gonna 
go [shrugs and pulls face], you know
 it's err you know
 you could probably 
tell them
 till you're blue in the face  
(Janet, 92-97) 
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For m
any participants there w
as an expectation that the results w
ould not 
capture how
 things really w
ere because the SI w
as just not good enough 
technology.  Isla described how
 having separate inhalers at both her parents’ 
hom
es, m
eant that the S
I (w
hich w
as left at her m
um
’s house) did not capture 
her inhaler use at her dad’s house: 
 
Isla: Yeh and then I got to m
um
's and I used it for a few
 days and then like 
I w
ent to dad's w
here, I norm
ally live at dad's longer than m
um
's [Am
y: A
h 
ok yeh] and I left it at m
um
's and so that m
issed out like tw
o w
eeks and 
then like I cam
e back and then it w
as beeping at m
e and I w
as like w
hat 
ya doing [laughs] so it w
as really com
plicated  
A
m
y: Yeh and I guess lots of young people said that because yeh either 
cause your parents are in different places or they have relatives that they 
go stay w
ith [Isla: Y
eh] like it’s hard to take it everyw
here [Isla:Y
eh] and 
then if you don’t have it it’s not gonna show
 how
 you’ve used your inhaler 
Isla: I’ve got like m
y m
edicine at dad's and m
edicine at m
um
's and they’re 
separate and I don’t have, I don’t carry it w
ith m
e  
A
m
y: S
o it’s like you needed tw
o [Isla: Y
eh] one in each place? 
Isla: B
ut then the data w
ould be really [pulls aw
kw
ard face] 
(Isla 78-90) 
 
Jessica highlighted that the lim
itations of the S
I technology could result in a 
young person being perceived as not taking their inhaler by healthcare 
professionals, w
hen in fact the fam
ily’s approach to using inhalers w
as to 
prepare for the different tim
es and places one m
ay need an inhaler: 
  
A
m
y: W
hen you got the sm
art-inhaler w
hat do you think your son thought 
it w
as for?  
Jessica: To check up on him
 
A
m
y: A
nd did you have a conversation about that betw
een you? 
Jessica: Just in the fact that w
hen he didn’t take it and used another one 
that they’d see that as him
 not taking it w
hen actually w
e’re just prepared 
for different situations and have them
 in different places, I’ve got a 2 year 
old and w
e have to be out the house quickly so w
e have one in the car for 
him
 to use instead, w
e have 3 and so w
hen I cam
e I asked about this and 
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said but he uses a different one at school and she said it w
ould be fine 
and it didn’t m
atter, it w
ould have been better if it’s tracking his use then to 
only use one inhaler but that w
asn’t im
plied to us that w
ould have given a 
better reading 
(Jessica, 20-31) 
 D
uring m
y interview
 w
ith Theo, I w
as struck by his suggestion that the 
m
onitoring device should be put in his throat.  R
eflecting on this, it suggested to 
m
e that for Theo his experience of using the SI had m
ade him
 feel that if he 
w
as going to be m
onitored using this technology, it could at least have been 
done properly: 
 A
m
y: O
k and so like you said w
hile you’ve had it other then w
hen you w
ent 
to your dad's, have you alw
ays had it on it? 
Theo: E
rh yeh m
ainly, I have a separate one for sport at school w
hich 
doesn’t have it so so it’s only going to show
 w
hat I take in the house  
A
m
y: That’s a good point 
Theo: They should put the tracker in your throat then they’d be able to see 
that I w
as taking it because w
hen w
e w
ent to the caravan I have a different 
inhaler there 
(Theo, 147-155) 
 3.3. W
ho Is Responsible? 
 This them
e focuses on participants’ accounts of taking responsibility and 
ow
nership for their asthm
a and som
e of the com
plexities w
ith this process.  It 
com
prises of 2 subordinate them
es.  “A
s I’m
 older now
 she tells m
e it’s m
y 
responsibility” describes som
e of the developm
ental expectations that exist 
around taking responsibility for asthm
a during the period of adolescence.  “It 
reversed back to being us” describes how
 the introduction of the S
I reduced the 
level of responsibility young people possessed for their asthm
a.  It also 
illustrates that even w
hen the presence of the S
I increased young people’s 
inhaler use, this increase w
as short-term
, w
ith participants follow
ing the 
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instructions of their healthcare professional rather than taking responsibility for 
their asthm
a.  
 3.3.1. “A
s I’m
 O
lder N
ow
 S
he Tells M
e It’s M
y R
esponsibility”  
Throughout the interview
s I heard about participants' ow
n w
ays of m
anaging 
asthm
a and in particular I listened to m
any accounts that w
ere shaped by an 
expectation that the young people living w
ith asthm
a should be the ones 
responsible for m
anaging it:  
 
Lizzie: Yeh because w
hen he w
as at prim
ary school they had all his 
m
edication for him
 in a case but they said as he m
oves to high school the 
nurse w
as like no he’s got to take responsibility so if he goes out his blue 
inhaler he got to m
ake sure he’s got his blue inhaler 
(Lizzie, 49-52) 
 
C
laire: A
s I’m
 older now
 she tells m
e it’s m
y responsibility I’ve gotta 
rem
em
ber I’ve gotta take part in things and m
ake sure I do things and I’m
 
like yeh 
(C
laire, 66-68) 
 For Isla, her view
 of young people becom
ing responsible for their asthm
a 
influenced her perception of the appropriateness of the S
I: 
 
A
m
y: A
nd I- overall generally w
hat do you think about doctors and nurses 
using these things [sm
art-inhalers] to check up? 
Isla: I think it’s err ok like I guess they are trying to find out i- like if parents 
say that you take it if you’ve got other people w
itnessing that and saying 
then I guess you know
 it depends, if I w
as like really responsible all by 
m
yself for taking it then yeh but if it w
as like like m
um
 and dad som
etim
es 
help m
e then I don’t need it in that sense  
A
m
y: S
o it m
ight be som
ething that could help if that felt like the tim
e w
as 
right to help but actually if you’ve got parents w
ho kind of help already 
Isla: I guess at m
y age now
 w
ould be m
ore suitable to have it like now
 to 
like a bit older cause you’re getting m
ore responsibility 
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A
m
y: Y
eh I thinks that’s w
hat they w
ant these to be used for [Isla: Y
eh] to 
try help them
 be m
ore in charge so that your m
um
 doesn’t have to say 
have you taken it because actually there’s som
ething else saying have 
you taken it  
Isla: Yeh I think that age range m
aybe 13 to w
hatever like I don’t know
 but 
like children your parents w
ill like alw
ays m
ake you take your m
edicine 
cause it’s like a hazard but you know
 so 
(Isla, 246-262) 
 
These descriptions contributed to the sense of young people gradually taking 
on m
ore responsibility for their asthm
a as they entered the period of 
adolescence.  H
ow
ever not all participants shared this view
 and caregiver 
D
anielle described som
e of the issues this period presented her w
ith:  
 A
m
y: A
nd so during that tim
e your daughter w
as still in charge of her 
inhaler? It w
asn’t’ that you kind of yeh felt like you needed to do m
ore? 
D
anielle: Y
eh w
ell this has only happened recently though because I’ve 
alw
ays been in charge of her m
edication just because obviously she’s a 
teenager and to m
ake sure like she’s taking it you know
 and yeh I’ve 
alw
ays I’ve alw
ays been on her case to take it because w
ith her you know
 
if there’s a day like a m
orning that she didn’t take it you know
 because her 
body’s used to it then she’d suffer from
 it, and I think that now
 she’s a 
teenager it’s m
ore like w
hen she w
ants to go som
ew
here and I don’t w
ant 
her to go like w
ith staying over friends and that, she’s only sort of really 
done that recently because over the years she’s had som
e really bad turns 
and she’s actually stopped breathing and sort of like w
e w
orry that she’s 
out and som
ething’s gonna happen and that that person m
ight not b- 
cause m
y husbands had to give her m
outh to m
outh before so w
e w
orry 
that that person m
ight not really know
 w
hat they w
ere doing and you know
 
and it’s only now
 and the not all the tim
e, to be honest it is a w
orry 
A
m
y: Yes, Yes I bet  
D
anielle: E
specially now
 she’s getting to this age now
 w
here she’s w
anting 
to do things that other children do her age and it is hard if she’s gone on a 
sleepover I’d be on the phone to that parent to m
ake sure that she’s 
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actually taken it you know
 just for that specific reason that I didn’t w
ant her 
m
issing it you know
 
(D
anielle, 62-81) 
 
3.3.2. “It R
eversed B
ack To B
eing U
s”  
H
ow
ever, during the interview
s it becam
e apparent that for som
e fam
ilies, the 
introduction of the SI created tensions in the negotiation of responsibility, w
ith 
som
e participants describing how
 the introduction of the S
I had resulted in 
young people losing their recently acquired responsibility for their inhalers.  
S
everal of the caregivers explained how
 their fears about breaking w
hat they 
view
ed as an expensive device had led them
 to take on m
ore responsibility for 
their child’s inhalers then they had previously done:    
 A
m
y: Yes and you said earlier that your son usually takes responsibility for 
his inhaler and I w
onder during the tim
e you had the sm
art-inhaler did you 
feel that changed?  
Lizzie: Yeh I guess usually w
e keep it in like a box w
ith his m
edication but 
I thought I’d better keep the sm
art-inhaler high up on a shelf because w
e 
have babies and I thought they m
ay sm
ash it or they’ll think that it’s a 
com
puter and press all the buttons and confuse it so w
here he w
as m
ore 
independent it rem
oves that say the I’m
 going to take m
y inhaler now
 and 
m
y peak flow
 because w
e keep it w
ith the peak flow
 in a box and he can 
just go and get that him
self w
hereas now
 he has to stand on a chair to get 
it because he’s nearly 13 you w
ant him
 to have a bit m
ore independence 
and say I’m
 taking m
y inhaler because he’s at high school you know
 he 
has to do things like that on his ow
n so it reversed back to being us, w
hich 
I don’t think is good at all because at his age you w
ant him
 to be taking 
responsibility 
A
m
y: Yeh and that is som
ething I am
 really interested in for m
y research 
how
 it affects this age group in term
s of them
 taking responsibility for their 
inhalers 
Lizzie: Yeh because w
hen he w
as at prim
ary school they had all his 
m
edication for him
 in a case but they said as he m
oves to high school the 
nurse w
as like no he’s got to take responsibility so if he goes out his blue 
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inhaler he got to m
ake sure he’s got his blue inhaler and then w
e’ve had to 
take all that aw
ay from
 him
 
A
m
y: That’s really interesting as I guess m
y next question w
as about 
w
hether you think there are any w
ays the sm
art-inhaler helps your son 
take responsibility? 
Lizzie: N
o it w
as the reverse as they w
ere saying it’s so expensive [puts 
voice on] so expensive don’t break it w
e don’t have m
any 
(Lizzie, 33-57) 
 A
m
y: A
nd you’ve said about a few
 conversations w
here you w
ere having 
to take the recorder off, did it feel like she w
as looking after the recorder 
[S
arah: N
o] or did it feel like you w
ere? 
S
arah: It w
as m
e [laughs] yeh cause she w
asn’t too sure how
 to take it off 
and I w
as like give it here cause you’re gonna break it yeh so in like that 
w
ay no I dealt w
ith m
ost of you know
 taking it off  
A
m
y: O
k so did that feel then like 
S
arah: = Yeh a bit of pressure yeh I suppose cause I didn’t w
anna break it 
and I’m
 thinking ooh 
A
m
y: A
nd w
ith that is that not usually there w
hen the recorders not on it 
cause they are like her inhalers? 
S
arah: Y
eh she w
ouldn’t norm
ally care  
A
m
y: S
o m
aybe then a-, w
hich is interesting cause I guess if w
e are 
thinking about her taking m
ore responsibility for her asthm
a [S
arah: M
m
m
] 
you’re then having to get back involved? 
S
arah: N
o exactly and charging it as w
ell so yeh, but the charger and that 
it’s quite good really I didn’t really charge it that often so there’s quite a 
long yeh it’s pretty good I did it a couple of tim
es but I w
asn’t in very often  
A
m
y: A
h okay so that’s interesting as it sounds like you w
ere having to do 
the charging? 
S
arah: O
h yes that’s right [laughs] yeh I did all that yeh  
A
m
y: O
k so I guess listening to you it sounds like you’ve had a big part to 
play [S
arah: A
 bigger role yeh definitely] w
hich and it sound like i- you do 
have a role anyw
ay [S
arah:Y
eh] in m
anaging your daughter’s asthm
a but 
m
aybe it w
as a bit increased because she had the recorder on it? 
S
arah: Yeh 
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A
m
y: A
nd w
hat do you think about that in the kind of long term
 w
ould you 
w
ant to have that role or do you think it is m
ore about kind of 
S
arah:= O
h no I didn’t m
ind doing it but obviously you know
 I had to m
ake 
sure she din’t break it   
A
m
y: S
o the pressure of actually having this thing  [S
arah: Yeh], w
hereas I 
guess if it w
as yours to keep I guess it m
ight not feel  
S
arah:= W
ell it w
ouldn’t be so bad but I probably w
ouldn’t w
anna break it 
cause [laughs] replacing it yeh m
m
 
  (S
arah, 227-260) 
 
This reduced sense of responsibility w
as also evident during participants’ 
descriptions of how
 the S
I had led to young people questioning their ow
n 
judgem
ent and ability to be responsible for taking their inhalers.  O
n several 
occasions participants described defaulting to their parents’ judgem
ent to 
confirm
 they had taken their IC
S
:  
 
A
m
y: Yeh so it kind of like feels like i- there’s this thing w
here they are like 
here’s som
e evidence and [G
ary: Y
eh] and that doesn’t feel very nice cause 
like you say you’re trying to plead your innocence 
G
ary: Yeh exactly and then say if you get m
ore they are gonna be like w
hy 
are you doing this for and then you think oh I don’t know
 if I have tooken it 
so I took it again but I don’t know
 if I took it  
(G
ary, G
ary &
 E
stelle, line 164-166)  
 A
m
y: Y
eh and I guess there’s a few
 thing then so for your daughter know
ing 
that w
as on there did she have any conversations w
ith you about being 
w
atched or [S
arah: E
rm
] or w
as it som
ething you just kind of sensed she 
m
ight be w
orried about or did you think did it not seem
 that she w
as 
bothered? 
S
arah: I don’t think she seem
ed really bothered but I know
 that it’s m
ore 
that she going ah you know
 I don’t thi-. som
etim
es she m
ight have thought 
to herself oh did I take it this m
orning or did I forget and then things like that 
som
etim
es she m
ight have w
orried and I say no you’ve taken it  
(S
arah, 50-57) 
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Interestingly, even for those young people w
here the S
I w
as view
ed as 
som
ething that could help them
 taking som
e responsibility for taking their IC
S
 
regularly, there w
as a sense that once the S
I w
as taken aw
ay and there w
as no 
longer anyone checking, their inhaler use w
ould reduce again.  This prom
oted 
the idea that for m
any participants they w
ere not taking responsibility for their 
asthm
a but w
ere instead dependent on the actions of their healthcare 
professional: 
 
R
abhya: A
nd I think that if they w
ere given the sm
art-inhaler then they are 
gonna be like quite scared like oh no I’m
 not taking m
y m
edication I’m
 
gonna get in trouble and then that’s only w
hen they’re gonna start using it 
and then w
hen the sm
art-inhaler is taken back then they are gonna stop 
using it 
(R
abhya, 93-96) 
 A
m
y: A
nd so you’ve said about this a bit already but can you tell m
e about 
any w
ays the recorder helps you or your fam
ily to take care or responsibly 
for asthm
a?  
C
laire: It w
ould alw
ays m
ake m
e think about taking it if it w
as on there all 
the tim
e 
A
m
y: B
ut if they took it off, so have you handed it back today?  
C
laire: Y
eh they’ve took it now
  
A
m
y: S
o do you think going hom
e now
 that it’ll feel a bit m
ore relaxed and 
that you m
ight drop off a bit in doing it, or do you think that because you’ve 
seen a difference you’d w
ant to try and  
C
laire: = I’ll try and carry on but I think it’ll slow
ly go like I just w
on’t take it 
properly 
(C
laire, 281-292) 
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4. DISCUSSION 
  This chapter sum
m
arises and evaluates the study’s results in relation to the 
research questions and the existing literature.  I then reflect on the study’s 
lim
itations and m
y role as researcher, before discussing the im
plications of the 
findings. 
 4.1. Sum
m
ary of Findings 
 The study aim
ed to explore the experiences of young people w
ith asthm
a w
hilst 
having their adherence to IC
S assessed through the SI.  It also aim
ed to 
explore the experiences of their caregivers and healthcare professionals.  In 
particular, the study sought to exam
ine w
hether the S
I w
as experienced as 
prom
oting young people’s responsibility to self-care.  The study also aim
ed to 
explore how
 the SI m
onitoring process im
pacted on the healthcare relationship.   
 The research questions posed w
ere as follow
s: 
 
1. 
H
ow
 do young people and their caregivers experience being assessed 
through the S
I? 
 
2. 
H
ow
 do healthcare professionals involved in assessing adherence using 
the SI experience this process? 
 
3. 
H
ow
 does the process of having IC
S
 adherence assessed through the S
I 
influence experiences of self-care and do participants experience the S
I 
as prom
oting young people’s responsibility for self-care or not? 
 
4. 
H
ow
 does the process of being given the S
I interact w
ith the relationship 
betw
een the healthcare professional and the young person/caregiver?  
 This section sum
m
arises the results in relation to these research questions. 
The them
es identified and discussed in the findings described the young 
people, caregivers and healthcare professionals’ experiences of the S
I.  In 
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particular the findings highlighted that young people and caregivers 
experienced being assessed through the S
I positively w
hen they view
ed the S
I 
as supporting healthcare professionals’ ability to take care of their patient’s 
health.  Young people and caregivers shared their view
s of the S
I as a new
 and 
health-im
proving technology, w
hich w
ould hopefully aid healthcare 
professionals' ability to look after their patient’s asthm
a.  The findings also 
indicated that w
hen healthcare interventions such as the S
I w
ere consistent 
w
ith participants’ m
ain priorities, they w
ere m
ore likely to be experienced as 
positive and helpful then w
hen they w
ere not consistent w
ith these priorities.  
For healthcare professionals in the study, w
hose m
ain priorities w
ere focused 
on im
proving the health of their patients, the S
I w
as experienced as a useful 
tool for assessing adherence and prom
oting patients’ health.  The findings also 
raised the idea that as an electronic adherence assessm
ent tool that m
onitors 
IC
S
 use, the S
I w
as experienced as a form
 of health surveillance.  For m
any of 
the young people in the study, the experience of surveillance prom
oted feelings 
of m
istrust from
 healthcare professionals, and for caregivers contributed to their 
experience of feeling underm
ined by healthcare professionals.  This led to the 
healthcare relationship feeling som
ew
hat fractious at tim
es follow
ing the 
introduction of the SI.  Finally, the findings highlighted that having IC
S
 
adherence assessed through the SI can im
pact on the relationship betw
een a 
young person and caregiver.  In particular it can im
pact on the transfer of 
responsibility from
 caregiver to young person, w
ith the introduction of the SI in 
m
any cases actually depriving young people of opportunities to take 
responsibility for asthm
a related self-care.  
 4.2. Evaluation of Findings 
 This section considers the overarching issues from
 the three them
es and six 
sub-ordinate them
es identified.  It evaluates these in relation to the current 
literature and outlines the contributions the findings offer.  
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4.2.1. Shared D
ecision-M
aking: Identifying the D
ifferent Perspectives and 
P
riorities of Those in the H
ealthcare R
elationship 
A
n issue that em
erged very strongly w
hilst developing and review
ing the 
them
es relates to the different priorities participants had for taking care of 
asthm
a and the variety of perspectives that existed regarding the introduction of 
the SI.   
 M
ost participants described asthm
a as a serious and life-long health condition 
that needs to be m
anaged through engaging w
ith a variety of healthcare 
behaviours (i.e. taking IC
S
 regularly, avoiding allergens and irritants, attending 
m
edical appointm
ents).  These descriptions resem
bled features of Leventhal et 
al.’s (1992) S
R
M
 w
hich w
as described in the Introduction.  The S
R
M
 assum
es 
that an individual w
ill hold beliefs about the identity, tim
eline, consequences, 
cause and control/cure of an illness and these beliefs w
ill influence their health 
behaviours, in particular their m
edication adherence (Bucks et al., 2009, C
lifford 
et al., 2008, H
orne &
 W
einm
an, 2002, M
enckeberg et al., 2008, O
’C
arroll et al., 
2011).  H
ow
ever, participants’ specific reasons for engaging w
ith healthcare 
behaviours varied depending on how
 each behaviour connected w
ith w
hat they 
regarded as m
ost im
portant to them
.  These different priorities can be seen 
through looking at each participant group’s perceptions of the S
I.  For exam
ple, 
for m
any of the young people in the study, participating in activities that w
ere 
im
portant to them
 such as spending tim
e w
ith their peers and developing 
independence in their lives aw
ay from
 asthm
a and the supervision of their 
parents w
as one of their m
ain priorities.  For m
any young people this m
eant 
there w
ere tim
es w
hen they hadn’t taken their IC
S
.  S
ubsequently, the young 
people’s perceptions of the S
I w
ere often accom
panied by feelings of fear, 
m
istrust and blam
e, w
ith the technology view
ed as som
ething that could get 
them
 into trouble.  They predicted their explanations for not taking their IC
S
 
w
ould not be listened to by healthcare professionals.  For m
any of the 
caregivers in the study a m
ain priority w
as for fam
ily life to run sm
oothly, w
ith 
asthm
a related tasks often incorporated into the daily routines of the fam
ily.  
H
ere, the S
I could be perceived as a bit of nuisance due to the lim
itations of the 
technology (w
hich m
eant that it only recorded the activity of one inhaler despite 
m
ultiple inhalers being used).  It could also be perceived as assisting these 
priorities, helping fam
ily life to run sm
oothly by reducing the need for lengthy 
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hospital stays through assessing their child’s health rem
otely.  Finally, for 
healthcare professionals, their priorities w
ere often focused on prom
oting the 
health of their patients, w
ith their descriptions at tim
es dom
inated by their 
m
otivations to understand and im
prove the health outcom
es of their patients
8.  
 The observation of the participant groups having different perceptions 
com
pares to the findings of Jonsson et al. (2013), w
here young people and their 
caregivers held differing view
s on living w
ith and m
anaging asthm
a.  The 
findings also lend support to the recom
m
endations of H
orne and W
einm
an 
(2002) for healthcare professionals to use a “necessity-concern fram
ew
ork” in 
their interactions w
ith patients as a useful m
eans of eliciting and understanding 
their perception of asthm
a and its treatm
ent.  H
ow
ever, this research has 
highlighted the im
portance of also acknow
ledging that different priorities can 
exist w
ithin the healthcare relationship, w
ith w
hat is m
ost im
portant to one 
m
em
ber of the healthcare relationship not necessarily being that w
hich is m
ost 
im
portant to another.  The value of healthcare professionals identifying patients’ 
preferences and priorities in relation to treatm
ent decisions has been 
recognised by other researchers previously and is often view
ed as an im
portant 
step in the process of shared decision-m
aking.  For exam
ple M
ulley, Trim
ble 
and E
lw
yn (2012) have advocated for healthcare professionals to com
m
unicate 
w
ith patients in a w
ay that allow
s both the m
edical expertise of a healthcare 
professional and the expertise of a patient on his or her priorities to be 
acknow
ledged.  Through a process of shared decision-m
aking, a healthcare 
professional, patient and in m
any cases a relative or carer, w
ould then choose a 
treatm
ent together as a team
.  R
esearch carried out in an adult asthm
a 
population has also highlighted the benefits of engaging patients in a shared 
decision-m
aking process and dem
onstrated that w
hen healthcare professionals 
and patients negotiated a treatm
ent regim
en that accom
m
odated patient goals 
and preferences, there w
ere significant im
provem
ents to patients’ adherence 
levels and other clinical outcom
es
9 (W
ilson et al., 2010).  
                                                        
8 This is not to say that the young people and caregivers in the study did not see health 
prom
otion as im
portant, w
ith m
any in fact agreeing that the SI offered health benefits.  H
ow
ever, 
for healthcare professionals in the study this appeared to be their m
ain priority, w
hereas for the 
young people and caregivers there w
ere com
peting priorities.  
9 Including im
proved controller adherence, asthm
a-related quality of life, health care use, rescue 
m
edication use, asthm
a control and lung function.  
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H
ow
ever, the process of shared decision-m
aking and negotiating priorities can 
be com
plex, and challenges one of the longstanding assum
ptions of m
edicine 
that “the doctor know
s best” (M
ulley et al., 2012).  The challenges associated 
w
ith the shifts in healthcare betw
een com
pliance, adherence and concordance 
m
odels of healthcare w
ere described in the Introduction, and it w
as 
acknow
ledged that in reality, healthcare practices rem
ain m
ore closely aligned 
to a com
pliance m
odel of healthcare (Segal, 2007).  C
ertainly, w
ithin the current 
study the fundam
ental view
 of the healthcare relationship appeared to be of one 
w
here the healthcare professional possessed the expertise and ability to bring 
about im
provem
ents in their patients’ health, w
ith the caregiver and young 
person positioned as recipients of healthcare, acting on the instructions given to 
them
 by their healthcare professionals.  These descriptions appeared to 
resem
ble a m
ore “doctor know
s best” com
pliance healthcare relationship, rather 
than one of shared decision-m
aking.  C
ontributors to this relationship dynam
ic 
are easy to identify, for instance m
any of the participants gave exam
ples of 
w
here healthcare professionals had saved their patients’ lives through their 
m
edical skill and expertise.  H
ow
ever, it is possible that because of this, m
any 
of the young people and caregivers in the study accepted the introduction of the 
S
I based on their healthcare professionals priorities rather than their ow
n.  In 
not being entirely synonym
ous w
ith their ow
n m
ain priorities how
ever, m
any 
participants then experienced aspects of the S
I negatively and consequently did 
not engage fully w
ith the technology.   
 O
verall these findings add to the existing literature on telem
onitoring and 
electronic adherence assessm
ent by illustrating the significance of participants’ 
priorities in influencing their perceptions and experiences of the S
I.  For those 
participants w
here the purposes and functions of the S
I w
ere synonym
ous w
ith 
w
hat w
as im
portant to them
 in life, the technology w
as experienced as a 
valuable addition to the healthcare relationship.  For those w
here this w
as not 
the case, the S
I w
as m
ore likely to be perceived negatively, for exam
ple as a 
nuisance or som
ething that could lead to negative consequences.  These 
findings suggest that for all m
em
bers of the healthcare relationship to be fully 
engaged in treatm
ent decisions (such as w
hether to use the S
I), the different 
priorities and perspectives of each person m
ust be acknow
ledged and a shared 
decision about future actions m
ust be agreed upon.  For this process to occur it 
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is likely that a shift m
ust take place w
ithin the healthcare relationship tow
ards 
interactions m
ore closely connected w
ith an adherence m
odel of healthcare.  
For young people, caregivers and healthcare professionals w
here expertise is 
located solely w
ithin the healthcare professional, this process m
ay be a 
challenge.  
 4.2.2. The C
onsequences and C
om
plexities of H
ealth Surveillance Technology 
 A
nother key issue identified w
hilst developing and review
ing the them
es relates 
to participants’ experiences of the S
I technology as a form
 of health 
surveillance.  This surveillance im
pacted not only on the healthcare relationship, 
but also on the relationship betw
een young person and caregiver; specifically 
on the transferring of responsibility for asthm
a related self-care tasks from
 
caregiver to young person.  
 4.2.2.1. The SI and the healthcare relationship 
D
uring the interview
s participants shared their aw
areness of the S
I’s m
onitoring 
capabilities and likened the technology to form
s of surveillance such as being 
like “big brother” or a “spy”.  A
s acknow
ledged in the Introduction, practices of 
surveillance surround individuals living in W
estern society and are becom
ing 
increasingly utilised in healthcare settings  (S
tow
e &
 H
arding, 2010, V
az &
 
B
runo, 2003).  U
nsurprisingly, young people and caregivers in the current study 
reported feeling checked up on by healthcare professionals due to the nature of 
the technology.  Interestingly how
ever, participants experienced feeling 
checked up by healthcare professionals in different w
ays.  For som
e 
participants, particularly those w
here their beliefs about asthm
a w
ere of a 
severe and life threatening illness, being checked up on provided a sense of 
reassurance that healthcare professionals w
ere looking after and “helping” their 
patients.  This is consistent w
ith the findings of Fairbrother et al. (2013) w
hereby 
telem
onitoring provided a sense of reassurance and support to patients.  It also 
highlights that w
hen participants view
ed the SI as part of a standard helping 
process that aided healthcare professionals in their routine practices of 
assessm
ent, the practice of health surveillance w
as far m
ore accepted w
ithin 
the healthcare relationship. 
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H
ow
ever, for other participants, there w
as a sense of dissatisfaction in response 
to the introduction of the S
I as a health surveillance tool.  For instance several 
young people described the S
I as being introduced because healthcare 
professionals didn’t believe they w
ere taking their inhaler, evoking feelings of 
m
istrust and suspicion w
ithin the healthcare relationship.  The caregivers in the 
study also described thinking that the S
I had been introduced because 
healthcare professionals did not believe their child w
as using their inhaler and in 
som
e cases, caregivers described thinking the S
I had also been introduced 
because healthcare professionals did not believe them
 as parents.  It is likely 
that this contributed to som
e caregivers’ feelings of shock and insult, w
ith the S
I 
in a w
ay questioning their truthfulness and reliability as parents.  Isla’s 
description of the S
I not being needed for young people w
hose parents w
itness 
them
 taking their inhalers and confirm
 this to healthcare professionals illustrates 
her view
 of her parents as reliable sources.  In this sense, the introduction of the 
S
I could be seen to underm
ine her parent’s reliability, arguably com
m
unicating 
to Isla that healthcare professionals didn’t believe her parents, as they needed 
the SI to confirm
 her adherence.  This could create tensions in not only the 
relationships the healthcare professional has w
ith young person and caregiver, 
but also in the relationship betw
een the caregiver and young person.   The 
caregivers' subsequent descriptions of hoping to use the S
I to check on their 
child’s adherence for them
selves m
ay also in part be related to this process, 
w
ith caregivers possibly w
anting to re-establish their position as reliable 
sources.  The healthcare professionals' descriptions of parents now
 supervising 
their child’s inhaler use better because of the S
I is also consistent w
ith this.    
 These descriptions paint the picture of a chain of observation, w
here both 
young people and caregivers are m
onitored through health surveillance 
technology.  W
hilst for som
e, this process w
as experienced as reassuring, for 
m
any, the m
onitoring process evoked negative feelings w
ithin the healthcare 
relationship.  The use of the SI technology in this setting specifically, (w
hereby a 
young person’s inhaler use w
as recorded over a period of tim
e, then returned to 
a healthcare professional w
ho could view
 the results them
selves before sharing 
w
ith a young person or caregiver) m
ay have contributed to this experience.  
W
ithout seeing the results for them
selves, it is conceivable that for the young 
people and caregivers in the study, the m
onitoring process felt very m
uch out of 
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their control.  It w
as acknow
ledged in the Introduction that overt m
onitoring by 
healthcare professionals, even w
hen done sensitively, w
ill feel too confronting 
for patients (M
cN
icholl &
 H
eaney, 2013).  The research findings of Seto et al. 
(2012) also highlighted that som
e participants experienced being w
atched by 
healthcare professionals through telem
onitoring equipm
ent negatively.  In the 
face of increasing health surveillance technology, it is therefore im
portant to 
acknow
ledge the im
pact technology such as the S
I can have on the healthcare 
relationship.  The m
ultiple perspectives gained through the current study have 
also highlighted the im
pact electronic adherence assessm
ent tools can have on 
the relationship betw
een the healthcare professional and caregiver.     
 4.2.2.2 The SI and transferring responsibility for asthm
a self-care  
A
s w
ell as im
pacting on the relationship betw
een healthcare professional and 
young person/caregiver, the interview
s also highlighted the im
pact the 
introduction of the SI had on the relationship betw
een the young person and 
their caregiver.  O
ne issue in particular that w
as raised related to how
 the 
process of being m
onitored through the S
I affected the young people’s ability to 
take on responsibility and ow
nership for their asthm
a.  
 The relationship betw
een young people and their caregivers as they approach 
adulthood has received considerable attention in chronic health literature 
(A
nderson &
 C
oyne, 1993, A
nderson et al., 1997, C
erreto &
 Travis, 1984, 
E
isner, 1993, H
olm
beck, 2002).  R
ecent research and policy recom
m
endations 
have focused on the need for responsibility for asthm
a to be transferred from
 
caregiver to young person as they approach adulthood (B
laakm
an et al., 2014, 
The B
ritish Thoracic Society, 2011, P
rice, 1996).  In the current study, m
any 
participants’ accounts w
ere inform
ed by this expectation, how
ever they also 
highlighted that this transfer of responsibility is not alw
ays straightforw
ard and in 
som
e cases posed a challenge to caregivers in relinquishing the responsibility 
for supervising asthm
a related tasks.  C
aregivers’ descriptions of hoping to use 
the S
I to help them
 m
onitor their child’s inhaler use offer one exam
ple of this.  
The challenges associated w
ith this period of transition have been 
acknow
ledged previously.  For exam
ple, E
isner (1993) described how
 
caregivers can struggle w
ith transferring responsibility to their child due to their 
concerns about their child’s level of conscientiousness regarding these 
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responsibilities.  This struggle can be aggravated w
hen caregivers perceive 
their child's behaviour or failure to im
plem
ent treatm
ent appropriately as life 
threatening.  This conflict w
as clear for caregiver D
anielle, w
ho described 
fearing her daughter m
ight end up needing to be resuscitated if she forgot to 
take m
edication w
hen staying at a friend’s house.  
 It is therefore som
ew
hat unsurprising that in response to feeling checked up on 
by healthcare professionals; young people w
ere described as having lost any 
recently acquired responsibility for their inhalers.  In m
ost cases this 
responsibility w
as transferred back to their caregivers, w
ho becam
e m
ore 
involved in response to their ow
n experiences of having their supervision ability 
m
onitored through the S
I.  Several caregivers explained how
 they took on m
ore 
responsibility for their child’s IC
S
 then they had previously done.  This included 
caregivers placing inhalers out of reach of young people, taking on the 
responsibility for charging up the SI and transferring the S
I onto new
 inhalers 
w
hen the IC
S
 ran out.  This behaviour contradicts the recom
m
endations of 
C
erreto and Travis (1984) that young people need to take on m
ore 
responsibility for self-care activities, w
ith fam
ily m
em
bers w
ithdraw
ing their 
involvem
ent.  It also contradicts the suggestions of R
iekert and R
and (2002) 
that the process of telem
onitoring can assist fam
ilies in appropriately 
transferring responsibility of asthm
a care from
 caregivers to young people.  
 In a sim
ilar vein, the m
onitoring process also im
pacted on young people’s 
confidence in being responsible for taking their inhalers.  There w
ere several 
exam
ples w
here young people described feeling m
ore w
orried about forgetting 
to take their IC
S
 follow
ing the introduction of the S
I and subsequently they had 
sought reassurance from
 their caregivers around this.  H
olm
beck et al.’s (2002) 
suggestion that increased caregiver involvem
ent can lead to low
er levels of 
autonom
y in young people trying to take responsibility for their self-care offers 
one possible explanation for this finding.  It m
ay be that the increase in 
caregiver involvem
ent (resulting from
 caregivers experiences of feeling checked 
up on them
selves through the technology) reduced the young people’s 
autonom
y in m
anaging their asthm
a, leading to them
 becom
ing m
ore 
dependent on their caregivers.  It could also be related to the young people’s 
fear that the S
I m
onitoring could get them
 into trouble.  It is conceivable that the 
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anticipation of negative feedback from
 healthcare professionals prom
oted 
young people’s desire to m
ake sure they took their inhalers regularly and to 
achieve this they becam
e increasingly thorough in their ow
n checking.  This, 
arguably, is sim
ilar to a form
 of self-surveillance, w
hich has been described by 
V
az and B
runo (2008) as “the attention one pays to one’s behaviour w
hen 
facing the actuality or virtuality of an im
m
ediate or m
ediated observation by 
others w
hose opinion he or she deem
s as relevant – usually, observers of the 
sam
e or superior social position (p. 274).  This is consistent w
ith the 
observation from
 the results that for som
e participants, the introduction of the S
I 
had m
otivated them
 to use their inhaler regularly.  This w
as also the case in the 
research conducted by S
paulding et al. (2012), w
here electronic m
onitoring and 
feedback on adherence m
otivated patients to use their inhalers correctly in 
order to avoid a clinic visit w
here data w
ould show
 non-adherence.  H
ow
ever, 
despite this, there w
as a sense am
ongst participants that once the SI w
as taken 
aw
ay and there w
as no longer anyone checking, their inhaler use w
ould reduce 
again.  
 These findings em
phasise that in introducing the SI to the healthcare 
relationship, the level of responsibility young people held for asthm
a related 
self-care tasks reduced.  This decrease in responsibility w
as tw
o-fold, w
ith 
caregivers becom
ing m
ore involved than they had previously done because of 
the introduction of the S
I, and young people becom
ing less autonom
ous in their 
asthm
a self-care, relying m
ore on the judgem
ent of their caregivers then 
previously.  This shift occurred despite young people and caregivers’ 
aw
areness that young people should be taking m
ore responsibility for their 
asthm
a.  The findings also illustrated that for young people w
ho reported that 
their adherence behaviour had im
proved during the tim
e they had the S
I and 
w
ho hoped to m
aintain this once the S
I w
as rem
oved, there w
as still an 
expectation that their adherence w
ould reduce once they w
ere no longer being 
m
onitored.  
 O
verall these findings have highlighted an im
portant issue; that introducing 
electronic adherence assessm
ent and telem
onitoring equipm
ent such as the S
I 
into healthcare settings is com
plex and can lead to a range of consequences, 
not all of w
hich are experienced positively.  W
hilst som
e participants felt 
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reassured by the presence of the S
I and in som
e cases expressed an interest 
to continue using the equipm
ent, other participants w
ere unhappy about its 
introduction and w
ere dissatisfied w
ith the technology itself.  H
ow
 healthcare 
professionals present and engage fam
ilies w
ith the technology is therefore key.  
A
dditionally this research has highlighted the w
ays in w
hich the S
I w
as 
experienced as a form
 of health surveillance.  This surveillance underm
ined 
young people and caregivers’ confidence; depriving young people of 
responsibility for m
anaging their asthm
a and underm
ining caregivers’ reliability 
in supervising their child’s inhaler use.  A
dditionally, the unintended 
consequence of young people feeling less inclined to take responsibility and 
perhaps reverting to m
ore ad-hoc use once the S
I w
as gone suggests that 
young people ultim
ately rem
ain dependent on their healthcare professional.  
The extent to w
hich the S
I prom
otes the aim
s of the patient em
pow
erm
ent 
agenda and the increased drive w
ithin the N
H
S
 for patients to take 
responsibility for their ow
n self-care (N
H
S
 C
hoices, 2012b) is therefore 
questionable.     
 4.3 Lim
itations 
 H
aving sum
m
arised the results and considered how
 they relate and contribute 
to the literature, it is now
 im
portant to reflect on som
e of the lim
itations to the 
study: 
 4.3.1. Sam
ple  
4.3.1.1. Absence of m
ale caregivers 
W
ithin the current sam
ple there w
as an absence of m
ale caregivers.  D
uring 
recruitm
ent very few
 m
ale caregivers w
ere identified, w
ith the m
ajority of young 
people attending hospital and clinic appointm
ents w
ith fem
ale caregivers.  
R
esearchers have stressed that im
portant and m
eaningful findings can em
erge 
w
hen fathers are included in research designs (P
hares, Lopez, Fields, 
K
am
boukos & D
uhig, 2005).  H
ow
ever, the absence from
 the hospital setting 
and from
 the current research study is not surprising.  R
esearch has previously 
acknow
ledged the scarcity of fathers in clinical and paediatric setting and this 
under-representation poses a challenge to researchers recruiting fathers 
  
76 
(C
ostigan & C
ox, 2001, D
uhig, P
hares, & B
irkeland, 2002, P
hares, 1992, 
Q
uittner &
 D
iG
irolam
o, 1998, Seiffge-K
renke, 2002).  I w
ould have been 
interested to have heard m
ore about the view
s of m
ale caregivers and w
onder 
w
hat different perspectives this m
ay have brought to the findings.  Participants 
did at tim
es share the view
s of absent m
ale figures, and I encouraged 
participants to share w
ith m
e any conversations they’d had and the view
s of 
absent fam
ily m
em
bers regarding the SI.  
 4.3.1.2. Restricting the findings to the problem
atic severe asthm
a population 
A
ll participants recruited w
ere view
ed as having PS
A
.  H
ow
ever only 5%
 of the 
childhood asthm
a population is estim
ated to have P
S
A
 (Lang et al., 2008).  The 
issues and experiences this sm
all population experience are therefore likely to 
be qualitatively different to the experiences of the other 95%
 of children w
hose 
asthm
a is less severe.  The findings of the current study therefore need to be 
considered carefully and any attem
pts to generalise should be done so w
ith 
caution.  
 4.3.2. Study D
esign and D
ata C
ollection  
4.3.2.1. Research setting 
W
hen designing the study, I decided to carry out the interview
s at R
B
H
.  This 
decision w
as m
ade for pragm
atic reasons, such as tim
e and funding lim
itations, 
w
hich am
ongst other things, w
ould have m
ade it difficult for m
e to travel to carry 
out interview
s in participants’ hom
e.  Furtherm
ore it seem
ed excessive to ask 
participants, w
ho had already travelled from
 their hom
es to R
B
H
 for their 
appointm
ents, to travel further to carry out interview
s in other locations (e.g. at 
m
y university).  A
dditionally, the R
esearch and D
evelopm
ent team
 at R
B
H
 
required a m
em
ber of the paediatric asthm
a team
 to introduce the study and 
m
yself to participants.  W
hilst I m
ade considerable effort to com
m
unicate m
y 
independence from
 R
B
H
 and participants’ right to confidentiality, I w
as m
indful 
that this process m
ay have influenced how
 som
e participants view
ed m
e; 
possibly as connected to the m
edical team
.  C
onsequently I w
ondered w
hether 
any of the participants w
ho declined to take part m
ight have done so as they did 
not feel com
fortable sharing their view
s about aspects of their experiences at 
R
B
H
 w
ith m
e.  It is also possible that this m
ay have influenced the responses of 
  
77 
those w
ho did participate, potentially increasing the likelihood of them
 giving 
socially desirable answ
ers.   
 4.3.2.2. One-off interviews 
The decision to carry out one-off interview
s w
ith participants can also be view
ed 
as a lim
itation of this study.  C
ham
berlain (2012) criticises the use of one-off 
interview
s w
ith participants in qualitative research, suggesting they lim
it the 
scope, depth and potential of research, view
ing participants as nothing m
ore 
than data sources.  Instead, he advocates for researchers to use m
ore than one 
interview
 w
ith each participant, arguing that this w
ould deepen rapport, 
expanding the scope and depth of data collected and allow
 opportunities for 
reflection by both researcher and participant.  W
hen listening to the interview
 
recordings I often w
anted to speak again w
ith participants and hear m
ore about 
their experiences at different tim
es.  W
ith all participants being interview
ed at 
the appointm
ent w
here they w
ere due to return the S
I, the insight I could 
achieve into their experiences stopped there.  This m
eans that w
hat happened 
next for participants e.g. their experience of receiving feedback on the S
I from
 
healthcare professionals rem
ains unknow
n and any reflections on the long-term
 
im
plications of the S
I are hypothetical.   
 4.3.2.3. Joint young person and caregiver interviews 
A
nother unanticipated issue in the current study relates to the request from
 tw
o 
sets of young people and their caregivers (A
ysha and S
am
ia /G
ary and E
stelle) 
to be interview
ed at the sam
e tim
e.  A
s discussed earlier, I considered this at 
the tim
e w
ith m
y university supervisor and w
e agreed that during these 
interview
s I w
ould pay extra attention to the interactions betw
een the young 
person and caregiver and record m
y observations in m
y reflexive journal.  I 
considered these interactions again during analysis.  Through attending to 
these interview
s in this w
ay, I w
as aw
are that there w
ere occasions w
hen the 
caregivers w
ould answ
er on behalf of the young people and vice versa and at 
other tim
es there w
as a dialogue betw
een them
.  This m
eant that in contrast to 
other participants, I w
as not solely hearing about a young person or caregiver’s 
experience of the S
I, I w
as hearing about their shared experience.  I w
as 
therefore concerned that neither participant’s view
 w
ould be fully represented in 
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their joint account, possibly leading to salient inform
ation being lost.  I w
as also 
aw
are that there m
ight be things that A
ysha and G
ary did not w
ant to say in 
front of their m
others and vice versa.  Furtherm
ore I w
as concerned that if either 
participant’s voice w
as m
ore dom
inant during the joint interview
s, the view
 of 
the quieter participant could be subjugated.  H
ow
ever, the shared experiences 
described w
ere extrem
ely rich in detail, w
ith both dyads adding to and at tim
es 
contradicting w
hat each other had said.  M
oreover, for A
ysha, as one of the 
quietest participants, the presence of her m
other arguably helped her to be able 
to say m
ore.  
 4.3.2.4. Focus group dynam
ics   
The decision to carry out a focus group w
ith staff also presented several 
challenges, particularly around attending to the group dynam
ic, in addition to 
listening to and m
aking note of the content of their discussions.  I w
as m
indful 
that w
ithin the group there w
ere various professionals w
ith different histories, 
including senior doctors, long-serving nurses and new
ly em
ployed nurses.  This 
raised issues of pow
er and authority and I w
ondered w
hether som
e group 
m
em
bers m
ay have felt less able to share any conflicting view
s they m
ay have 
had w
ith other group m
em
bers.  W
ith healthcare professional view
s having 
already been thoroughly investigated w
ithin the literature concerning electronic 
adherence assessm
ent, often via interview
s, the experiences of healthcare 
professionals are not lim
ited.  The decision to carry out a focus group therefore, 
although raising som
e dilem
m
as, is not an overarching concern.   
 4.3.3. R
esearch Journey 
A
s a novice qualitative researcher, carrying out this research has developed m
y 
know
ledge and confidence in carrying qualitative research in a healthcare 
setting and som
e of the issues this raises.  For instance during the earlier 
interview
s I w
ould often stick m
ore closely to the interview
 schedule through 
fear of m
issing questions.  Transcribing each interview
 as I w
ent along helped 
develop m
y confidence in asking questions in different w
ays and in being able 
to follow
 the accounts of each participant rather than being led by the order of 
the interview
 schedule.  C
onsequently m
y earlier interview
s w
ere shorter and 
arguably less rich then those com
pleted later on.  
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 A
dditionally, carrying out research in a busy hospital environm
ent w
ith som
e 
participants having been adm
itted as inpatients for routine assessm
ent w
hilst 
others attended scheduled outpatient appointm
ents, m
eant that interview
s w
ere 
carried out in tw
o different settings; these being the hospital bedside and 
outpatient clinic room
s.  A
s w
ell as presenting logistical challenges such as 
trying to lim
it w
ard noise w
hen carrying out interview
s bedside and tim
e 
pressures w
hen interview
ing in the clinic environm
ent, it also raised ethical 
pressures around ensuring confidentiality.  I often had to be very m
indful of 
stopping interview
s quickly and at tim
es cutting participants off w
hen m
em
bers 
of staff disturbed us.  C
onsequently m
y ow
n and participants’ trains of thought 
w
ere at tim
es disrupted, potentially losing salient inform
ation.  
 Finally, having previously been a m
ore experienced quantitative researcher, the 
process of conducting qualitative research has m
ade m
e m
ore alert to the pros 
and cons of the tw
o approaches.  Q
ualitative research is often com
pared 
negatively to quantitative research due to its sm
all sam
ple sizes, increased 
researcher bias and challenges in establishing validity (M
ays &
 P
ope, 1995).  
H
ow
ever, given that the current study w
as carried out in an em
erging field, 
w
here lim
ited research findings w
ere available, the qualitative approach taken, 
w
hilst w
ith its lim
itations, generated a valuable and in-depth understanding into 
participants’ experiences.  This w
ould arguably have been lost w
ere a m
ore 
quantitative approach em
ployed (Flick, 2009).  
 4.4. The Role of The Researcher  
 The role of the researcher in qualitative research has been w
idely 
acknow
ledged.  M
any authors agree that any notion of objectivity is problem
atic 
for the qualitative researcher, as their experiences, values and beliefs am
ongst 
other factors w
ill inevitably play an integral role in the w
ay in w
hich their 
research is conducted and reported (N
ightingale &
 C
rom
by, 1999, Patton, 1990, 
S
pencer &
 R
itchie, 2012, W
illig, 2013).  There is therefore a call for reflexivity 
w
ithin the qualitative research field.  In line w
ith this thinking, I have tried to 
share som
e of the reasons w
hy I have found the results I did and w
hy they have 
been reported in the w
ay they have below
.  
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 4.4.1. R
eflections on R
esearch 
A
s I discussed in m
y M
ethod, I am
 a young, w
hite B
ritish, fem
ale w
ho has been 
fortunate enough to experience relatively good health during m
y lifetim
e.  M
y 
personal experiences of interacting w
ith healthcare professionals are typically of 
visiting a doctor or nurse for the purpose of seeking their expertise on a given 
health concern.  I also w
ork as a trainee clinical psychologist, a position w
hich 
has afforded m
e several opportunities to w
ork alongside doctors and nurses in 
healthcare settings.  M
y professional experiences have w
idened m
y view
 of 
healthcare professionals, as people w
ith their ow
n w
ork and life pressures, 
values and subjective experiences.  I also identify m
yself as a critical realist.  
This epistem
ological position fits w
ith m
y view
 of healthcare professionals as 
being able to offer m
edical treatm
ent for  “real” m
edical conditions such as 
asthm
a.  H
ow
ever, it also captures m
y view
 that peoples’ descriptions of 
receiving healthcare interventions such as the S
I can be influenced by their ow
n 
and others values, preferences and experiences.  
 In reflecting on m
y ow
n experiences and view
 of the w
orld, I w
as struck at tim
es 
by the w
ays m
y ow
n taken for granted assum
ptions about asthm
a, healthcare 
professionals, m
edical care etc. influenced the w
ay I approached certain tasks 
w
hilst carrying out this research.  For instance w
hen interview
ing the young 
people I w
ould often start w
ith questions related to their asthm
a history such as 
“can you tell m
e how
 you found out that you had asthm
a?”.  This question w
as 
influenced by m
y ow
n view
 that w
hilst asthm
a is a “real” health condition, 
children living w
ith it m
ay not realise they have it until som
eone tells them
/ they 
are old enough to understand w
hat it is.  H
ow
ever, at tim
es m
y w
ording 
confused young people and they w
ould ask for m
ore clarity or reply by saying 
som
ething like “I’ve just alw
ays had it”.  O
n reflection I w
ondered w
hether these 
interactions and other sim
ilar ones m
ight have been influenced by m
y ow
n 
assum
ptions about asthm
a and m
y view
 of the w
orld.  In order to keep these 
ideas alive throughout the research process I kept a reflexive journal  (see 
appendix 2 for exam
ples). 
 In w
riting this report, I also becam
e aw
are of the im
pact this research had on 
m
e.  I feel it has helped m
e reflect on m
y clinical practice, especially follow
ing 
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the transcription process w
here I becam
e aw
are of m
y tendency to ask tw
o or 
three questions in one go, or to try and “help out” participants by giving them
 a 
few
 ideas, w
hen it w
ould have been less leading to have w
aited and see w
hat 
they cam
e up w
ith on their ow
n.  
 4.5 Evaluating the Quality of Qualitative Research 
 The im
portance of evaluating qualitative research has becom
e increasingly 
recognised (W
illig, 2009).  Yet the idea of evaluating the quality of qualitative 
research is still contested by som
e, w
ith concerns raised about the applicability 
of standardised assessm
ent principles such as validity and reliability to 
qualitative research m
ethods (R
eicher, 2000).  H
ow
ever, m
any have sought to 
evaluate the quality of qualitative research in less traditional w
ays (G
uba &
 
Lincoln, 1981, M
ays &
 P
ope, 2000, Yardley, 2000).  M
ore recently S
pencer and 
R
itchie (2012) have brought together som
e of the recurring principles that 
underpin the concept of quality in order to evaluate all qualitative research, 
including the critical realist TA
 adopted for this study.  These include 
contribution, credibility and rigour.  
 4.5.1. C
ontribution 
C
ontribution refers broadly to the value and relevance of research evidence, in 
particular beyond the purpose of the study.  This m
ay be to theory, policy, 
practice, etc.  R
egardless of w
hich, it requires an enhancem
ent of existing 
understanding (Spencer &
 R
itchie, 2012).  I have therefore sum
m
arised and 
evaluated the results and considered how
 these m
ay relate to the existing 
research.  The lim
itations of the study have also been described and I consider 
possible im
plications of the findings shortly. 
 4.5.2. C
redibility 
C
redibility has been likened to interpretive validity and relates to the 
defensibility and plausibility of claim
s m
ade by the research, not just in the 
believability of findings but also the ability to see how
 conclusions have been 
reached (S
pencer &
 R
itchie, 2012).  D
escriptive accounts of raw
 data and 
interpretive accounts show
ing how
 data is put together to develop explanations, 
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reach conclusions and generate hypotheses and theories can support the 
credibility of research (M
iles &
 H
uberm
an, 1994).  Som
e authors have also 
recom
m
ended the process of triangulation be used to prom
ote credibility.  H
ere 
different m
ethods and data sources w
ould be used during the research, in 
addition to peer review
 and respondent validation (S
pencer &
 R
ichie, 2012).  I 
used a thorough transcription process during the research to ensure that the 
interview
s w
ere represented as accurately as possible.  In addition, num
erous 
extracts have been presented w
ithin the R
esults.  The m
ulti-perspective nature 
of this research also provides support for the credibility of the study.  B
earing in 
m
ind the critical realist approach I adopted and the social constructionist ideas 
this holds in m
ind, I did not ask anyone else to analyse the data or assess inter-
rater reliability.  I did, how
ever, share a draft of m
y R
esults and the relevant 
appendices w
ith m
y supervisor.  
 4.5.3. R
igour 
 R
igour is associated w
ith m
ethodological validity.  It involves the careful 
docum
entation of the research process, and is linked to the appropriate 
research decisions, dependability of evidence and general safe conduct of the 
research (S
pencer &
 R
itchie, 2012).  The rigour of a study can be evaluated 
through a consideration of the follow
ing:  
 4.5.3.1. Reflexivity  
S
pencer and R
itchie (2012) encourage qualitative researchers to explore and 
reflect on the w
ays their role in the research and the w
ays their values, beliefs 
and experiences m
ay influence their responses and im
pact on the study 
outcom
es.  I have considered this in both m
y M
ethod and D
iscussion chapters.   
 4.5.3.2. Audibility  
E
m
phasis has also been placed on the im
portance of docum
enting and 
reporting how
 and w
hy certain decisions w
ere m
ade, particularly in regards to 
the analysis of results (S
pencer &
 R
itchie, 2012).  I have therefore docum
ented 
and described m
any of m
y research decisions during the M
ethod chapter and 
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have provided exam
ples of raw
 data in the R
esults chapter.  I have also 
included several appendices to further evidence this (see appendices 18-25).  
 4.5.3.3. Defensibility  
S
pencer and R
itchie (2012) also recom
m
end that researchers provide a clear 
logic and rationale for their choice of m
ethod, design and analysis, as w
ell as 
decisions around sam
ple and consider how
 these helped the study to m
eet its 
aim
s.  These have been given in both the Introduction and the M
ethod and then 
critiqued in this chapter.  
 4.6. Im
plications of Findings  
 4.6.1. Im
plications for H
ealthcare P
rofessionals, S
ervices and O
rganisations 
This research has highlighted the need for healthcare professionals to engage 
in a shared decision-m
aking process w
ith their patients w
hen introducing 
healthcare interventions.  This requires healthcare professionals to 
acknow
ledge and accept that their patients’ priorities, preferences and goals 
m
ay not alw
ays m
irror their ow
n professional view
.  This process is particularly 
im
portant w
hen thinking about children and young people, w
here other fam
ily 
m
em
bers are likely to be involved in the healthcare relationship and m
ay not be 
m
otivated by the sam
e priorities as the child.  H
ere the process of shared 
decision-m
aking w
ill involve healthcare professionals openly exploring the 
potentially different (and possibly conflicting) priorities their young people and 
fam
ily m
em
bers m
ay have for engaging w
ith particular healthcare interventions 
and reaching a joint agreem
ent about the m
ost appropriate w
ay forw
ard.  For 
som
e this m
ay m
ean that healthcare professionals do not introduce a particular 
healthcare intervention, w
hereas for others they m
ay do so.  This w
ould be 
im
portant in the case of the S
I, w
here there w
ere m
ixed view
s and different 
priorities. 
 This suggestion is neither new
 nor radical and previous research has already 
highlighted the benefits of engaging patients in shared decision-m
aking (W
ilson 
et al., 2010).  Yet at present, there is still am
bivalence am
ongst healthcare 
professionals about their ability to practice in this w
ay (S
egal, 2007).  O
ne need 
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not look far to find stories in the m
edia about healthcare professionals 
neglecting their duty of care or the advertisem
ents of legal com
panies offering 
their services in m
edical negligence claim
s.  For the healthcare professionals in 
this study w
hose m
ain priority w
as to prom
ote the health of their patients, how
 
easy w
ould it be to allow
 a patient to not engage in a particular healthcare 
intervention, w
hen w
ithin the w
ider system
 they too have their practice 
m
onitored?  In the case of the S
I, w
here there is increasing pressure for 
healthcare professionals to accurately assess their patients’ adherence levels  
(B
ender et al., 2000), healthcare professionals w
ould arguably need to feel 
supported by their service and organisation to w
ork in this w
ay.  
 4.6.2. Im
plications For Future R
esearch  
4.6.2.1. Sam
ple 
Future research m
ay w
ish to explore the experiences of a w
ider sam
ple in order 
to generalise the findings to other populations.  This m
ay include prom
oting the 
involvem
ent of fathers; by focusing m
ore effort on this at the recruitm
ent stage, 
possibly contacting fathers directly or hearing their view
s in different w
ays, e.g. 
through questionnaires or telephone interview
s.  It m
ay also include exploring 
the view
s of a child population to explore w
hether the introduction of the S
I 
raises sim
ilar or different issues in the younger age group.  This w
ould m
ost 
likely require m
ore creative m
ethods of data collection to the sem
i-structured 
interview
.  Finally the view
s of young people living w
ith less severe form
s of 
asthm
a m
ay offer som
e different and insightful perspectives on the S
I to those 
raised in the current sam
ple.  
 4.6.2.2. Design 
Future research could also adopt different research designs to further answ
er 
the research questions posed.  A
s a relatively short-term
 piece of research, the 
current study cannot speak definitively to the long-term
 im
pact of S
I technology 
on prom
oting young people's ability to take responsibility for their self-care and 
it m
ay be that w
ith its continued use, young people could take over som
e of the 
responsibilities involved w
ith using the S
I.  Future research could adopt a 
longitudinal design to assess this further.  Q
uantitative designs could also be 
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em
ployed to m
easure w
hether the S
I influenced young people’s adherence, 
and w
hether there w
ere differences in the experiences of those w
hose 
adherence to IC
S
 w
as greater and those w
hose adherence w
as low
er.  Future 
research could also seek to recruit and m
eet w
ith participants aw
ay from
 the 
hospital setting to address issues around the researcher’s independence from
 
the hospital setting.  Finally, research could draw
 on C
ham
berlain’s (2012) 
recom
m
endations for m
ultiple interview
s to be carried out at various stages e.g. 
follow
ing the introduction of the S
I, after feedback on the SI results are given, 
six m
onths later.  W
hilst m
ore tim
e consum
ing for the researcher and 
participants, this approach w
ould offer greater insight into the experiences of 
participants.  
 4.6.2.3. Analysis 
C
arrying out a critical realist TA
, offered an accessible and flexible fram
ew
ork to 
explore the data obtained from
 participants.  H
ow
ever, there w
ere tim
es w
hilst 
carrying out this analysis w
hen I w
as particularly interested in how
 participants 
had talked about their experiences, especially in relation to features of the 
healthcare relationship and how
 they positioned them
selves in this relationship.  
W
ith this in m
ind, a discursive m
ethod of analysis
10 m
ay have offered deeper 
insights into the m
ore socially produced elem
ents of participants’ realities 
(W
illig, 2013).  O
ne possibility for future research w
ould be to audio-record the 
healthcare appointm
ents w
here the S
I w
as discussed.  These interactions could 
then be analysed; w
ith the w
ays participants used language to talk about the 
sm
art-inhaler being explored in m
ore detail.   
 E
ach of the possibilities for future research described could add valuable 
insights to this em
erging area.   
 4.7. Conclusions 
 The aim
 of this study w
as to explore young people w
ith asthm
a, their caregivers 
and healthcare professionals’ experiences of having adherence to IC
S
 
assessed through the S
I.  U
sing sem
i-structured interview
s and a focus group 
                                                        
10 See A
ppendix 1 for m
ore inform
ation on discourse analysis. 
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offered a helpful m
eans to explore these experiences.  The use of TA
 to 
analyse experiences provided a useful fram
ew
ork w
ith w
hich them
es could be 
identified and placed in the context of current literature.  G
iven the lim
ited 
am
ount of published studies, the current findings are therefore able to offer 
som
e indication of participants’ experiences of the use of electronic adherence 
assessm
ent and telem
onitoring equipm
ent in N
H
S
 services.  H
ow
ever it is 
acknow
ledged that further research em
ploying different m
ethods of recruitm
ent, 
designs and analysis is w
arranted.  
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 Appendix 1 – Choosing a M
ethod  
 I considered several approaches w
hen selecting a m
ethod including content 
analysis, interpretative phenom
enological analysis and discourse analysis, 
before choosing to carry out a them
atic analysis.  I w
ill give som
e inform
ation on 
the other form
s of analysis I considered and w
hy I did not choose them
 in this 
instance. 
C
ontent analysis [C
A
] offers a system
atic and objective m
eans of describing 
and quantifying phenom
ena and allow
s a researcher to distill w
ords into few
er 
content related categories.  It is assum
ed that w
hen classified into the sam
e 
categories, w
ords, phrases, etc. w
ill share the sam
e m
eaning (E
lo &
 K
yngas, 
2007).  W
as the current research seeking to quantify and categorise 
participants’ experiences of using the sm
art-inhaler num
erically, C
A
 m
ay have 
offered one possibility for doing so.  H
ow
ever w
ith the current research aim
s in 
m
ind, this m
ethod w
ould likely have distilled the m
ultiple view
s and experiences 
of participants too extensively, lim
iting the am
ount of insight that could be 
achieved into participants’ experiences.  
Interpretative P
henom
enological Analysis [IP
A
] 
aim
s to “explore in detail how
 
participants are m
aking sense of their personal and social w
orld” (S
m
ith &
 
O
sborn, 2008, p.53), w
hilst also acknow
ledging the role of the researcher and 
their relationship w
ith participants (W
illig, 2013).  IPA
 w
ould therefore have 
offered one possible m
ethod for exploring participants’ experiences.  H
ow
ever 
as this study focused on the broader investigation of participants’ experiences 
w
ith sm
art-inhalers and factors that influenced this, rather than focusing on 
interpreting how
 participants m
ade sense of their experiences, I decided that TA
 
w
as m
ore in line w
ith the study’s research aim
s then IP
A
.  
D
iscourse A
nalysis [D
A
] focuses on the role of language in participants’ 
construction of reality.  It is concerned w
ith “w
hat people do w
ith language and 
it em
phasises the perform
ance qualities of discourse” (W
illig, 2013, p.117).  D
A
 
involves analysing naturally occurring text and talk and requires researchers to 
look at the language used and ask different questions about it (H
epburn & 
W
iggins, 2005).  H
ad the current study been aim
ing to explore how
 participants 
had talked about their experiences, especially in relation to features of the 
healthcare relationship and how
 they positioned them
selves in this relationship, 
D
A
 m
ay have offered an appropriate m
ethod.  H
ow
ever, to answ
er the research 
questions posed in the current study, TA
 offered a m
ore suitable m
ethod for 
exploring participants’ experiences of the sm
art-inhaler. 
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Appendix 2 – Sam
ple Extracts from
 M
y Reflexive Journal 
 Thoughts Follow
ing Interview
 w
ith G
ary &
 E
stelle: 
 P
rior to the interview
 starting G
ary spoke about being w
atched by big brother in 
front of the nurse w
ho’d introduced us.  I thought this w
as interesting and I 
w
ondered if this w
ould com
e across in his interview
.  D
uring the interview
 G
ary 
spoke a lot about the sm
art-inhaler as being like a lie detector, as did his m
um
 
E
stelle and this prom
oted a sense of the sm
art-inhaler being used alm
ost 
“legally” to catch him
 out (he said several tim
es about not being able to argue 
his “innocence”).  S
im
ilarly to m
y earlier interview
 w
ith S
am
ia, E
stelle raised the 
idea of portability and the introduction of the sm
art-inhaler m
eaning less tim
e in 
hospital.  This got m
e thinking about the process of joint interview
s (these being 
the only tw
o w
here young people and caregivers interview
ed together and I 
w
ondered w
hether both caregivers had felt a need to prom
ote the positive 
aspects of the sm
art-inhaler w
hilst in the presence of their children.  
 O
ther thoughts I had during/after the interview
 related to the long-term
 
im
plications of the sm
art-inhaler.  This w
as som
ething the healthcare 
professionals focus group had raised in term
s of w
anting to know
 the sm
art-
inhaler im
pacted young people’s adherence behaviour/ asthm
a control once the 
inhaler w
as taken aw
ay and in previous interview
s participants had brought up 
this idea of the sm
art-inhaler being used long term
 and then it feeling m
ore 
norm
al and part of health care.  This m
ade m
e think about w
hen the sm
art-
inhaler is taken aw
ay and is only has a short-term
 presence, it m
ay feel a bit 
strange and “catchy outy” rather than part of routine health care.   
 A
dditionally this interview
 got m
e thinking about the im
pact of the sm
art-inhaler 
on relationships w
ith the doctors and nurses and I thought it w
as interesting that 
even w
hen there w
ere strong feelings about the sm
art-inhaler (such as in 
G
ary’s case), that participants did not seem
 to think it affected their 
relationships w
hen asked directly (despite im
plying through their responses that 
it had).  
 Thoughts Follow
ing Interview
 w
ith Isla: 
 A
s m
y oldest young person so far I w
as aw
are that Isla appeared a bit m
ore 
open to thinking m
ore w
idely about the process of adherence m
onitoring and I 
w
as able to help her to generate ideas about w
hat w
ould have m
ade the 
process m
ore effective.   
 A
s an interview
 carried out separately, I w
as also aw
are that there w
ere not any 
substantial differences in the content of Isla’s answ
ers com
pared to the young 
people w
ho had asked to do the interview
s jointly w
ith their caregivers.  For 
instance in response to the question “is parents involvem
ent helpful?” Isla said 
sim
ilar to those w
ho’d been interview
ed w
ith their m
um
s present, 
acknow
ledging that it is a bit annoying, but nothing m
ore.  This w
as reassuring 
as I w
as w
orried that other young people w
ho had been interview
ed in their 
parent’s presence m
ay have not w
anted to say m
ore in front of them
.  
A
dditionally Isla later alluded to the idea of her parents being allies som
ew
hat 
w
hen healthcare professionals question her about adherence.  
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The w
ay Isla spoke about the pill box and others checking it also m
ade m
e think 
about som
e of the w
ays adherence m
onitoring is taking place less form
ally 
anyw
ay w
ith parents and it rem
inded m
e of earlier interview
s for instance w
ith 
Theo and Jessica; having the school log had brought that issue up and given 
them
 proof that he w
as taking his inhaler.  
 I w
as also able to ask questions hypothetically/prospectively w
hich I felt I hadn't 
done as m
uch previously.  H
ow
ever I w
as m
indful that this w
as not a “lived 
experience”.  Finally I w
as also m
indful during m
y interview
 w
ith Isla that I m
ay 
be “giving ideas” w
hen she said she didn’t know
.  In m
y efforts not to lead her, I 
therefore endeavoured to give a range of ideas e.g. w
ere you w
orried about 
getting in trouble, did it not bother you, w
as it helpful.  
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 Appendix 3 – Young Person Inform
ation Sheet  
UNIVERSITY OF EAST LONDON 
S
chool of P
sychology 
S
tratford C
am
pus 
W
ater Lane 
London E
15 4LZ 
 The Principal Investigator 
A
m
y S
tew
art 
u1235007@
uel.ac.uk 
 M
y nam
e is A
m
y and I am
 carrying out som
e research about young people’s 
view
s of sm
art-inhalers for m
y university studies.  I have put together this letter 
to tell you m
ore about this research and to help you think about w
hether you 
w
ould like to be part of it.  
 Research Title 
 E
xperiences of A
dherence A
ssessm
ent in A
sthm
a 
 Research Description 
 I am
 interested in w
hat young people think about sm
art-inhalers.   
 I w
ould like to ask you w
hat you think about the sm
art-inhaler you w
ere given at 
one of your appointm
ents at the R
oyal B
rom
pton H
ospital.  
 I’d like to hear w
hat you think is good about the sm
art-inhaler and w
hat you 
think is not so good about it.  I’d like to know
 w
hy you think you have it and how
 
you w
ere told about it.  I’d also like to hear about your experiences of using it 
over the last few
 m
onths. 
 There are no right or w
rong answ
ers.  I just w
ant to hear w
hat you think.  
 If you w
ould be happy to talk to m
e about the sm
art-inhaler then I w
ill m
eet w
ith 
you at the R
oyal B
rom
pton H
ospital w
hen you bring the sm
art-inhaler back.  W
e 
w
ill m
eet for around 30-40 m
inutes in a private room
 in the hospital.   
 A
s I w
ill be interview
ing a lot of young people about the sm
art-inhaler I w
ould 
like to be able to record our conversation on a voice recorder.  This w
ill help m
e 
think about all the young people’s view
s in m
ore detail and w
ill help m
e w
hen I 
w
rite up the research for m
y studies.  
 Confidentiality of the Data 
 E
verything w
e talk about w
hen w
e m
eet w
ill be treated confidentially.  This 
m
eans that our conversation is private.  The only tim
e I w
ill tell anyone w
hat w
e 
have talked about is if I am
 w
orried about your safety or som
eone else’s.  I 
w
ould let you know
 if I w
as going to do this.  
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O
nly I w
ill be able to listen to the recording of our conversation.  I w
ill type up 
this recording, but I w
ill do this w
ithout including your nam
e or anyone else’s, so 
that you cannot be identified and neither can anyone else you m
ight m
ention.  
This m
eans that things you say m
ight be used as exam
ples of young people’s 
view
s on sm
art-inhalers w
hen I w
rite m
y research up but nobody w
ould be able 
to tell that it w
as you w
ho had said it.  
 The recording of our conversation and the typed up copy w
ill be kept safe in a 
secure place that only I can access.   
 A
ny inform
ation that includes your nam
e, date of birth or contact details w
ill also 
be kept in this secure place and w
ill not be seen by anyone else.  
 The recording of our conversation w
ill be destroyed as soon as the research is 
finished.   
 I w
ill keep copies of our typed up conversation for three years but this w
ill still 
be kept anonym
ously so that you cannot be identified from
 it.  This is in case I 
w
ant to do m
ore w
ith the research.  
 Location 
 I w
ill m
eet w
ith you at the R
oyal B
rom
pton H
ospital w
hen you bring the sm
art-
inhaler back.  W
e w
ill m
eet for around 30-40 m
inutes in a private room
 in the 
hospital.   
 Disclaim
er 
 You do no have to take part in m
y research and should not feel pressured by 
anyone to.  If you change your m
ind about talking to m
e after saying yes then 
that is okay and you can decide not to m
eet m
e w
ithout having to give a reason.  
This w
ill not affect your care at the hospital.  
 If you w
ould like to ask m
e any questions please contact m
e through the em
ail 
address at the start of this letter. 
 If you w
ould like to m
eet w
ith m
e to tell m
e w
hat you think about the sm
art-
inhaler then please fill in your details on the assent form
. (I w
ill give you a copy 
of this).  
 Thank you  
 A
m
y S
tew
art 
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Appendix 4 – Caregiver Inform
ation Sheet on Behalf of the 
Young Person 
UNIVERSITY OF EAST LONDON 
S
chool of P
sychology 
S
tratford C
am
pus 
W
ater Lane 
London E
15 4LZ 
 The Principal Investigator 
A
m
y S
tew
art 
u1235007@
uel.ac.uk 
 M
y nam
e is A
m
y and I am
 carrying out som
e research about young people’s 
view
s of sm
art-inhalers for m
y university studies.  I have put together this letter 
to tell you m
ore about this research and to help you think about w
hether you 
w
ould like to be part of it.  
 Research Title 
 E
xperiences of A
dherence A
ssessm
ent in A
sthm
a 
 Research Description 
 I am
 interested in w
hat young people think about sm
art-inhalers.   
 I w
ould like to ask you w
hat you think about the sm
art-inhaler you w
ere given at 
one of your appointm
ents at the R
oyal B
rom
pton H
ospital.  
 I’d like to hear w
hat you think is good about the sm
art-inhaler and w
hat you 
think is not so good about it.  I’d like to know
 w
hy you think you have it and how
 
you w
ere told about it.  I’d also like to hear about your experiences of using it 
over the last few
 m
onths. 
 There are no right or w
rong answ
ers.  I just w
ant to hear w
hat you think.  
 If you w
ould be happy to talk to m
e about the sm
art-inhaler then I w
ill m
eet w
ith 
you at the R
oyal B
rom
pton H
ospital w
hen you bring the sm
art-inhaler back.  W
e 
w
ill m
eet for around 30-40 m
inutes in a private room
 in the hospital.   
 A
s I w
ill be interview
ing a lot of young people about the sm
art-inhaler I w
ould 
like to be able to record our conversation on a voice recorder.  This w
ill help m
e 
think about all the young people’s view
s in m
ore detail and w
ill help m
e w
hen I 
w
rite up the research for m
y studies.  
 Confidentiality of the Data 
 E
verything w
e talk about w
hen w
e m
eet w
ill be treated confidentially.  This 
m
eans that our conversation is private.  The only tim
e I w
ill tell anyone w
hat w
e 
have talked about is if I am
 w
orried about your safety or som
eone else’s.  I 
w
ould let you know
 if I w
as going to do this.  
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O
nly I w
ill be able to listen to the recording of our conversation.  I w
ill type up 
this recording, but I w
ill do this w
ithout including your nam
e or anyone else’s, so 
that you cannot be identified and neither can anyone else you m
ight m
ention.  
This m
eans that things you say m
ight be used as exam
ples of young people’s 
view
s on sm
art-inhalers w
hen I w
rite m
y research up but nobody w
ould be able 
to tell that it w
as you w
ho had said it.  
 The recording of our conversation and the typed up copy w
ill be kept safe in a 
secure place that only I can access.   
 A
ny inform
ation that includes your nam
e, date of birth or contact details w
ill also 
be kept in this secure place and w
ill not be seen by anyone else.  
 The recording of our conversation w
ill be destroyed as soon as the research is 
finished.   
 I w
ill keep copies of our typed up conversation for three years but this w
ill still 
be kept anonym
ously so that you cannot be identified from
 it.  This is in case I 
w
ant to do m
ore w
ith the research.  
 Location 
 I w
ill m
eet w
ith you at the R
oyal B
rom
pton H
ospital w
hen you bring the sm
art-
inhaler back.  W
e w
ill m
eet for around 30-40 m
inutes in a private room
 in the 
hospital.   
 Disclaim
er 
 You do no have to take part in m
y research and should not feel pressured by 
anyone to.  If you change your m
ind about talking to m
e after saying yes then 
that is okay and you can decide not to m
eet m
e w
ithout having to give a reason.  
This w
ill not affect your care at the hospital.  
 If you w
ould like to ask m
e any questions please contact m
e through the em
ail 
address at the start of this letter. 
 If you w
ould like to m
eet w
ith m
e to tell m
e w
hat you think about the sm
art-
inhaler then please fill in your details on the assent form
. (I w
ill give you a copy 
of this).  
 Thank you  
 A
m
y S
tew
art 
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Appendix 5 – Caregiver Inform
ation Sheet  
UNIVERSITY OF EAST LONDON 
School of Psychology 
Stratford C
am
pus 
W
ater Lane 
London E15 4LZ 
 The Principal Investigator 
Am
y Stew
art 
u1235007@
uel.ac.uk 
 
Consent to Participate in a Research Study 
The purpose of this letter is to provide you w
ith the inform
ation that you need to 
consider in deciding w
hether to participate in m
y research study.  The study is being 
conducted as part of m
y D
octorate in C
linical Psychology at the U
niversity of East 
London. 
 
Project Title 
Experiences of Adherence A
ssessm
ent in A
sthm
a 
 Project Description 
x 
This research project aim
s to understand different experiences of adherence 
assessm
ent.  I am
 interested in your thoughts and experiences of the 
sm
art-inhaler that a healthcare professional w
ithin the Asthm
a team
 at The 
R
oyal Brom
pton H
ospital has issued your son/daughter/young person in 
your care.   
x 
If you decide to participate, you w
ill be invited to share your experiences 
through an interview
 w
ith m
yself.  This interview
 w
ill last for approxim
ately 20 
m
inutes and you w
ill be asked to talk about how
 your son/daughter/young 
person you care for w
as introduced to the sm
art-inhaler, your thoughts about 
the sm
art-inhaler and how
 you and your son/daughter /young person you care 
for are finding the sm
art-inhaler.  Interview
s w
ill be audio-recorded and 
transcribed for analysis.  
 Confidentiality of the Data 
x 
Any inform
ation you choose to share w
ith m
e w
ill be w
ill be treated confidentially 
and all nam
es and identifying references (e.g. a nam
e of a place) w
ill be 
rem
oved/anonym
ised from
 the transcriptions of interview
s (that m
ay be read by m
y 
supervisor or exam
iners) and for w
rite up/dissem
ination purposes.   
x 
All inform
ation collected w
ill be kept in a safe and secure place that only the 
researcher has access to.  Personal inform
ation w
ill not be shared w
ith anyone 
else.  
x 
All audio recordings w
ill be destroyed at the end of the study, how
ever electronic 
copies of anonym
ised transcripts w
ill be kept for 3 years for possible further 
developm
ent of the research project. 
 
Location 
x 
Interview
s w
ill be carried out face to face at The R
oyal Brom
pton H
ospital.   
x 
This interview
 w
ill take place in a private setting during one of your regular clinic 
appointm
ents and w
ill last approxim
ately 20 m
inutes.  
  Disclaim
er 
x 
You are not obliged to take part in this study and should not feel coerced.   
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x 
You are free to w
ithdraw
 at any tim
e.  Should you choose to w
ithdraw
 from
 the 
study you m
ay do so w
ithout disadvantage to yourself and w
ithout any 
obligation to give a reason.   
x 
Should you w
ithdraw
 from
 the research after you have com
pleted your 
interview
, the researcher reserves the right to use your anonym
ised data in the 
w
rite-up of the study and any further analysis that m
ay be conducted by the 
researcher. 
 Please feel free to ask m
e any questions.  If you are happy to continue you w
ill be 
asked to sign a consent form
 prior to your participation. Please retain this invitation 
letter for reference.  
 If you have any questions or concerns about how
 the study has been conducted, 
please contact the study’s supervisor D
r K
en G
annon, S
chool of P
sychology, 
U
niversity of East London, W
ater Lane, London E15 4LZ. Tel: 020 8223 4576 
K.N
.G
annon@
uel.ac.uk] 
 or  
 C
hair of the School of Psychology R
esearch Ethics Sub-com
m
ittee: D
r. M
ark Finn, 
School of Psychology, U
niversity of East London, W
ater Lane, London E15 4LZ. 
(Tel: 020 8223 4493. Em
ail: m
.finn@
uel.ac.uk) 
 Thank you in anticipation. 
 Yours sincerely, 
 Am
y Stewart 
Trainee C
linical Psychologist 
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Appendix 6 – Young Person Assent Form
  
UNIVERSITY OF EAST LONDON 
  Experiences of Adherence Assessm
ent in Asthm
a 
 I have read the inform
ation letter about the research and have been given a copy to 
keep.   
 The research has been explained to m
e, and I have had the chance to talk about the 
research and ask any questions I m
ay have. 
 I understand w
hat I w
ill be doing.  
 I understand that m
y inform
ation and the conversations I have w
ith A
m
y are 
confidential. 
 It has been explained to m
e w
hat w
ill happen once the research has finished. 
 I know
 I can change m
y m
ind about m
eeting Am
y at any tim
e w
ithout having a reason.  
I understand this w
ont affect m
y care at the hospital.  
 I w
ould like to take part in A
m
y’s research project. 
  Assent to participate in a research study  
 N
am
e   
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
. 
 Signature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s N
am
e  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s S
ignature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
 
  D
ate: …
…
…
…
…
…
…
…
..…
…
. 
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Appendix 7 – Caregiver Consent Form
 on Behalf of Young 
Person  
UNIVERSITY OF EAST LONDON 
Consent to participate in a research study  
 Experiences of Adherence A
ssessm
ent in A
sthm
a 
 
x 
I have the read the inform
ation sheet relating to the above research study and 
have been given a copy to keep.   
 
x 
The nature and purposes of the research have been explained to m
e, and I 
have had the opportunity to discuss the details and ask questions about this 
inform
ation.  I understand w
hat is being proposed and the procedures in w
hich 
m
y son/daughter w
ill be involved have been explained to m
e. 
 
x 
I understand m
y son/daughter’s/young person in m
y care’s involvem
ent in this 
study, and particular data from
 this research, w
ill rem
ain strictly confidential.  
O
nly the researcher(s) involved in the study w
ill have access to identifying data.  
It has been explained to m
e w
hat w
ill happen once the research study has been 
com
pleted. 
 
x 
I understand that relevant data collected during the study, m
ay be looked at by 
individuals from
 the U
niversity of East London, from
 regulatory authorities or 
from
 N
H
S Trusts, w
here it is relevant to m
y taking part this research. I give 
perm
ission for these individuals to have access to m
y son/daughter’s/young 
person in m
y care’s data. 
 
x 
I understand that you w
ill contact the G
P of m
y son/daughter/young person I 
care for to inform
 them
 of their participation in the research.  
 
x 
I hereby freely and fully consent to m
y son/daughter/young person in m
y care 
participating in the study, w
hich has been fully explained to m
e and them
.   
 
x 
H
aving given this consent I understand that I have the right to w
ithdraw
 from
 the 
study at any tim
e w
ithout disadvantage to m
yself or m
y son/daughter/young 
person in m
y care and w
ithout being obliged to give any reason.  I also 
understand that should I w
ithdraw
, the researcher reserves the right to use m
y 
anonym
ous data in the w
rite-up of the study and in any further analysis that 
m
ay be conducted by the researcher]. 
 P
articipant’s N
am
e (B
LO
C
K
 C
A
P
ITA
LS
)  
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
. 
 P
articipant’s S
ignature  
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s N
am
e (B
LO
C
K
 C
APITALS)  
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s S
ignature  
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
 
D
ate: …
…
…
…
…
…
…
…
.. 
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Appendix 8 – Caregiver Consent Form
  
UNIVERSITY OF EAST LONDON 
 Consent to participate in a research study  
 Experiences of Adherence A
ssessm
ent in A
sthm
a 
 
x 
I have the read the inform
ation sheet relating to the above research study and 
have been given a copy to keep.   
 
x 
The nature and purposes of the research have been explained to m
e, and I 
have had the opportunity to discuss the details and ask questions about this 
inform
ation.  I understand w
hat is being proposed and the procedures in w
hich I 
w
ill be involved have been explained to m
e. 
 
x 
I understand that m
y involvem
ent in this study, and particular data from
 this 
research, w
ill rem
ain strictly confidential.  O
nly the researcher(s) involved in the 
study w
ill have access to identifying data.  It has been explained to m
e w
hat w
ill 
happen once the research study has been com
pleted. 
 
x 
I understand that relevant data collected during the study, m
ay be looked at by 
individuals from
 the U
niversity of East London, from
 regulatory authorities or 
from
 N
H
S Trusts, w
here it is relevant to m
y taking part this research. I give 
perm
ission for these individuals to have access to m
y data. 
 
x 
I hereby freely and fully consent to participate in the study, w
hich has been fully 
explained to m
e.   
 
x 
H
aving given this consent I understand that I have the right to w
ithdraw
 from
 the 
study at any tim
e w
ithout disadvantage to m
yself and w
ithout being obliged to 
give any reason.  I also understand that should I w
ithdraw
, the researcher 
reserves the right to use m
y anonym
ous data in the w
rite-up of the study and in 
any further analysis that m
ay be conducted by the researcher]. 
 P
articipant’s N
am
e (B
LO
C
K
 C
A
P
ITA
LS
)  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
. 
 P
articipant’s S
ignature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s N
am
e (B
LO
C
K
 C
A
P
ITA
LS
)  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s S
ignature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
 
 D
ate: …
…
…
…
…
…
…
…
..…
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Appendix 9 – Healthcare Professional Inform
ation Sheet  
UNIVERSITY OF EAST LONDON 
School of Psychology 
Stratford C
am
pus 
W
ater Lane 
London E15 4LZ 
 The Principal Investigator 
Am
y Stew
art 
u1235007@
uel.ac.uk 
 
Consent to Participate in a Research Study 
The purpose of this letter is to provide you w
ith the inform
ation that you need to 
consider in deciding w
hether to participate in m
y research study.  The study is being 
conducted as part of m
y D
octorate in C
linical Psychology at the U
niversity of East 
London. 
 
Project Title 
Experiences of Adherence A
ssessm
ent in A
sthm
a 
 Project Description 
x 
This research project aim
s to understand different experiences of adherence 
assessm
ent.  I am
 interested in your experiences of using the sm
art-inhaler in 
your clinical practice w
ithin the Asthm
a team
 at The R
oyal Brom
pton H
ospital.   
x 
If you decide to participate, you w
ill be invited to share your experiences 
through a focus group facilitated by m
yself, w
here your other colleagues w
ho 
use the sm
art-inhaler w
ill also be present (and sharing their view
s).  This focus 
group w
ill last for approxim
ately 30 m
inutes and you w
ill be asked to share your 
thoughts regarding the sm
art-inhaler.  
 Confidentiality of the Data 
x 
Any inform
ation you choose to share w
ith m
e w
ill be w
ill be treated confidentially 
and all nam
es and identifying references (e.g. a nam
e of a place) w
ill be 
rem
oved/anonym
ised from
 the transcriptions of the focus group (that m
ay be read 
by m
y university supervisor or exam
iners) and for w
rite up/dissem
ination purposes.   
x 
All inform
ation collected w
ill be kept in a safe and secure place that only the 
researcher has access to.  Personal inform
ation w
ill not be shared w
ith anyone 
else.  
x 
 Anonym
ised notes m
ade during the focus group w
ill be kept for 3 years for 
possible further developm
ent of the research project. 
 Location 
x 
The focus group w
ill be carried out face to face at The R
oyal Brom
pton 
H
ospital.  
 Disclaim
er 
x 
You are not obliged to take part in this study and should not feel coerced.   
x 
You are free to w
ithdraw
 at any tim
e.  Should you choose to w
ithdraw
 from
 the 
study you m
ay do so w
ithout disadvantage to yourself and w
ithout any 
obligation to give a reason.   
x 
Should you w
ithdraw
 from
 the research after you have com
pleted your 
interview
, the researcher reserves the right to use your anonym
ised data in the 
w
rite-up of the study and any further analysis that m
ay be conducted by the 
researcher. 
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 Please feel free to ask m
e any questions.  If you are happy to continue you w
ill be 
asked to sign a consent form
 prior to your participation.  Please retain this invitation 
letter for reference.  
 If you have any questions or concerns about how
 the study has been conducted, 
please contact the study’s supervisor D
r K
en G
annon, S
chool of P
sychology, 
U
niversity of East London, W
ater Lane, London E15 4LZ. Tel: 020 8223 4576 
K.N
.G
annon@
uel.ac.uk] 
 or  
 C
hair of the School of Psychology R
esearch Ethics Sub-com
m
ittee: D
r. M
ark Finn, 
School of Psychology, U
niversity of East London, W
ater Lane, London E15 4LZ. 
(Tel: 020 8223 4493. Em
ail: m
.finn@
uel.ac.uk) 
 Thank you in anticipation. 
 Yours sincerely, 
 Am
y Stew
art 
 Trainee C
linical Psychologist 
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Appendix 10 – Healthcare Professional Consent Form
  
UNIVERSITY OF EAST LONDON 
 Consent to participate in a research study  
 Experiences of Adherence A
ssessm
ent in A
sthm
a 
 
x 
I have the read the inform
ation sheet relating to the above research study and 
have been given a copy to keep.   
 
x 
The nature and purposes of the research have been explained to m
e, and I 
have had the opportunity to discuss the details and ask questions about this 
inform
ation.  I understand w
hat is being proposed and the procedures in w
hich I 
w
ill be involved have been explained to m
e. 
 
x 
I understand that m
y involvem
ent in this study, and particular data from
 this 
research, w
ill rem
ain strictly confidential.  O
nly the researcher(s) involved in the 
study w
ill have access to identifying data.  It has been explained to m
e w
hat w
ill 
happen once the research study has been com
pleted. 
 
x 
I understand that relevant data collected during the study, m
ay be looked at by 
individuals from
 the U
niversity of East London, from
 regulatory authorities or 
from
 N
H
S Trusts, w
here it is relevant to m
y taking part this research. I give 
perm
ission for these individuals to have access to m
y data. 
 
x 
I hereby freely and fully consent to participate in the study, w
hich has been fully 
explained to m
e.   H
aving given this consent I understand that I have the right 
to w
ithdraw
 from
 the study at any tim
e w
ithout disadvantage to m
yself and 
w
ithout being obliged to give any reason.  
 
x 
 I also understand that should I w
ithdraw
 after the focus group is com
plete, the 
researcher reserves the right to use m
y anonym
ous data in the w
rite-up of the 
study and in any further analysis that m
ay be conducted by the researcher]. 
 P
articipant’s N
am
e (B
LO
C
K
 C
A
P
ITA
LS
)  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
. 
 P
articipant’s S
ignature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s N
am
e (B
LO
C
K
 C
A
P
ITA
LS
)  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
.. 
 R
esearcher’s S
ignature  
 …
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
 
 D
ate: …
…
…
…
…
…
…
…
..…
…
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Appendix 11 – Young Person Interview Schedule  
 G
ender: M
/F   
A
ge: 
 History of asthm
a, m
edical treatm
ents, m
anagem
ent/self care 
1. 
C
an you tell m
e about your asthm
a? 
P
R
O
M
P
TS: H
ow
 long have you had asthm
a? W
ho told you about it? W
hat did 
they say? H
ow
 does it affect you? W
hat do you think about it (asthm
a)?  
 
2. 
H
ow
 have the R
B
H
 asthm
a team
/ other doctors/nurses treated your 
asthm
a? 
P
R
O
M
P
TS: w
hat treatm
ents/m
edicines/ care have they given you up to now
? 
H
ow
 do they explain things to you? 
FO
LLO
W
 U
P
: W
hat do you think about that/them
? P
R
O
M
PTS
: 
helpful/unhelpful, useful/not useful etc.  
 
3. 
H
ow
 do you look after your asthm
a? / W
hat sort of things do you have to 
do to look after yourself w
ith your asthm
a? 
P
R
O
M
P
TS: D
o you have to take your inhaler at certain tim
es? If so, w
hen? 
H
ow
 do you rem
em
ber to? D
o you have to avoid certain things?  
 
4. 
 D
oes anyone in your fam
ily help you w
ith your asthm
a, if so w
ho and 
how
? 
P
R
O
M
P
TS: w
hat do they do to help, is that alw
ays helpful or not, how
 does it 
m
ake you feel? W
hat do you think about that?  
 Sm
art Inhaler 
     5. You w
ere given a sm
art-inhaler at your last visit; can you tell m
e about 
how
 you got it? 
P
R
O
M
P
TS: H
ow
 did you get it? D
id som
eone explain w
hat it w
as for? W
ho? 
W
hat did they say?  
      6. W
hy do you think the doctor/nurse gave it you?  
P
R
O
M
P
TS: did they say it w
ould rem
ind you to take it, did they say it w
ould 
help them
 see how
 you use it?  
FO
LLO
W
 U
P
: W
hat do you think about that? 
      7. W
hat do you think the sm
art-inhaler is for?  
P
R
O
M
P
TS: H
ow
 is the sm
art-inhaler different to your other inhalers? 
      8. W
hat do you think your parent/s/caregiver thinks the sm
art-inhaler is for?   
P
R
O
M
P
TS: H
ave you spoken w
ith them
 about it, w
hat did they say? 
       9.  Y
ou’ve had the sm
art-inhaler for about 2 m
onths now
, how
 did you find 
that? H
ow
 did you use it?  
FO
LLO
W
 U
P
: A
sk for exam
ples of w
hen, w
here and if not w
hy.  H
ow
 w
as this 
different to before?  
 10. W
ho w
as in charge of the sm
art-inhaler w
hile you had it?  
FO
LLO
W
 U
P
: W
hy? H
ow
? E
xam
ples? 
 11. H
as the sm
art-inhaler helped w
ith the control of your asthm
a? H
ow
/W
hy? 
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 12. C
an you tell m
e about any w
ays the sm
art-inhaler helps you/or parent take 
care/responsibility for your asthm
a? O
r any w
ays it m
akes this harder? 
 13. W
hat do you think about your doctor/nurse being able to use the sm
art-
inhaler to see w
hen you are taking your m
edication?  
FO
LLO
W
 U
P
: H
as this changed w
hat you think about your doctor/nurse? W
hy? 
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Appendix 12 – Caregiver Interview Schedule  
G
ender: M
/F   
R
elation to young person:  
 
 Sm
art Inhaler 
     1. Your son/daughter w
as given a sm
art-inhaler at their last visit; can you tell 
m
e about how
 this cam
e about? 
P
R
O
M
P
TS: H
ow
 did they get it? D
id som
eone explain w
hat it w
as for? W
ho? 
W
hat did they say?  
      2. W
hy do you think the doctor/nurse gave it to them
?  
P
R
O
M
P
TS: did they say it w
ould rem
ind your son/daughter to take their inhaler, 
did they say it w
ould help them
 see how
 your son/daughter uses it?  
FO
LLO
W
 U
P
: W
hat do you think about that? 
      3. W
hat do you think the sm
art-inhaler is for?  
P
R
O
M
P
TS: H
ow
 is the sm
art-inhaler different to other inhalers? 
      4. W
hat do you think your son/daughter thinks the sm
art-inhaler is for?   
P
R
O
M
P
TS: H
ave you spoken w
ith them
 about it, w
hat did they say? 
       5.  Your son/daughter has had the sm
art-inhaler for about 2 m
onths now
, 
how
 has that been? H
ow
 did they use it?  
FO
LLO
W
 U
P
: A
sk for exam
ples of w
hen, w
here and if not w
hy.  H
ow
 w
as this 
different to before?  
 6. W
ho w
as in charge of the sm
art-inhaler during this tim
e?  
FO
LLO
W
 U
P
: W
hy? H
ow
? E
xam
ples? 
 7. H
as the sm
art-inhaler helped w
ith the control of your son/daughter’s asthm
a? 
H
ow
/W
hy? 
 8. C
an you tell m
e about any w
ays the sm
art-inhaler helps your son/ 
daughter/or yourself take care/responsibility for the asthm
a? O
r any w
ays it 
m
akes this harder? 
 9. W
hat do you think about your doctor/nurse being able to use the sm
art-
inhaler to see w
hen your son/daughter is taking their m
edication?  
FO
LLO
W
 U
P
: H
as this changed w
hat you think about your doctor/nurse? W
hy? 
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Appendix 13 – Healthcare Professional Focus Group Schedule  
1. H
ow
 is the sm
art-inhaler used in your service/ in your clinical practice? 
   2. H
ow
 do you explain/introduce the sm
art-inhaler to patients/fam
ilies? 
   3. W
hat do you think are the benefits to your patients of using the sm
art-
inhaler? 
   4. W
hat do you think are the benefits to the staff/service of using the sm
art-
inhaler?  
  5. W
hat do you think are the disadvantages to your patients of using the sm
art-
inhaler? 
   6. W
hat do you think are the disadvantages to the staff/service of using the 
sm
art-inhaler?  
   7. H
ow
 do you discuss the data collected from
 the sm
art-inhaler w
ith patients? 
   8.  D
oes the sm
art-inhaler help patients/fam
ilies take responsibility for their 
healthcare or not? W
hy/H
ow
? 
   9. W
hat im
pact (if any) has the sm
art-inhaler had on your relationships w
ith 
patients/fam
ilies? E
xam
ples? 
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Appendix 14 – School of Psychology Ethical Approval  
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Appendix 15 – University of East London Ethical Approval  
5 A
ugust 2014 
  D
ear Am
y, 
    Project Title: 
   
  Experiences of Adherence Assessm
ent in Asthm
a  
  
  Researcher(s):  
  
 Am
y Stewart 
 Principal 
Investigator:  
  
 Am
y Stewart 
 I am
 w
riting to confirm
 that the application for the aforem
entioned N
H
S research study 
reference 14/LO/0732 has received U
R
EC
 ethical approval and is sponsored by the 
U
niversity of East London.   
 The lapse date for ethical approval for this study is 05 August 2018.  If you require 
U
R
EC
 approval beyond this date you m
ust subm
it satisfactory evidence from
 the N
H
S 
confirm
ing that your study has current N
R
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w
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R
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research 
m
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w
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H
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ents specified as part of your N
H
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m
ittee’s best w
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Ethics Integrity M
anager 
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U
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esearch Ethics C
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Appendix 16 – NHS Ethical Approval Docum
ents 
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Appendix 17 – The Royal Brom
pton R & D Approval  
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Appendix 18 – Transcription Conventions  
 [unclear]  
Indicates that the person transcribing w
as not sure 
about w
hat w
as said  
=  
Indicates w
here som
eone has finished another’s 
sentence  
[ ]  
Indicates w
hen the author w
ants to add com
m
ent 
e.g. [som
eone enters room
]  
[interruption] 
B
rief interruptions show
n by inserting interruption in 
square brackets e.g. C
laire: They said that they w
ere 
gonna erm
 record m
e to see if I w
as taking it cause I 
w
eren’t really taking it before [A
m
y: O
k] and they 
said that err they w
ere trying like to help m
e get 
better  
 (unclear ‘insert w
ord’)   
W
hen the transcribe w
as uncertain w
hat w
as said 
but able to m
ake a reasonable guess  
,  
P
erson speaking changes their sentence 
e.g Focus 
group discussion: O
ne patient has refused, possibly 
for fear of being found out 
 -  
U
nfinished w
ord 
e.g. A
m
y: A
nd is that different to 
before did it not fe-, did you now
 feel so pressured 
before cause they didn’t- they w
eren’t able to look at 
it like is it any different or w
as there still that 
argum
ent about 
 A
dapted from
 Parker (2005)  
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Appendix 19 – Worked Extract Example 
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 Appendix 20 – Initial Coding 
 
No. 
Initial Coding 
1 
acceptance of hcps recom
m
endation 
2 
acceptance of hcps recom
m
endation/ being told 
3 
adherence checked in other w
ays 
4 
adherence decreases escalation in healthcare needed 
5 
A
dherence is not sim
ple 
6 
adherence m
odel of healthcare 
7 
adherence questioned 
8 
adjusting to hospital routine 
9 
age influences acceptance of results  
10 
am
bivalence about si 
11 
assessm
ent process overw
helm
ing  
12 
asthm
a affects physically and psychologically 
13 
asthm
a as annoying 
14 
asthm
a as life long  
15 
asthm
a as long term
 
16 
asthm
a as serious 
17 
asthm
a as som
ething can ignore 
18 
asthm
a as som
ething you just have 
19 
asthm
a as unpredictable 
20 
asthm
a can affect people differently 
21 
asthm
a feels like dying 
22 
asthm
a gets in the w
ay of things 
23 
asthm
a im
pact 
24 
asthm
a is annoying 
25 
asthm
a is frightening  
26 
asthm
a is life threatening 
27 
asthm
a is scary 
28 
asthm
a is severe 
29 
asthm
a is unpredictable 
30 
asthm
a like being non existent 
31 
asthm
a m
akes unw
ell 
32 
asthm
a m
akes you ill  
33 
asthm
a m
akes you poorly 
34 
asthm
a m
akes you poorly at tim
es (asthm
a varies?)  
35 
asthm
a m
eans hospital 
36 
asthm
a non adherence as dangerous 
37 
asthm
a stops you doing stuff 
38 
asthm
a w
ill affect life in the future  
39 
avoiding extrem
e w
eather  
40 
aw
areness of hcp m
onitoring 
41 
aw
areness of hcps w
orkload 
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42 
barriers to adherence- lim
ited tim
e 
43 
being m
onitored m
eans adherence m
atters 
44 
being m
onitored m
eans it m
atters 
45 
being proved w
rong 
46 
being told 
47 
benefits to sm
art inhaler but not the m
onitoring  
48 
checking up good 
49 
children like praise 
50 
com
m
unication about non adherence 
51 
com
m
unication about responsibility 
52 
com
m
unication about si 
53 
com
m
unication w
ith w
ider fam
ily system
 about m
onitoring 
54 
com
pliance m
odel of healthcare 
55 
concealing asthm
a im
pact 
56 
confusion about how
 si w
orks 
57 
confusion in hcp interaction 
58 
confusion over how
 si w
orks 
59 
dependency on si 
60 
disagreem
ent in parent child relationship 
61 
discrepancy in responsibility  
62 
discrepancy in responsibility talk 
63 
doctor w
as w
orried 
64 
doctors are suspicious of adherence 
65 
doctors asking parent's view
 
66 
doing for their ow
n good, good intentions 
67 
doing to him
 
68 
dr as expert  
69 
drs need to know
 w
hether young people using inhalers 
properly 
70 
excuses for not using si 
71 
expectations of inhaler use 
72 
experiencing poor healthcare 
73 
explaining non-adherence a challenge 
74 
fam
ily excuses for not using si 
75 
fam
ily planning 
76 
fear of being found out 
77 
fear of breaking si 
78 
fear of hcp 
79 
fear of losing raised through C
om
m
unication 
80 
fear of losing si 
81 
fear of w
asting doctors tim
e 
82 
forgetting 
83 
forgetting to take inhalers 
84 
get better 
85 
get used to sm
art inhaler 
86 
getting used to si if there long term
 
87 
going through results together 
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88 
good intentions 
89 
good intentions of si 
90 
good si explanation encourages use 
91 
good things about si 
92 
grow
 out of asthm
a 
93 
harder for parents to be responsible for teenagers inhaler use 
94 
having ow
n asthm
a routine and know
ledge 
95 
hcp gives m
e m
edicine 
96 
hcp is w
rong 
97 
hcp m
istrust 
98 
hcp m
onitoring 
99 
hcp not listening to yp view
s 
100 
hcp pow
er 
101 
hcp questioning adherence 
102 
hcp trying to catch you out 
103 
hcp uncertainty about how
 ts use the si 
104 
hcps can see w
hat he's done 
105 
hcps checking m
edicine is w
orking 
106 
hcps don’t believe you 
107 
hcps encourage inhaler use 
108 
hcps listen to parental view
s 
109 
hcps m
oan 
110 
hcps responsible for m
y asthm
a 
111 
hcps talks to m
e 
112 
hcps trusting si but not yp 
113 
hcps w
ant m
e to take inhaler 
114 
hcr partnership 
115 
health benefits to si 
116 
history of adherence m
onitoring 
117 
hospital school different 
118 
hospitalisation 
119 
hcp sees yp aw
ay from
 asthm
a 
120 
I don't like the si 
121 
I don’t need the si 
122 
I just leave it 
123 
I told them
 m
y view
 
124 
I'll prove it 
125 
if forget inhalers asthm
a w
ill be w
orse 
126 
increasing age increasing responsibility 
127 
increasing age: increasing understanding of asthm
a 
128 
increasing responsibility at secondary school 
129 
inhaler know
ledge  
130 
inhaler necessity belief 
131 
inhaler representing asthm
a (sym
bol of asthm
a) 
132 
inhaler use during sport 
133 
inhaler: necessity beliefs 
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134 
inhalers im
portant to m
um
/nan 
135 
instructions w
ith si helpful 
136 
insulting/ infantilising 
137 
intentional &
 un-intentional non adherence 
138 
intentional non adherence 
139 
intentional non use of si 
140 
interest in new
 technology 
141 
intrusive 
142 
it's hard to go against doctor's w
ishes 
143 
keep inhalers by side 
144 
keeping inhalers in sam
e place helps rem
em
ber  
145 
know
ledge of asthm
a m
anagem
ent/adherence expectations 
146 
know
ledge of healthcare treatm
ent 
147 
learning from
 results 
148 
less responsibility at prim
ary school 
149 
lim
ited interest 
150 
lim
ited know
ledge of w
hat happens next 
151 
lim
ited understanding of si m
onitoring process 
152 
m
ake you take it 
153 
m
edical testing to check heart  
154 
m
edication beliefs 
155 
m
edication in different places 
156 
m
edication supervision necessary to get better  
157 
m
edicines help m
e get better 
158 
m
inim
al concern for si 
159 
m
inim
ising of non-adherence 
160 
m
isrepresenting adherence 
161 
m
istrust  
162 
m
ixed view
s about si 
163 
m
onitoring changes behaviour artificially 
164 
need responsibility for asthm
a 
165 
need si for a w
hile for im
pact, or for it to show
 any changes, 
influence behaviour 
166 
needing parental reassurance 
167 
neg feedback affects hcp relationship negatively 
168 
negative feedback 
169 
new
 inform
ation on inhaler use 
170 
no necessity 
171 
non adherence dangerous 
172 
norm
alising non adherence 
173 
norm
alising non adherence 
174 
not being believed  
175 
not believing results  
176 
not bothered by si process 
177 
not happy about si 
178 
not keen on hospital 
179 
observed the benefits of si 
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180 
older children don't like being checked up on  
181 
older yp should have m
ore responsibility 
182 
other adherence m
easures used: G
P
 prescription pick up 
183 
overprotective parents experienced as unhelpful 
184 
parent  rem
inders 
185 
parent gets on w
ith hcps 
186 
parent giving different inhaler for w
hen parent not there 
187 
parent not happy si 
188 
parent w
anting to check but aw
are yp doesn’t like 
189 
parent's can't control inhaler use 
190 
parental checking 
191 
parental checking helpful 
192 
parental checking/questioning 
193 
parental checking/questioning annoying 
194 
parental m
onitoring 
195 
parental positivity tow
ards si 
196 
parental pow
er 
197 
parental pow
er to force 
198 
parental rem
inders 
199 
parental responsibility 
200 
parental responsibility m
eans S
i doesn’t influence adherence 
201 
parental responsibility to check child inhaler use 
202 
parental role 
203 
parental supervision 
204 
parental threatening 
205 
parental w
ays of checking adherence 
206 
parents getting questions about adherence because of si 
207 
parents nervous about si m
onitoring 
208 
parents not believing results 
209 
parents see as positive thing 
210 
parents should be supervising their kids 
211 
physical sym
ptom
s  
212 
physical sym
ptom
s indicate non adherence 
213 
poor planning in introducing sm
art inhaler 
214 
portability issues w
ith si 
215 
positive feedback helpful 
216 
pow
er 
217 
pow
er of si 
218 
pow
er of si: H
C
 interactions inform
ed by si data 
219 
practicalities talk  
220 
practicalities talk (si not practical) 
221 
practicalities talk: inhaler hard to rem
em
ber 
222 
practicalities talk: in-practicalities prom
ote non adherence 
(un-intentional non adherence) 
223 
practicalities talk: keeping inhaler nearby 
224 
practicalities talk: m
any m
edications lead to forgetting 
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225 
practicalities: lost the sm
art inhaler 
226 
pressure 
227 
psychological  features of asthm
a 
228 
pt refusal to use si 
229 
qus asked by fam
ilies about how
 m
onitoring w
orks 
230 
reasons for non adherence 
231 
regular healthcare reducing hospital adm
issions 
232 
regular hospital visits 
233 
rem
inders help adherence 
234 
rem
inders on si helpful 
235 
responsibility sharing 
236 
responsibility shifting 
237 
results not fed back 
238 
routine helps adherence 
239 
scared about using si right 
240 
self care  
241 
self care as adherence to m
edicines and inhaler 
242 
self care as taking m
edicine w
hen really ill 
243 
severity of asthm
a w
arrants si 
244 
shared responsibility 
245 
si  influences adherence 
246 
si a new
 thing 
247 
si a w
aste of tim
e 
248 
si acts as rem
inder 
249 
si aids m
edical understanding  
250 
si allow
s parents to supervise adherence better 
251 
si an eye opener for parents 
252 
si as allow
ing hcps to disregard verbal info in favour info 
recorded 
253 
si as becom
ing the focus of the hc interaction 
254 
si as being w
atched 
255 
si as lie detector 
256 
si as objective w
ay of m
easuring adherence 
257 
si as portable healthcare  
258 
si as specificity tool 
259 
si as tracker of adherence 
260 
si avoids escalations in treatm
ent 
261 
si avoids hcps doing m
ore invasive treatm
ents 
262 
si belongs to hospital 
263 
si broke 
264 
si can be used to m
aintain good health 
265 
si can get you in trouble 
266 
si changes (parents?) priorities 
267 
si checks not forgetting 
268 
si checks up 
269 
si checks up on parents 
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270 
si confusing 
271 
si data can look like but be w
rong 
272 
si data kept in m
edical records 
273 
si doesn’t affect relationship w
ith hcp 
274 
si doesn’t change/im
prove adherence 
275 
si doesn’t change/im
prove adherence (not an intervention in 
itself) 
276 
si doesn’t reflect reality 
277 
si encourages routine inhaler use 
278 
si for bad asthm
a 
279 
si for difficult asthm
a 
280 
si gets you into trouble 
281 
si given as part of practice 
282 
si gives evidence 
283 
si gives hcps pow
er 
284 
si gives inform
ation on asthm
a control and D
A
 
285 
si gives opportunity to take responsibility 
286 
si gives parents pow
er 
287 
si gives proof 
288 
si good for severe asthm
a 
289 
si helps doctors decide if need to increase m
eds 
290 
si helps hcps get the basics right 
291 
si helps hcps m
onitor adherence 
292 
si helps hcps problem
 solve other w
ays to prom
ote 
adherence 
293 
si helps hcps see if rem
em
bering  
294 
si helps hcps understand link betw
een health and adherence 
295 
si helps parental m
onitoring 
296 
si helps parents take responsibility for supervising yp's 
adherence/inhaler use 
297 
si helps pts avoids m
ore invasive treatm
ents 
298 
si helps w
ith plan of attack 
299 
si helps w
ith shifting responsibility to yp 
300 
si helps yp take inhaler regularly 
301 
si helps yp use inhaler 
302 
si helps hands off parental m
onitoring 
303 
si identifies poor parental supervision 
304 
si im
portance 
305 
si im
proves hcis vs shifts pow
er to device 
306 
si im
proves health 
307 
si increases parental aw
areness of child's adherence/inhaler 
use 
308 
si influences adherence but only in the short term
 
309 
si influences hcp actions 
310 
si influences parent behaviour 
311 
si introduced as helping hcps see how
 the inhaler is used 
and D
A linked 
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312 
si introduced in routine assessm
ent procedure 
313 
si introduced to parent 
314 
si introduced w
hen concerns about asthm
a control 
315 
si is insulting 
316 
si kept on one inhaler 
317 
si lets hcps see how
 taking inhaler 
318 
si like big brother w
atching you 
319 
si lim
ited to short term
 
320 
si m
akes hc relationships easier 
321 
si m
akes non-adherence a big deal 
322 
si m
akes question ow
n inhaler use 
323 
si m
akes question self 
324 
si m
eans adherence on the m
ind 
325 
si m
eans hcps w
atching you 
326 
si m
eans yp not responsible? 
327 
si m
onitoring im
proves health 
328 
si m
onitoring influences adherence 
329 
si m
onitoring scary 
330 
si m
onitors 
331 
si m
onitors adherence 
332 
si m
onitors self care 
333 
si negatively affects hcp relationship 
334 
si not appropriate for adults 
335 
si not changing parental checking 
336 
si not explained 
337 
si not explained w
ell 
338 
si not needed if parental m
onitoring 
339 
si not relevant? 
340 
si ok 
341 
si okay if adherent 
342 
si opens up com
m
unication about inhaler use 
343 
si optional  
344 
si part of assessm
ent protocol 
345 
si part of hcps job 
346 
si pow
er over w
ord of m
outh 
347 
si process as generalised 
348 
si process frightening 
349 
si process infantilising 
350 
si process scary 
351 
si records inhaler use 
352 
si records m
e/ m
y inhaler use 
353 
si reduces excuses 
354 
si reduces fam
ily stroppiness 
355 
si rem
inds you 
356 
si rem
oves argum
ents about adherence in hci 
357 
si rem
oves confrontation in hcr 
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358 
si reverses parental involvem
ent, m
um
 m
ore involved 
359 
si reverses yp responsibility 
360 
si scary 
361 
si show
s room
 for im
provem
ent 
362 
si spys on you 
363 
si tim
er m
ade it hard 
364 
si too big 
365 
si used as proof 
366 
si used to understand poor health 
367 
si used w
hen concerns about adherence 
368 
si used w
hen non-adherence 
369 
si used w
hen parental supervision of child a concern 
370 
si useful for older yp 
371 
si w
atches you 
372 
si w
hen hcps think you're not adhering 
373 
side effects to using inhalers  
374 
sim
ilar experiences at different hospitals 
375 
staff changes  
376 
surveillance 
377 
taking inhalers and m
eds looks after asthm
a 
378 
taking m
edicine properly 
379 
technical difficulties 
380 
technical difficulties, unable to go through results w
ith pts in 
clinic 
381 
technology but not at its best 
382 
teenagers forget to take inhaler 
383 
teens are stubborn 
384 
teens need to be m
onitored 
385 
tension in holding responsibility vs needing support 
386 
the inhaler hurts m
y leg as its bulging out 
387 
they [hcps] tell m
e w
hat to do 
388 
they w
on't believe m
e 
389 
thought asthm
a w
ould go aw
ay 
390 
tim
e im
plications of using si in hc practice 
391 
transparency in com
m
unication 
392 
trust 
393 
uncertainty about long term
 im
pact/effect of si once taken off 
394 
understanding of si technology 
395 
ups and dow
ns of asthm
a control 
396 
using inhaler as norm
al 
397 
using inhalers reduces unpredictability 
398 
using visual inform
ation to feedback results 
399 
w
e got told 
400 
w
ider fam
ily role in checking/questioning 
401 
w
orking together in hcp relationship 
402 
w
orry 
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403 
yp independence in m
anaging asthm
a 
404 
yp responsibility 
405 
yp responsible for asthm
a 
406 
yp responsible for inhaler use 
407 
yp should be responsible for asthm
a 
408 
yp taking responsibility for si 
409 
yp w
anting their individuality recognised, si as dism
issing 
individuality 
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Appendix 21 – Higher-Level Coding 
 No 
Higher-Level Codes 
 1 
adherence aids 
 2 
adherence is not sim
ple 
 3 
asthm
a beliefs 
 4 
com
m
unication 
 5 
dependency on si 
 6 
excuses 
 7 
fear of losing si 
 8 
hcp m
onitoring 
 9 
hcp relationship 
 
10 
hcp relationship- adherence 
 
11 
hcp relationship- com
pliance 
 
12 
history of adherence m
onitoring 
 
13 
intentional &
 un-intentional non adherence 
 
14 
m
inim
ising of non-adherence 
 
15 
m
istrust 
 
16 
negative feedback 
 
17 
non adherence com
m
on 
 
18 
other w
ays of m
onitoring adherence 
 
19 
parental m
onitoring 
 
20 
parental responsibility 
 
21 
pow
er 
 
22 
responsibility 
 
23 
responsibility discrepancy 
 
24 
self care 
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25 
short term
 effect of si 
 
26 
si as part of standard assessm
ent 
 
27 
si beliefs 
 
28 
si concern beliefs 
 
29 
si gives proof 
 
30 
si im
proves unintentional non-adherence 
 
31 
si influences parent behaviour 
 
32 
si m
akes non-adherence a big deal 
 
33 
si m
onitoring didn’t influence adherence 
 
34 
si m
onitoring influences adherence 
 
35 
si necessity beliefs 
 
36 
si not needed if parental m
onitoring 
 
37 
si used w
hen concerns about adherence 
 
38 
surveillance 
 
39 
treatm
ent beliefs 
 
40 
treatm
ent concern belief 
 
41 
treatm
ent necessity beliefs 
 
42 
trust 
 
43 
unintentional non adherence 
 
44 
w
hat helps adherence 
 
45 
w
ider fam
ily m
onitoring 
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Appendix 22 – Coded Extract Example  
Interview  Line no 
Higher-
Level 
Code 
Initial 
Code Extract 
YP 2 
Sam   
95-102 mistrust mistrust  
Amy: And the way [nurse] explained it can you remember how 
Sam: = She said that she said that it would record how many times I 
take it and that they can see you and whether whether I’ve been taking 
it or not 
Amy: An so you said like it felt a little bit spyee do you think anything 
else about it and why you were given it? 
Sam: Maybe she thought I wasn’t taking it 
Amy: And what do you think about that? 
Sam: That she was wrong 
YP 6 Isla  
108-113 mistrust mistrust  
Amy: Yeh yeh and like you say I guess if you’d given it in and you 
knew they were gonna look at it and obviously like you say you’ve not 
been able to use it all the time [Isla: Yeh] do you think that would have 
been like quite hard to explain or how do you think you would have 
managed that? Isla: I would have explained it but I don’t think like they 
would believe me sort of thing [Amy: Yeh ok] but I have been [laughs] I 
have [Amy: Yeh]  
  153 
YP 6 Isla  
174-182 mistrust mistrust  
Amy: And do you think you would fe-, if you knew that you were 
coming to an appointment where they were gonna look at the results 
and you’d had the chance to use if for say a period of time and where 
you had it and you knew how to use it er would you be feeling alright 
with that or do you think you would be a bit worried about what they 
were gonna see or what? 
Isla: Well if I took it all properly I’d still be worried but there’s no reason 
really to be if I’ve took it properly but it’s just I dunno 
Amy: What do you think that worry is about do you think it’s cause it’s 
just  
Isla: =They don’t trust me yeh 
YP & CG 
5 Gary 
and 
Estelle  
148-153 mistrust 
si as lie 
detector 
Estelle:= Yeh just seen them judging by his erm his the breathing he’s 
done today they can tell that he hasn’t been using it properly they said 
it’s really obvious and then when we come back in a couple of weeks 
time they are going to plug it in an they are going to see if what they’ve 
seen today is gonna be so they can see if Gary has been telling them 
lies or not [pitch of voice goes higher] 
YP & CG 
5 Gary 
and 
Estelle  
154-160 mistrust 
they won't 
believe 
me 
Amy: And how does it feel for you Gary, kind of knowing that they are 
going to look at them in that way? 
Gary: It feels scary cause whenever I don’t, whenever I think of taking 
it but I haven’t it’s like oh, whenever your found or someone says you 
haven’t done this and you plead innocence they are always gonna say 
that they won't believe you cause it’s the results but you thi-, you say 
ok I’d thought I’d tooken it but I didn’t know if I had and yeh  
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Appendix 23 – Map of Provisional Themes
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Provisional Thematic Map 1 
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Provisional Thematic Map 2 
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Provisional Thematic Map 3 
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Appendix 24 – Them
atic M
ap of Revised Them
es 
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Appendix 25 – Defining & Naming Themes 
 
Name Of Theme Definition 
What Was Of Interest/Relevance To 
Research Question 
Theme 1: “They Were 
Trying To Help Me 
Get Better” 
Illustrates how participants’ 
beliefs/understandings of asthma influenced 
their expectations of the healthcare relationship 
and their experience of being given the smart-
inhaler 
Highlights participants’ perceived need for the 
smart-inhaler & how this interacts with the 
healthcare relationship 
Sub-ordinate theme: “It 
Feels Like I’m Kind Of 
Dying” 
Outlines some of the beliefs participants held 
about asthma and the need for medical 
treatment 
Highlights participants’ perceived need for the 
smart-inhaler 
Sub-ordinate theme: “It 
Helps Us To Get The 
Basics Right” 
Describes participants’ views of the smart-
inhaler as helping healthcare professionals to 
improve patient’s health 
Describes how process of being given the 
smart-inhaler interacts with the healthcare 
relationship 
Theme 2: “It’s Clearly 
Just To Check Up” 
Illustrates how participants experienced the 
introduction of the smart-inhaler as being to 
monitor their inhaler use and how this influenced 
their inhaler use 
Describes participants’ concerns with the 
introduction of the smart-inhaler and the issues 
it raises in the healthcare relationship 
Sub-ordinate theme: “It 
Was A Little Bit Spyee” 
Outlines how the introduction of the smart-
inhaler raised issues of mistrust, fear of getting 
into trouble & promoted a sense of surveillance 
of young people, both in the healthcare 
relationship and from caregivers  
Describes participants’ experiences of the 
smart-inhaler raising issues of surveillance & 
mistrust & blame in the healthcare relationship 
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Sub-ordinate theme: 
“They Should Put The 
Tracker In Your 
Throat” 
Illustrates the ways some participants viewed 
the smart-inhaler as inadequate at recording 
real life inhaler use 
Highlights participants’ concerns about the 
smart-inhaler's inability to capture inhaler use 
accurately & the need for improved technology 
Theme 3: Who Is 
Responsible? Focuses on participants’ accounts of taking responsibility and ownership for their asthma 
and some of the complexities with this process 
Describes participants’ experiences of YP taking 
responsibility/ caring for their asthma & how the 
smart-inhaler influenced this process 
Sub-ordinate theme: 
“As I’m Older Now She 
Tells Me It’s My 
Responsibility” 
Describes some of the developmental 
expectations that exist around taking 
responsibility for asthma during the period of 
adolescence 
Highlights participants’ beliefs that YP should be 
taking responsibility for their asthma self-care 
Sub-ordinate theme: “It 
Reversed Back To 
Being Us” 
Describes how the introduction of the smart-
inhaler reduced the level of responsibility young 
people possessed for their asthma in most 
cases, & when inhaler use was promoted, this 
was short term 
Describes how the process of being given the 
smart-inhaler reduced YPs responsibility. 
Highlights that the smart-inhaler promotes 
adherence but only in the short-term, raising 
concerns about where responsibility lies; with 
the YP, or the HCP & the smart-inhaler  
